<SEC-DOCUMENT>0001178913-23-002860.txt : 20241204
<SEC-HEADER>0001178913-23-002860.hdr.sgml : 20241204
<ACCEPTANCE-DATETIME>20230814080556
ACCESSION NUMBER:		0001178913-23-002860
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		28
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20230814
DATE AS OF CHANGE:		20230814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		231166423

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2330149.htm
<DESCRIPTION>6-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:cmmb="http://www.anchiano.com/20230630" xmlns:ecd="http://xbrl.sec.gov/ecd/2023"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>Chemomab Therapeutics Ltd. - 1534248 - 2023</title></head><body>
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20230101to20230630"  id="FFact_288" >false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="C_20230101to20230630"  id="FFact_289" >--12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20230101to20230630"  id="FFact_290" >Q2</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20230101to20230630"  id="FFact_292" >0001534248</ix:nonNumeric></ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="cmmb-20230630.xsd"/>
        </ix:references></ix:header></div><div><div style="">
  <div>
    <div style="line-height:1.25">
      <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
    </div>
    <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:400">&#160;</div>
    <div style="text-align:center;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',serif;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>UNITED STATES</span></span></span></span></div>
    <div>
      <div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt">SECURITIES AND EXCHANGE COMMISSION</span><br /><span style="font-size:10pt">Washington, D.C. 20549</span></span></div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt">FORM <ix:nonNumeric id="FFact_1" name="dei:DocumentType" contextRef="C_20230101to20230630">6-K</ix:nonNumeric></span></span></div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br />UNDER THE SECURITIES EXCHANGE ACT OF 1934</span></span></div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the month of August 2023</span></span></div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commission File Number <ix:nonNumeric id="FFact_5" name="dei:EntityFileNumber" contextRef="C_20230101to20230630">001-38807</ix:nonNumeric></span></span></div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16pt;font-weight:bold"><ix:nonNumeric id="FFact_6" name="dei:EntityRegistrantName" contextRef="C_20230101to20230630">CHEMOMAB THERAPEUTICS LTD.</ix:nonNumeric></span><br /><span style="font-size:10pt"><span>(Translation of registrant&#8217;s name into English)</span></span></span></div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonNumeric id="FFact_9" name="dei:EntityAddressAddressLine1" contextRef="C_20230101to20230630">Kiryat Atidim</ix:nonNumeric>, <ix:nonNumeric id="FFact_10" name="dei:EntityAddressAddressLine2" contextRef="C_20230101to20230630">Building 7</ix:nonNumeric>, <ix:nonNumeric id="FFact_11" name="dei:EntityAddressCityOrTown" contextRef="C_20230101to20230630">Tel-Aviv</ix:nonNumeric>, <ix:nonNumeric id="FFact_12" name="dei:EntityAddressCountry" contextRef="C_20230101to20230630" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span></span></div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(Address of principal executive offices)</span></span></div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Form 20-F &#9746;&#160; &#160; &#160; &#160; &#160; &#160;Form 40-F &#9744;</span></span></div>
          <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
            </div>
          </div>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="line-height:1.25">
            <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><br /><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">EXPLANATORY NOTE</span></span></div>
          </div>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="text-align:justify;text-indent:35.9pt;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>This Report of Foreign Private Issuer on Form 6-K (the &#8220;Form 6-K&#8221;) is being furnished by Chemomab Therapeutics Ltd. (the &#8220;Company&#8221;) to the Securities and Exchange Commission (the &#8220;SEC&#8221;) for the sole purposes of: (i) furnishing, as Exhibit 99.1 to this Form 6-K, unaudited condensed consolidated financial statements of the Company as of and for the three and six-months ended <ix:nonNumeric id="Fxbrl_20230811013527039" name="dei:DocumentPeriodEndDate" contextRef="C_20230101to20230630" format="ixt:date-monthname-day-year-en">June 30, <ix:nonNumeric id="Fxbrl_20230811013617502" name="dei:DocumentFiscalYearFocus" contextRef="C_20230101to20230630">2023</ix:nonNumeric></ix:nonNumeric>&#894; </span></span>(ii) furnishing, as Exhibit 99.2 to this Form 6-K, Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, which discusses and analyzes the Company&#8217;s operational and financial condition and results of operations as of and for the three and six-month period ended June 30, 2023; and (iii) furnishing as Exhibit 99.3 to this Form 6-K a press release, dated August 14, 2023, titled &#8220;Chemomab Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Corporate Update&#8221;.</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Exhibits</span></span>&#160;99.1, 99.2 and 99.3 to this Report on Form 6-K shall be deemed to be incorporated by reference into Company&#8217;s Registration Statements on Form S-3 (File No. 333-255658) and Form S-8 (File No. 333-259489 and No. 333-266868).</span></span></span></span></div>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">EXHIBIT INDEX</span></span></div>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:8%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">
                <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Exhibit</span></span></div>
              </td>
              <td style="width:2%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:90%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Description</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:8%;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:normal">
                <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><a href="exhibit_99-1.htm"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">99.1</span></span></a></span></span></div>
              </td>
              <td style="width:2%;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td>
              <td style="width:90%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><a href="exhibit_99-1.htm"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Unaudited Condensed Consolidated Financial Statements for the three and six months ended June 30, 2023</span></span></a></span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:8%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:2%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:90%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:8%;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:normal">
                <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><a href="exhibit_99-2.htm"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">99.2</span></span></a></span></span></div>
              </td>
              <td style="width:2%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:90%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><a href="exhibit_99-2.htm"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></span></a></span></span></div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width:8%;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:normal;color:rgb(0, 0, 0)">&#160;</td>
              <td rowspan="1" style="width:2%;vertical-align:top;font-family:'Times New Roman',Times,serif;color:rgb(0, 0, 0)">&#160;</td>
              <td rowspan="1" style="width:90%;vertical-align:top;font-family:'Times New Roman',Times,serif;color:rgb(0, 0, 0)">&#160;</td>
            </tr>
            <tr>
              <td style="width:8%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:normal"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><a href="exhibit_99-3.htm"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">99.3</span></span></a></span></span></div>
              </td>
              <td style="width:2%;vertical-align:top;font-family:'Times New Roman',Times,serif;color:rgb(0, 0, 0)">&#160;</td>
              <td style="width:90%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><a href="exhibit_99-3.htm"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Press Release dated August 14, 2023 titled &#8220;Chemomab Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Corporate Update&#8221;</span></span></a></span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:8%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:2%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:90%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:8%;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:normal">
                <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">101</span></span></div>
              </td>
              <td style="width:2%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:90%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Interactive data files pursuant to Rule 405 of Regulation S-T: (i) Unaudited Interim Consolidated Balance Sheets, (ii) Unaudited Interim Consolidated Statements of Operations, (iii) Unaudited Interim Consolidated Statements of Comprehensive Loss, (iv) Unaudited Consolidated Statements of Redeemable Convertible Preferred Shares and Changes in Shareholders&#8217; Equity (v) Unaudited Consolidated Statements of Cash Flows and (vi) related notes to these consolidated financial statements.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
            </div>
          </div>
          <div style="line-height:1.25">&#160;<div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SIGNATURE</span></span>
              <p style="margin:0pt">&#160;</p>
            </div>
            <div style="line-height:1.25">
              <div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></span></div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
            </div>
          </div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:47.6%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td colspan="2" style="width:52.4%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">CHEMOMAB THERAPEUTICS LTD.</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:47.6%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:3.48%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:48.92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:47.6%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Date: August 14, 2023</span></span></div>
              </td>
              <td style="width:3.48%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">By:</span></span></div>
              </td>
              <td style="width:48.92%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap">
                <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">/s/ Sigal Fattal</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:47.6%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:3.48%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:48.92%;vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap">
                <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Sigal Fattal</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:47.6%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:3.48%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div>
              </td>
              <td style="width:48.92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Chief Financial Officer</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        </div>
      </div>
    </div>
    <div style="line-height:1.25;color:rgb(33, 37, 41);font-family:Times New Roman, Times, serif">
      <div style="page-break-after:always">
        <hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;width:100%;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
      </div>
    </div>
  </div>
</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:cmmb="http://www.anchiano.com/20230630" xmlns:ecd="http://xbrl.sec.gov/ecd/2023"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>Chemomab Therapeutics Ltd. - 1534248 - 2023</title></head><body>
        <div style="display:none">
        <ix:header><ix:hidden><ix:footnote id="FN20230810010143416" xml:lang="en-US">1 American Depositary Share (ADS) represents 20 Ordinary Shares</ix:footnote>
</ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="cmmb-20230630.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20230101to20230630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230630_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-25</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230630_srtTitleOfIndividualAxis_cmmbDalePfostAndDonaldMarvinMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cmmb:DalePfostAndDonaldMarvinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:unit id="Share"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_per_share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<ix:relationship fromRefs="FFact_78" toRefs="FN20230810010143416"/><ix:relationship fromRefs="FFact_79" toRefs="FN20230810010143416"/><ix:relationship fromRefs="FFact_80" toRefs="FN20230810010143416"/><ix:relationship fromRefs="FFact_81" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20220505093047469" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20220505093055381" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20220719155003261" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20220719155025581" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20220719200901554_Fact_85" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20220719200901554_Fact_84" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230501130254826" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230501130942230" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230501131017943" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230809214010119" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230809214014304" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20220801220211119" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20220801220307005" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230501140723514" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230501141042185" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230809215334095" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230809215336487" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230809215343204" toRefs="FN20230810010143416"/><ix:relationship fromRefs="Fxbrl_20230809215346232" toRefs="FN20230810010143416"/></ix:resources></ix:header></div><div><div style=""> <div><hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" /><div style="margin-top:0pt;margin-bottom:0pt">&#160;</div><div><div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline;font-weight:bold">Exhibit 99.1</span></span></span></div><div style="text-align:right;line-height:1.25">&#160;<div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab Therapeutics Ltd. and its subsidiaries</span></span></div><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div><div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Condensed Consolidated Interim Financial Statements</span></span></div><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div><div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of June 30, 2023</span></span></div><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div><div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Unaudited)</span></span></div></div><div style="line-height:1.25">&#160;</div><div><div style="line-height:1.25">&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab Therapeutics Ltd.</span></span></div><div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and its subsidiaries</span></span></div><div style="line-height:1.25">&#160;</div><div style="line-height:1.25"><div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unaudited Condensed Consolidated Interim Financial Statements as of June 30, 2023</span></span><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="line-height:1.25">&#160;</div><div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contents</span></span></div><div style="line-height:1.25">&#160;</div>&#160;<table border="0" cellpadding="2" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"><tr><td style="width:85%;vertical-align:top">&#160;</td><td style="width:15%;vertical-align:top"><div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Page</span></span></div></td></tr><tr><td style="width:85%;vertical-align:top">&#160;</td><td style="width:15%;vertical-align:top;text-align:right">&#160;</td></tr><tr><td style="width:85%;vertical-align:top"><div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#BalanceSheets_integixAnchor">Condensed Consolidated Interim Balance Sheets</a></span></span></div></td><td style="width:15%;vertical-align:top"><div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div></td></tr><tr><td style="width:85%;vertical-align:top">&#160;</td><td style="width:15%;vertical-align:top;text-align:right">&#160;</td></tr><tr><td style="width:85%;vertical-align:top"><div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#StatementsofOperations_integixAnchor">Condensed Consolidated Interim Statements of Operations</a></span></span></div></td><td style="width:15%;vertical-align:top"><div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div></td></tr><tr><td style="width:85%;vertical-align:top">&#160;</td><td style="width:15%;vertical-align:top;text-align:right">&#160;</td></tr><tr><td style="width:85%;vertical-align:top"><div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#ChangesinEquity_integixAnchor">Condensed Consolidated Interim Statements of Changes in Equity</a></span></span></div></td><td style="width:15%;vertical-align:top"><div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5-6</span></span></div></td></tr><tr><td style="width:85%;vertical-align:top">&#160;</td><td style="width:15%;vertical-align:top;text-align:right">&#160;</td></tr><tr><td style="width:85%;vertical-align:top"><div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#CashFlows_integixAnchor">Condensed Consolidated Interim Statements of Cash Flow</a></span></span></div></td><td style="width:15%;vertical-align:top"><div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div></td></tr><tr><td style="width:85%;vertical-align:top">&#160;</td><td style="width:15%;vertical-align:top;text-align:right">&#160;</td></tr><tr><td style="width:85%;vertical-align:top"><div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#NOTES_integixAnchor">Notes to the Condensed Consolidated Interim Financial Statements</a></span></span></div></td><td style="width:15%;vertical-align:top"><div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8-9</span></span></div></td></tr></table><div style="line-height:1.25">&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">2</span></span></span></div><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div></div></div><div style="">
  <div>
    <div>
      <div>
        <div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Chemomab Therapeutics Ltd.</span></span></span></span></span></span></span></span></div>
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>and its subsidiaries</span></span></span></span></span></span></span></span></div>
        <div style="text-align:right;line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span id="BalanceSheets_integixAnchor"></span> <span><span>Condensed Consolidated Balance Sheets</span></span></span></span></span></span></span></span>
            <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:5pt;margin-top:5pt" />
          </div>
        </div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>In USD thousands (except for share amounts)</span></span></span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table border="0" cellpadding="0" cellspacing="0" style="width:100%" width="100%">

            <tr>
              <td rowspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td rowspan="1" style="vertical-align:top" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="vertical-align:top" valign="bottom">
                <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>June 30,</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;text-align:right" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="vertical-align:top" valign="bottom">
                <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>December&#160;31,</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td rowspan="1" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Note</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>2023</span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;text-align:right" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:right" valign="bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>2022</span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Assets</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td rowspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Unaudited</span></strong></p>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);text-align:right" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:right" valign="bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Audited</span></strong></p>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:top;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:top;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Current assets</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Cash and cash equivalents</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_30" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,382</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_31" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,519</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Short term bank deposits</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_32" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,207</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_33" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,374</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Restricted cash</span></span></span></span></p>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20230501160610892_Fact_30" name="us-gaap:RestrictedCashCurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></strong></span></span></span></span></p>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230501160610892_Fact_31" name="us-gaap:RestrictedCashCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction></span></span></span></span></p>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Other receivables and prepaid expenses</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_34" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,042</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_35" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,766</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Total current assets</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_36" name="us-gaap:AssetsCurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,705</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_37" name="us-gaap:AssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,736</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Non-current assets</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Long term prepaid expenses</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220504175928392" name="us-gaap:PrepaidExpenseNoncurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">646</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_40" name="us-gaap:PrepaidExpenseNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">733</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:top;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Property and equipment, net</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_42" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">338</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_43" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">367</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Operating lease right-of-use assets</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_46" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">160</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_47" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">227</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Total non-current assets</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_48" name="us-gaap:AssetsNoncurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,144</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_49" name="us-gaap:AssetsNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,327</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:4px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Total assets</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_50" name="us-gaap:Assets" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,849</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_51" name="us-gaap:Assets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,063</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Current liabilities</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Trade payables</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_52" name="us-gaap:AccountsPayableTradeCurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,347</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_53" name="us-gaap:AccountsPayableTradeCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,688</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Accrued expenses</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_54" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,503</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_55" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,378</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Employee and related expenses</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_56" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,867</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_57" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,560</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Operating lease liabilities</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_58" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">108</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_59" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Total current liabilities</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_60" name="us-gaap:LiabilitiesCurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,825</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_61" name="us-gaap:LiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,749</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Non-current liabilities</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Operating lease liabilities - long term</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_62" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_63" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">91</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Total non-current liabilities</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_64" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_65" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">91</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Commitments and contingent liabilities</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;text-align:center;background-color:rgb(255, 255, 255)" valign="bottom"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></strong></td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20221108051943260_Fact_64" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20230630" unitRef="USD" xsi:nil="true"></ix:nonFraction></span></span></span></span></span></span></td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20221108051943260_Fact_65" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20221231" unitRef="USD" xsi:nil="true"></ix:nonFraction></span></span></span></span></span></span></td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;padding-bottom:4px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Total liabilities</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_66" name="us-gaap:Liabilities" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,858</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_67" name="us-gaap:Liabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,840</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shareholders' equity (*)</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td rowspan="1" style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td rowspan="1" style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Ordinary shares <ix:nonFraction id="Fxbrl_20220505092446513" name="us-gaap:CommonStockNoParValue" contextRef="C_20221231" unitRef="USD_per_share" scale="0" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="Fxbrl_20220719155003261" name="us-gaap:CommonStockNoParValue" contextRef="C_20230630" unitRef="USD_per_share" scale="0" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> par value - Authorized: <ix:nonFraction id="Fxbrl_20220505092709497" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220719155025581" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20230630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">650,000,000</ix:nonFraction></ix:nonFraction> shares as of&#160; June&#160;30, 2023 and&#160;December 31, 2022;&#160;</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>-</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>-</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td rowspan="1" style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Issued and outstanding: <ix:nonFraction id="Fxbrl_20230810033306000" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20230630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230809214010119" name="us-gaap:CommonStockSharesIssued" contextRef="C_20230630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">248,058,700</ix:nonFraction></ix:nonFraction> Ordinary shares as of June 30, 2023 and <ix:nonFraction id="Fxbrl_20230810033400540" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230809214014304" name="us-gaap:CommonStockSharesIssued" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">232,636,700</ix:nonFraction></ix:nonFraction> as of December 31, 2022;&#160;</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220505093047469" name="us-gaap:CommonStockValue" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220505093055381" name="us-gaap:CommonStockValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td rowspan="1" style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Treasury share at cost (<ix:nonFraction id="Fxbrl_20230526182645930" name="us-gaap:TreasuryStockCommonShares" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230501130254826" name="us-gaap:TreasuryStockCommonShares" contextRef="C_20230630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">11,640,460</ix:nonFraction></ix:nonFraction>&#160;Ordinary shares as of June 30, 2023 and December 31, 2022)</span></span></span></span></span></span></span></p>
              </td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong><span style="color:black">(<ix:nonFraction id="Fxbrl_20230501130942230" name="us-gaap:TreasuryStockValue" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,218</ix:nonFraction></span></strong></span></span></span></span></span></span></p>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></strong></td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="color:black">(<ix:nonFraction id="Fxbrl_20230501131017943" name="us-gaap:TreasuryStockValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,218</ix:nonFraction></span></span></span></span></span></span></span></p>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Additional paid in capital</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_78" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103,751</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_79" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101,260</ix:nonFraction></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Accumulated deficit</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;padding-bottom:2px;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(<ix:nonFraction id="FFact_80" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">80,542</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(<ix:nonFraction id="FFact_81" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">63,819</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></div>
                </div>
              </td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Total shareholders&#8217; equity</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;padding-bottom:2px;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220719200901554_Fact_84" name="us-gaap:StockholdersEquity" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,991</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220719200901554_Fact_85" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,223</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;padding-bottom:4px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Total liabilities and shareholders&#8217; equity</span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;padding-bottom:4px;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:4px double black;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double black;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="FFact_84" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,849</ix:nonFraction></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25">&#160;</div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:4px double black;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double black;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                <div style="line-height:1.25">
                  <div style="line-height:1.25">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20221108131652038" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,063</ix:nonFraction></span></span></span></span></span></span></span></p>
                  </div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
      </div>
    </div>
    <div>
      <div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman, serif;font-size:10pt;color:black">(*)&#160; 1 American Depositary Share (ADS) represents 20 Ordinary Shares</span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;margin-bottom:0pt;margin-top:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="color:black;margin-top:0pt;margin-bottom:0pt">The accompanying notes are an integral part of the condensed consolidated interim financial statements.</span></span></span></div>
        <div style="line-height:1.25">
          <p style="margin:0pt">&#160;</p>
          <p style="text-align:center;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span style="font-weight:normal;font-style:normal">3</span></span></span></span></span></span></span></span></span></p>
        </div>
        <div style="clear:both;margin-top:4pt;margin-bottom:10pt">
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
      </div>
    </div>
  </div>
</div><div style="">
  <div>
    <div>
      <div>
        <div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Chemomab Therapeutics Ltd.</span></span></span></span></div>
        <div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">and its subsidiaries</span></span></span></span></div>
        <div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;font-weight:bold">
            <p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span id="StatementsofOperations_integixAnchor"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Condensed Consolidated Interim Statements of Operations (Unaudited)</span></span></span></span></span></p>
            <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:5pt;margin-top:5pt" />
          </div>
        </div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span>In USD thousands&#160;</span></span>(except for share and per share amounts)</span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table border="0" cellpadding="0" cellspacing="0" style="width:100%;margin:auto">

            <tr>
              <td style="vertical-align:bottom;padding-bottom:2px;height:20px">&#160;</td>
              <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;border-bottom:1.5pt solid black;height:20px">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:center;border-bottom:1.5pt solid black;height:20px">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman, Times, serif;font-size:10pt"><strong><span>Three&#160;months</span></strong></span></p>
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman, Times, serif;font-size:10pt"><strong><span>Ended</span></strong></span></p>
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman, Times, serif;font-size:10pt"><strong>June 30,</strong></span></p>
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><strong><span><span>2023</span></span></strong></span></span></span></p>
                  </div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;height:20px;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;height:20px;text-align:right">&#160;</td>
              <td style="border-bottom:1.5pt solid black;vertical-align:bottom;height:20px;text-align:right">&#160;</td>
              <td style="border-bottom:1.5pt solid black;vertical-align:bottom;height:20px;text-align:right">
                <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>Three&#160;months</strong></span></p>
                <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>Ended</strong></span></p>
                <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>June 30,</strong></span></p>
                <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-family:Times New Roman, Times, serif;font-size:10pt"><strong><span>2022</span></strong></span></p>
              </td>
              <td style="vertical-align:bottom;height:20px;text-align:right">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;border-bottom:1.5pt solid black;height:20px;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:1.5pt solid black;height:20px">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold;text-align:right">
                    <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>Six&#160;months</strong></span></p>
                    <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>Ended</strong></span></p>
                    <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>June 30,</strong></span></p><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><strong><span><span><span>2023</span></span></span></strong></span></span></span>
                  </div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;height:20px;text-align:right">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;border-bottom:1.5pt solid black;height:20px;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:1.5pt solid black;height:20px">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold;text-align:right">
                    <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>Six&#160;months</strong></span></p>
                    <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>Ended</strong></span></p>
                    <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>June 30,</strong></span></p><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><strong><span><span><span>2022</span></span></span></strong></span></span></span>
                  </div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;height:20px">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Operating expenses</span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Research and development</span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230809215223124" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,020</ix:nonFraction></span></span></strong></p>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="text-align:right;width:9%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230809215220236" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,914</ix:nonFraction></span></span></p>
              </td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="FFact_88" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,907</ix:nonFraction></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="FFact_89" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,659</ix:nonFraction></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:9%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:53%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>General and administrative</span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;border-bottom:1.5pt solid black;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;padding-bottom:2px;border-bottom:1.5pt solid black;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230809215231300" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,175</ix:nonFraction></span></span></strong></p>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="border-bottom:1.5pt solid black;width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="text-align:right;border-bottom:1.5pt solid black;width:9%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230809215228919" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,340</ix:nonFraction></span></span></p>
              </td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:1.5pt solid black;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:1.5pt solid black;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="FFact_92" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,337</ix:nonFraction></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:1.5pt solid black;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:1.5pt solid black;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="FFact_93" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,915</ix:nonFraction></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:9%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Total operating expenses</span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230809215241397" name="us-gaap:OperatingExpenses" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,195</ix:nonFraction></span></span></strong></p>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="text-align:right;width:9%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230809215238845" name="us-gaap:OperatingExpenses" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,254</ix:nonFraction></span></span></p>
              </td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="FFact_96" name="us-gaap:OperatingExpenses" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,244</ix:nonFraction></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="FFact_97" name="us-gaap:OperatingExpenses" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,574</ix:nonFraction></span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:9%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:baseline;padding-bottom:2px;width:53%;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Financing expense (income), net</span></span></p>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:baseline;padding-bottom:2px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;padding-bottom:2px;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20230809215250293" name="cmmb:FinanceIncomeExpensesNet" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">259</ix:nonFraction></span></span></strong></p>
              </td>
              <td colspan="1" style="vertical-align:baseline;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)"><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></strong></td>
              <td style="width:1%;vertical-align:baseline;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:baseline;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="text-align:right;width:9%;vertical-align:baseline;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><ix:nonFraction id="Fxbrl_20230809215247462" name="cmmb:FinanceIncomeExpensesNet" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">480</ix:nonFraction></span></span></span></p>
              </td>
              <td style="width:1%;vertical-align:baseline;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:baseline;padding-bottom:2px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(<ix:nonFraction id="Fxbrl_20221026182150611" name="cmmb:FinanceIncomeExpensesNet" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">576</ix:nonFraction></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:baseline;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:baseline;padding-bottom:2px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><ix:nonFraction id="Fxbrl_20230501164940410" name="cmmb:FinanceIncomeExpensesNet" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">264</ix:nonFraction></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:baseline;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:9%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:2px;width:53%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Loss before taxes</span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;padding-bottom:2px;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230809215258235" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,936</ix:nonFraction></span></span></strong></p>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="text-align:right;width:9%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230809215256180" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,734</ix:nonFraction></span></span></p>
              </td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220808224756229" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">16,668</ix:nonFraction></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220808224804527" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,838</ix:nonFraction></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:9%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:baseline;padding-bottom:2px;width:53%;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Taxes on income (benefit) &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></span></p>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:baseline;padding-bottom:2px;border-bottom:1.5pt solid black;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;padding-bottom:2px;border-bottom:1.5pt solid black;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><ix:nonFraction id="Fxbrl_20230809215305931" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34</ix:nonFraction></span></span></span></strong></p>
              </td>
              <td colspan="1" style="vertical-align:baseline;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:baseline;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="border-bottom:1.5pt solid black;width:1%;vertical-align:baseline;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="text-align:right;border-bottom:1.5pt solid black;width:9%;vertical-align:baseline;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20230809215303547" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">544</ix:nonFraction></span></span></p>
              </td>
              <td style="width:1%;vertical-align:baseline;height:20px;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td>
              <td colspan="1" style="text-align:right;vertical-align:baseline;padding-bottom:2px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;border-bottom:1.5pt solid black;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;border-bottom:1.5pt solid black;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220728231430174" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:baseline;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:baseline;padding-bottom:2px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;border-bottom:1.5pt solid black;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;border-bottom:1.5pt solid black;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(<ix:nonFraction id="Fxbrl_20230809224849158" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">544</ix:nonFraction></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:baseline;padding-bottom:2px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:9%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;padding-bottom:4px;width:53%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Net loss for the period</span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;border-bottom:4px double black;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;padding-bottom:4px;border-bottom:4px double black;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230809215314651" name="us-gaap:NetIncomeLoss" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,970</ix:nonFraction></span></span></strong></p>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="border-bottom:4px double black;width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="text-align:right;border-bottom:4px double black;width:9%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230809215311694" name="us-gaap:NetIncomeLoss" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,190</ix:nonFraction></span></span></p>
              </td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:4px double black;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double black;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="FFact_104" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">16,723</ix:nonFraction></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-bottom:4px double black;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double black;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="FFact_105" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,294</ix:nonFraction></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td rowspan="1" style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:9%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td rowspan="1" style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Basic and diluted loss per Ordinary Share (*)</span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_s_20230809215336487" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20230401to20230630" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230809215336487" name="us-gaap:EarningsPerShareBasic" contextRef="C_20230401to20230630" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal">0.036</ix:nonFraction></ix:nonFraction></span></span></strong></p>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="text-align:right;width:9%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_s_20230809215334095" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220401to20220630" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230809215334095" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220401to20220630" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal">0.027</ix:nonFraction></ix:nonFraction></span></span></p>
              </td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20221108042029242" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20230101to20230630" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220801220211119" name="us-gaap:EarningsPerShareBasic" contextRef="C_20230101to20230630" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal">0.076</ix:nonFraction></ix:nonFraction></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20221108042048740" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220101to20220630" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220801220307005" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220101to20220630" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal">0.050</ix:nonFraction></ix:nonFraction></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td rowspan="1" style="vertical-align:bottom;width:53%;height:20px;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Weighted average number of Ordinary Shares outstanding, basic, and diluted (*)</span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_s_20230809215346232" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20230401to20230630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230809215346232" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20230401to20230630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">221,674,130</ix:nonFraction></ix:nonFraction></span></span></strong></p>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="text-align:right;width:9%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_s_20230809215343204" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220401to20220630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230809215343204" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220401to20220630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,173,276</ix:nonFraction></ix:nonFraction></span></span></p>
              </td>
              <td style="width:1%;vertical-align:bottom;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20230501140837133" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20230101to20230630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230501140723514" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20230101to20230630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">221,338,951</ix:nonFraction></ix:nonFraction></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;height:20px;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20230501141120971" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220101to20220630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230501141042185" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220101to20220630" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,132,249</ix:nonFraction></ix:nonFraction></span></span></span></span></div>
              </td>
              <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;height:20px;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>

        </table>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(*) </span></span></span></span><span style="font-size:10pt;font-family:Times New Roman, serif;color:black">1 <span style="font-family:Times New Roman,Times,serif">American Depositary Share (ADS) represents 20 Ordinary Shares</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div>
          <p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">The accompanying notes are an integral part of the condensed consolidated interim financial statements.</span></span></span></span></p>
          <p style="margin:0pt">&#160;</p>
          <p style="text-align:center;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center">4</span></p>
          <div style="clear:both;margin-top:4pt;margin-bottom:10pt">
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</div><div style="">
  <div>
    <div>
      <div>
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Chemomab Therapeutics Ltd.</span></span></span></span></span></div>
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>and its subsidiaries</span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span id="ChangesinEquity_integixAnchor"><span><span>Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</span></span></span></span></span></span>
            <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:5pt;margin-top:5pt" />
          </div>
        </div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In USD thousands (except share amounts)</span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table border="0" cellpadding="0" cellspacing="0" style="width:100%">

            <tr style="background-color:rgb(255, 255, 255)">
              <td rowspan="1" style="vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="6" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px;height:20px">
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>Ordinary</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></div>
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>Shares</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="6" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;border-bottom:2px solid black;height:20px">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong>Treasury<br />share</strong></span></span></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px;height:20px">
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>Additional</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>paid in</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></div>
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>capital</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px;height:20px">
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>Accumulated</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></div>
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>Deficit</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px;height:20px">
                <div style="line-height:1.25;font-weight:bold;border-top:0px">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>Total </span></span></strong></span></span></span></span></span></span></span></span></span></span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>Shareholders&#8217; </span></span></strong></span></span></span></span></span></span></span></span></span></span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>equity</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;height:20px">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td rowspan="1" style="vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px;height:20px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>Number</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px;height:20px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>USD</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;height:20px">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span>Number</span></strong></span></span></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;height:20px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong>USD</strong></span></span></span></span></span></span></span></span></span></span></span></td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px;height:20px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>USD</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px;height:20px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>USD</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;height:20px">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px;height:20px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><strong><span><span>USD</span></span></strong></span></span></span></span></span></span></span></span></span></span></span></td>
              <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;height:20px">&#160;</td>
            </tr>
            <tr style="height:15px;background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255)">
                <div style="line-height:1.25;font-weight:bold;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span>For the six-month period ended on June 30, 2023</span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="2" style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="2" style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td colspan="2" style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="height:15px;background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25;font-weight:bold;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span>Balance as of January 1, 2023</span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25;font-weight:bold;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171142064_xbrl_20220504161436664" name="us-gaap:SharesOutstanding" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">232,636,700 </ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25;font-weight:bold;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171142064_xbrl_20220505093740414" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0px;margin-bottom:0pt;text-align:right;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><strong style="text-align:right"><span>(<ix:nonFraction id="Fxbrl_20230501151602018" name="us-gaap:SharesOutstanding" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal" sign="-">11,640,460</ix:nonFraction></span></strong></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin:0px;text-align:left;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><strong style="text-align:left;margin:0px"><span>)</span></strong></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0px;margin-bottom:0pt;text-align:right;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><strong style="text-align:right"><span>(<ix:nonFraction id="Fxbrl_20230501151611321" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,218</ix:nonFraction></span></strong></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin:0px;text-align:left;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><strong style="text-align:left;margin:0px"><span>)</span></strong></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25;font-weight:bold;text-align:right;border-top:0px">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><strong><span><ix:nonFraction id="Fxbrl_20230501151742804" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101,260</ix:nonFraction></span></strong></span></span></span></span></span></span></span></span></span></p>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25;font-weight:bold;text-align:left;margin:0px;border-top:0px;border-bottom:0px">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin:0px;text-align:left;padding-top:0px">&#160;</p>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25;font-weight:bold;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span style="text-align:right"><span>(</span></span><span><ix:nonFraction id="Fxbrl_20230501152649480" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">63,819</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></span></strong></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255)">
                <div style="line-height:1.25;font-weight:bold;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20230501152914617" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,223</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="height:15px;background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:16%">
                <div style="line-height:1.25;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span>Share-based compensation</span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span style="text-align:right"><span>-</span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171155021_xbrl_20220505093821193" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809235850335" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230501153041825" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171155021_xbrl_20220504161917493" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">484</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171155021_xbrl_20220505093815054" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171155021_xbrl_20220504161939600" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">484</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="height:15px;background-color:rgb(255, 255, 255)">
              <td style="vertical-align:baseline;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255);width:16%">
                <div style="line-height:1.25;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span>Net loss for the year</span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px">
                  <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span>-</span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px">
                  <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220719171210751_xbrl_20220505093843525" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809235858412" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230501153100009" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px">
                  <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220719171210751_xbrl_20220505093847704" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px">
                  <div style="line-height:1.25;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span>(<ix:nonFraction id="Fxbrl_20230501152819814" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,753</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:baseline;padding:0px 0px 1pt;background-color:rgb(255, 255, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(255, 255, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px">
                  <div style="line-height:1.25;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span>(<ix:nonFraction id="Fxbrl_20230501152925490" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,753</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:baseline;padding:0px 0px 1pt;background-color:rgb(255, 255, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></span></td>
            </tr>
            <tr style="height:15px;background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:16%">
                <div style="line-height:1.25;font-weight:bold;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span>Balance as of March 31, 2023</span></span></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px">
                  <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230501152450068" name="us-gaap:SharesOutstanding" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">232,636,700</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px">
                  <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220719171143948_xbrl_20220505093740414" name="us-gaap:StockholdersEquity" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0px;margin-bottom:0pt;text-align:right;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><strong style="text-align:right"><span>(<ix:nonFraction id="Fxbrl_20230501152541868" name="us-gaap:SharesOutstanding" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal" sign="-">11,640,460</ix:nonFraction></span></strong></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px 0px 2.5pt;background-color:rgb(204, 238, 255);width:1%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin:0px;text-align:left;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><strong style="text-align:left;margin:0px"><span>)</span></strong></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0px;margin-bottom:0pt;text-align:right;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><strong style="text-align:right"><span>(<ix:nonFraction id="Fxbrl_20230501152556917" name="us-gaap:StockholdersEquity" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,218</ix:nonFraction></span></strong></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px 0px 2.5pt;background-color:rgb(204, 238, 255);width:1%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin:0px;text-align:left;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><strong style="text-align:left;margin:0px"><span>)</span></strong></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px">
                  <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230501152618776" name="us-gaap:StockholdersEquity" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101,744</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px">
                  <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span>(<ix:nonFraction id="Fxbrl_20230501152728382" name="us-gaap:StockholdersEquity" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">72,572</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:3pt 0px 2.5pt;background-color:rgb(204, 238, 255);width:1%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong style="text-align:left;margin:0px">)</strong></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25;text-align:right;border-top:0px">
                  <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230501152949713" name="us-gaap:StockholdersEquity" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,954 </ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="padding-top:0pt;padding-bottom:0in;height:20px;vertical-align:bottom;background-color:rgb(255, 255, 255);width:16%">
                <p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span style="line-height:115%"><span><span style="line-height:115%">Share-based compensation</span></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>-</span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809235554008" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234301148_xbrl_20220719171155021_xbrl_20220505093821193" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0pt 0px 2.5pt;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234301148_xbrl_20230501153041825" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0pt 0px 2.5pt;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234301148_xbrl_20220719171155021_xbrl_20220504161917493" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">639</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234301148_xbrl_20220719171155021_xbrl_20220505093815054" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0pt 0px 2.5pt;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234301148_xbrl_20220719171155021_xbrl_20220504161939600" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">639</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0pt 0px 0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="padding-top:0in;padding-bottom:0in;height:20px;vertical-align:baseline;background-color:rgb(204, 238, 255);width:16%">
                <p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span style="line-height:115%"><span><span style="line-height:115%">Net loss for the year</span></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>-</span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809235546224" name="us-gaap:NetIncomeLoss" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234310705_xbrl_20220719171210751_xbrl_20220505093843525" name="us-gaap:NetIncomeLoss" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;padding:0px 0px 2.5pt;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234310705_xbrl_20230501153100009" name="us-gaap:NetIncomeLoss" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;padding:0px 0px 2.5pt;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234310705_xbrl_20220719171210751_xbrl_20220505093847704" name="us-gaap:NetIncomeLoss" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>(<ix:nonFraction id="Fxbrl_20230809234310705_xbrl_20230501152819814" name="us-gaap:NetIncomeLoss" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,970</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:baseline;padding:0px 0px 2.5pt;background-color:rgb(204, 238, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>)</span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:baseline;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>(<ix:nonFraction id="Fxbrl_20230809234310705_xbrl_20230501152925490" name="us-gaap:NetIncomeLoss" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,970</ix:nonFraction></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>)</span></span></span></span></span></span></span></td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="padding-top:0in;padding-bottom:0in;height:20px;vertical-align:bottom;background-color:rgb(255, 255, 255);width:16%">
                <p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span style="line-height:115%"><span><span style="line-height:115%">Issuance of shares, net of issuance expenses</span></span></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span><span><ix:nonFraction id="Fxbrl_20230809234322626_xbrl_20230501152450068" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">15,422,000</ix:nonFraction></span></span></strong></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234322626_xbrl_20220719171143948_xbrl_20220505093740414" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234322626_xbrl_20230501152541868" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero" sign="-">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px 0px 2.5pt;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234322626_xbrl_20230501152556917" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero" sign="-">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px 0px 2.5pt;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234322626_xbrl_20230501152618776" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,368</ix:nonFraction></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234322626_xbrl_20230501152728382" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero" sign="-">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px 0px 2.5pt;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234322626_xbrl_20230501152949713" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,368</ix:nonFraction></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="padding-top:0in;padding-bottom:0in;height:20px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:16%">
                <p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span style="line-height:115%"><strong><span><span style="line-height:115%">Balance as of June 30, 2023</span></span></strong></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span><span><ix:nonFraction id="Fxbrl_20230809234317544_xbrl_20230501152450068" name="us-gaap:SharesOutstanding" contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">248,058,700</ix:nonFraction></span></span></strong></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234317544_xbrl_20220719171143948_xbrl_20220505093740414" name="us-gaap:StockholdersEquity" contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <p style="margin-top:0px;margin-bottom:0pt;padding-top:0px;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong style="text-align:right"><span>&#160;(<ix:nonFraction id="Fxbrl_20230809234317544_xbrl_20230501152541868" name="us-gaap:SharesOutstanding" contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal" sign="-">11,640,460</ix:nonFraction></span></strong></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px 0px 2.5pt;background-color:rgb(204, 238, 255);width:1%"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>)</span></span></span></span></span></span></span></strong></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <p style="margin-top:0px;margin-bottom:0pt;padding-top:0px;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong style="text-align:right"><span>(<ix:nonFraction id="Fxbrl_20230809234317544_xbrl_20230501152556917" name="us-gaap:StockholdersEquity" contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,218</ix:nonFraction></span></strong></span></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:4pt 0px 2.5pt;background-color:rgb(204, 238, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span><span>)</span></span></strong></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span><ix:nonFraction id="Fxbrl_20230809234317544_xbrl_20230501152618776" name="us-gaap:StockholdersEquity" contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103,751</ix:nonFraction></span></strong></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>(<ix:nonFraction id="Fxbrl_20230809234317544_xbrl_20230501152728382" name="us-gaap:StockholdersEquity" contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">80,542</ix:nonFraction></span></strong></span></span></span></span></span></span></span></p>
              </td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px 0px 2.5pt;background-color:rgb(204, 238, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span><span>)</span></span></strong></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;padding:0px;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230809234317544_xbrl_20230501152949713" name="us-gaap:StockholdersEquity" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,991</ix:nonFraction></span></span></span></span></span></span></span></td>
              <td style="font-size:10pt;height:20px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The accompanying notes are an integral part of the condensed consolidated interim financial statements.</span></span></p>
        </div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center">
            <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-weight:normal;font-style:normal">5</span></span></span></span></span></span>
          </div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Chemomab Therapeutics Ltd.</span></span></span></span></span></div>
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>and its subsidiaries</span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</span></span></span></span></span>
            <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:5pt;margin-top:5pt" />
          </div>
        </div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In USD thousands (except share amounts)</span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table border="0" cellpadding="0" cellspacing="0" style="width:100%">

            <tr>
              <td rowspan="1" style="padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="6" rowspan="1" style="text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom">
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Ordinary</span></span></span></span></span></span></span></span></span></div>
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" rowspan="1" style="font-weight:bold;padding-bottom:0pt;white-space:nowrap;text-align:center;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="font-weight:bold;padding-bottom:0pt;text-align:center;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom">
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Additional</span></span></span></span></span></span></span></span></span></div>
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>paid in</span></span></span></span></span></span></span></span></span></div>
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>capital</span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" rowspan="1" style="font-weight:bold;padding-bottom:0pt;white-space:nowrap;text-align:center;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="font-weight:bold;padding-bottom:0pt;text-align:center;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom">
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Accumulated</span></span></span></span></span></span></span></span></span></div>
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Deficit</span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" rowspan="1" style="font-weight:bold;padding-bottom:0pt;white-space:nowrap;text-align:center;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="font-weight:bold;padding-bottom:0pt;text-align:center;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="text-align:center;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom">
                <div style="line-height:1.25;font-weight:bold">
                  <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Total </span></span></span></span></span></span></span></span></span></div>
                  <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Shareholders&#8217; </span></span></span></span></span></span></span></span></span></div>
                  <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>equity</span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" rowspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="text-align:center;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom">
                <div style="line-height:1.25;font-weight:bold">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Number</span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>USD</span></span></span></span></span></span></span></span></span></td>
              <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>USD</span></span></span></span></span></span></span></span></span></td>
              <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>USD</span></span></span></span></span></span></span></span></span></td>
              <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="1" rowspan="1" style="text-align:center;font-weight:bold;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom">&#160;</td>
              <td colspan="2" rowspan="1" style="text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>USD</span></span></span></span></span></span></span></span></span></td>
              <td colspan="1" rowspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>For the six-month period ended on June 30, 2022</span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:39%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Balance as of January 1, 2022</span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220504161436664" name="us-gaap:SharesOutstanding" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,090,300</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220505093740414" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220504161607482" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">97,639</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>(<ix:nonFraction id="Fxbrl_20220504161812745" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,173</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220504161847247" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,466</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:39%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Share-based compensation</span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>-</span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220505093821193" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220504161917493" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">874</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220505093815054" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220504161939600" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">874</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="white-space:nowrap;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:39%">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Net loss for the period</span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>-</span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220505093843525" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220505093847704" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>(<ix:nonFraction id="Fxbrl_20220504162015389" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,104</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>(<ix:nonFraction id="Fxbrl_20220504162029289" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,104</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:39%">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>Balance as of March 31, 2022</span></span></span></span></span></span></span></span></span></div>
              </td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220504162054050" name="us-gaap:SharesOutstanding" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,090,300</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220505093917037" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220504162134224" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">98,513</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>(<ix:nonFraction id="Fxbrl_20220504162140381" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,277</ix:nonFraction></span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20220504162145961" name="us-gaap:StockholdersEquity" contextRef="C_20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">57,236</ix:nonFraction></span></span></span></span></span></span></span></div>
                </div>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:39%" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share-based compensation</span></span></span></span></span></p>
              </td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>-</span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809232027512_xbrl_20220505093821193" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809232027512_xbrl_20220504161917493" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">761</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809232027512_xbrl_20220505093815054" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809232027512_xbrl_20220504161939600" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">761</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:39%" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Exercise of options&#160;</span></span></span></span></span></p>
              </td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809234813983" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">542,820</ix:nonFraction></span></span></span></span></span></p>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809234833293" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809234835878" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809234838560" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809234841545" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:39%">
                <p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Net loss for the period</span></span></span></span></span></p>
              </td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>-</span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809232045869_xbrl_20220505093843525" name="us-gaap:NetIncomeLoss" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809232045869_xbrl_20220505093847704" name="us-gaap:NetIncomeLoss" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(<ix:nonFraction id="Fxbrl_20230809232045869_xbrl_20220504162015389" name="us-gaap:NetIncomeLoss" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,190</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>)</span></span></span></span></span></td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230810025638731" name="us-gaap:NetIncomeLoss" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,190</ix:nonFraction></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:39%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Balance as of June 30, 2022</strong></span></span></span></span></span></p>
              </td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:4px double black;border-top:1.5pt solid black;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:4px double black;border-top:1.5pt solid black;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><ix:nonFraction id="Fxbrl_20230809232054352_xbrl_20220504162054050" name="us-gaap:SharesOutstanding" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,633,120</ix:nonFraction></strong></span></span></span></span></span></p>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:4px double black;border-top:1.5pt solid black;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:4px double black;border-top:1.5pt solid black;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809232054352_xbrl_20220505093917037" name="us-gaap:StockholdersEquity" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:4px double black;border-top:1.5pt solid black;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:4px double black;border-top:1.5pt solid black;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><ix:nonFraction id="Fxbrl_20230809232054352_xbrl_20220504162134224" name="us-gaap:StockholdersEquity" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">99,303</ix:nonFraction></strong></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:4px double black;border-top:1.5pt solid black;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:4px double black;border-top:1.5pt solid black;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>(<ix:nonFraction id="Fxbrl_20230809232054352_xbrl_20220504162140381" name="us-gaap:StockholdersEquity" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">47,467</ix:nonFraction></strong></span></span></span></span></span></p>
              </td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>)</strong></span></span></span></span></span></td>
              <td colspan="1" style="text-align:right;padding-bottom:0pt;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="border-bottom:4px double black;border-top:1.5pt solid black;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td colspan="1" style="text-align:right;border-bottom:4px double black;border-top:1.5pt solid black;height:20px;padding-top:0pt;padding-bottom:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230809232054352_xbrl_20220504162145961" name="us-gaap:StockholdersEquity" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,836</ix:nonFraction></span></span></span></span></span></td>
              <td colspan="1" style="padding-bottom:0pt;white-space:nowrap;height:20px;padding-top:0pt;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The accompanying notes are an integral part of the condensed consolidated interim financial statements.</span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-weight:normal;font-style:normal">6</span></span></span></span></span></span></div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
        </div>
      </div>
    </div>
  </div>
</div><div style="">
  <div>
    <div>
      <div>
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Chemomab Therapeutics Ltd.</span></span></span></span></span></span></div>
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>and its subsidiaries</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;font-weight:bold"><span id="CashFlows_integixAnchor"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Condensed Consolidated Interim Statements of Cash flows (Unaudited)</span></span></span></span></span></span></span>
            <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:5pt;margin-top:5pt" />
          </div>
        </div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>In USD thousands</span></span></span></span></span></span></div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                  <tr>
                    <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Six months</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;text-align:right" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Six </span><span><span>months</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>ended</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;text-align:right" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Ended</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>June 30,</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;text-align:right" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>June 30,</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2023</span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;text-align:right" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;text-align:right" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2022</span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash flows from operating activities</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Net loss for the period</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="FFact_193" name="us-gaap:ProfitLoss" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">16,723</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="FFact_194" name="us-gaap:ProfitLoss" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,294</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                    </td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Adjustments for operating activities:</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:top;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Depreciation</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_195" name="us-gaap:Depreciation" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_196" name="us-gaap:Depreciation" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:top;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Share-based compensation</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_205" name="us-gaap:ShareBasedCompensation" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,123</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_206" name="us-gaap:ShareBasedCompensation" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,635</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:top;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Change in other receivables and prepaid expenses</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_197" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">811</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20220719185926153" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,483</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                    </td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:top;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Change in operating lease liability</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20220719190053059" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20230809222022215" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">15</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:top;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Change in trade payables</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_199" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">659</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_200" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">97</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:top;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Change in accrued expenses</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20230501141051534" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">875</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_202" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,157</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Change in employees and related expenses</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20230501141057759" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">307</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold">&#160;</div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_204" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">464</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230810032428783" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,051</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20220719185858022" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,882</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Net cash used in operating activities</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="FFact_209" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14,672</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="FFact_210" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,412</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash flows from investing activities</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Decrease in bank deposits</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_211" name="cmmb:ProceedsFromSaleOfDeposits" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,167</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20220719190124821" name="cmmb:ProceedsFromSaleOfDeposits" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,134</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Purchase of property and equipment</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="FFact_215" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="FFact_216" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                      </div>
                    </td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Net cash provided by investing activities</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_217" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,164</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_218" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,109</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash flows from financing activities</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issuance of Shares, net of issuance expenses&#160;</span></span></span></span></p>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230809221403519_Fact_215" name="cmmb:IssuanceOfSharesNetOfIssuanceCosts" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,368</ix:nonFraction></span></span></span></span></strong></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230809221403519_Fact_216" name="cmmb:IssuanceOfSharesNetOfIssuanceCosts" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exercise of options</span></span></span></span></p>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255);border-bottom:2px solid black" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255);border-bottom:2px solid black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230809221407295_Fact_215" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255);border-bottom:2px solid black" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255);border-bottom:2px solid black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230809221407295_Fact_216" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Net cash provided by financing activities</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_229" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,368</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_230" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Change in cash, cash equivalents and restricted cash</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20230809221912445" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,140</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>)</span></span></strong></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20230501141209877" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,281</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                    </td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash, cash equivalents and restricted cash at beginning of period</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_233" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,596</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_234" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,241</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash, cash equivalents and restricted cash at end of period</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_235" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,456</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="FFact_236" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,960</ix:nonFraction></span></span></span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></span></span></span></span></p>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Receivable related to exercise of options</span></span></span></span></p>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255);border-bottom:4px double black" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255);border-bottom:4px double black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230809221409968_Fact_215" name="cmmb:AccountReceivableDueToExerciseOfOptions" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255);border-bottom:4px double black" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255);border-bottom:4px double black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230809221409968_Fact_216" name="cmmb:AccountReceivableDueToExerciseOfOptions" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></span></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The accompanying notes are an integral part of the condensed consolidated interim financial statements.</span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="font-weight:normal;font-style:normal">7</span></span></span></span></span></span></span></div>
          </div>
        </div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="line-height:1.25">&#160;</div>
</div><div style="">
  <div>
    <div>
      <div>
        <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0px">
          <p style="margin:0pt"><span style="text-decoration-line:underline;font-family:Times New Roman, Times, serif;font-size:10pt">CHEMOMAB THERAPEUTICS LTD AND ITS SUBSIDIARIES</span></p>
        </div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span>&#160;<span style="font-weight:bold;text-decoration:underline">(FORMERLY ANCHIANO THERAPEUTICS LTD.)</span></span></span></span></span></span></span></span></span></span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span id="NOTES_integixAnchor"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span><span><span style="text-decoration:underline">NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20221108050710796" name="us-gaap:NatureOfOperations" contextRef="C_20230101to20230630" escape="true">
          <div>
            <div>
              <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note 1 - General.</span></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <table cellpadding="0" cellspacing="0">

                    <tr style="vertical-align:top">
                      <td style="width:36pt">&#160;</td>
                      <td style="text-align:right;vertical-align:top;width:36pt">
                        <div style="text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">A.</span></span></span></span></span></div>
                      </td>
                      <td style="text-align:left;vertical-align:top;width:auto">
                        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Chemomab Therapeutics Ltd. (the </span></span>&#8220;<span><span>Company") is an Israeli-based company incorporated under the laws of the State of Israel in September 2011. The </span></span>Company&#8217;s<span><span> registered office is located in Kiryat Atidim, Tel Aviv, Israel. The Company is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis. The wholly owned subsidiaries of the Company are: Chemomab Ltd. ("Chemomab"), Chemomab Therapeutics Israel Ltd. and Chemomab Therapeutics Inc.</span></span></span></span></div>
                        <div style="text-align:justify">&#160;</div>
                        <div>
                          <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company currently has no products approved for sale. The Company&#8217;s operations are funded primarily by its Shareholders. The Company has incurred operating losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval for its products. Continuation of the Company&#8217;s development programs depend on its future ability to raise sources of financing. The Company believes that its existing liquidity resources as of June 30, 2023, will enable it to fund its operations through December 31, 2024 with the ability to perform cost reductions in order to extend the operations even further, if required to do so.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="text-indent:-36pt;margin-left:72pt;line-height:1.25;font-weight:bold">&#160;</div>
              <table cellpadding="0" cellspacing="0">

                  <tr>
                    <td style="width:36pt">&#160;</td>
                    <td style="width:36pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>B.</span></span></span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On April 30, 2021, the Company entered into an At the Market Offering Agreement (the "ATM Agreement") with Cantor Fitzgerald &#38; Co., ("Cantor"). According to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $<ix:nonFraction id="Fxbrl_20230810001855292" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="C_20230101to20230630_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">75</ix:nonFraction> million through Cantor or the ATM Agreement. On April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance and sale of up to $<ix:nonFraction id="Fxbrl_20230810001930712" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">18,125,000</ix:nonFraction> of its ADSs in connection with the reactivation of the ATM Agreement Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject to certain exceptions, limits the amount of securities the Company is able to offer and sell under such registration statement to one-third of the Company's unaffiliated public float. From April 30, 2021, through June 30, 2023, the Company issued <ix:nonFraction id="Fxbrl_20230810002052582" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="C_20230101to20230630_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,470,906</ix:nonFraction> ADSs under the ATM Agreement, resulting in gross proceeds of $<ix:nonFraction id="Fxbrl_20230810002107131" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="C_20230101to20230630_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,327</ix:nonFraction> thousand.</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0">

                  <tr>
                    <td style="width:36pt">&#160;</td>
                    <td style="width:36pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>C.</span></span></span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On June 1, 2023, the board of directors </span></span>(the &#8220;Board&#8221;)<span><span> of the Company appointed Dr. Adi Mor as Chief Executive Officer of the Company (to replace Dr. Dale Pfost), and Sigal Fattal as the Chief Financial Officer of the Company (to replace Donald Marvin), effective as of the same date. The company has recorded in June 2023 a provision for severance payments to Dale Pfost and Donald Marvin in the amount of $<ix:nonFraction id="Fxbrl_20230810014738513" name="us-gaap:SeveranceCosts1" contextRef="C_20230101to20230630_srtTitleOfIndividualAxis_cmmbDalePfostAndDonaldMarvinMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,110</ix:nonFraction> thousand.</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <p style="margin:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:8pt;margin-bottom:5pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">8</span></span></p><div style="clear:both"><hr style="page-break-after:always;border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:5pt;margin-bottom:10pt" /></div><p style="margin:0px 0pt 0pt;text-align:center">&#160;</p><p style="margin:0px 0pt 0pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="text-decoration:underline"><strong>CHEMOMAB THERAPEUTICS LTD AND ITS SUBSIDIARIES<br />(FORMERLY ANCHIANO THERAPEUTICS LTD)<br />NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS</strong></span></span></span></p>
      </div>
    </div>
  </div>
  <div>
    <div>
      <div>
        <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right">&#160;</div>
      </div>
    </div>
  </div>
</div><div style="">
  <div style="margin-top:0pt">
    <ix:nonNumeric id="Fxbrl_20220505134338955" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_20230101to20230630" escape="true">
      <div>
        <div>
          <div>
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif">Note 2 -&#160; Basis of Presentation and Significant Accounting Policies</span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20221108051936803" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_20230101to20230630" escape="true">
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                      <tr style="vertical-align:top">
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">A.</span></span></span></span></div>
                        </td>
                        <td style="vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis of Preparation</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;line-height:normal;font-family:Times New Roman, serif">The condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#8217;s financial position as of June 30, 2023, and its results of operations for the six months ended June 30, 2023, and 2022, changes in shareholders&#8217; equity for the six months ended June 30, 2023 and 2022, and cash flows for the six months ended June 30, 2023 and 2022. The results of operations for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other future annual or interim period. These financial statements should be read in conjunction with the audited financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022. The Company&#8217;s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2022 included in the Company&#8217;s Annual Report on Form 10-K. Since the date of such financial statements, there have been no changes to the Company&#8217;s significant accounting policies.</span></p>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20221108051959534" name="us-gaap:UseOfEstimates" contextRef="C_20230101to20230630" escape="true">
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                      <tr style="vertical-align:top">
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">B.</span></span></span></span></div>
                        </td>
                        <td style="vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Use of estimates</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></p>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
  </div>
  <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">
    <p style="margin:0pt">&#160;</p>
  </div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20220728222325384" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_20230101to20230630" escape="true">
    <div>
      <div>
        <div>
          <div>
            <div>
              <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note 3 - Contingencies</span></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>During 2022, the Israeli tax authority ("ITA&#8221;) notified the Company that it had initiated a routine VAT audit to include tax years 2017 through 2020. The ITA raised several claims, mainly in respect with the recoverability of VAT with respect to Merger Agreement related expenses and the classification of the Company as a holding company. On July 2022, the ITA proposed a settlement, which the Company rejected. As a result, the ITA issued an assessment.&#160;On November 2022, The Company appealed the ITA&#8217;s assessment. The Company has recorded a provision in 2022 that is inherently subjective due to the inherent uncertainty of these matters and the judicial process. Therefore, the outcome may differ from the estimated liability recorded by the Company during 2022. &#160;</span></span></span></div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <div style="text-align:center"><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:normal;font-style:normal;color:rgb(0, 0, 0)">9</span></span></span></span></span>
    <hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;width:100%;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
  </div>
  <div style="clear:both;margin-top:0pt;margin-bottom:10pt">&#160;</div>
</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
      <div style="text-align: right;"><font style="font-weight: bold;"><u>Exhibit 99.2</u> </font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">CAUTIONARY NOTE ABOUT FORWARD-LOOKING STATEMENTS</font>&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">This Report on Form 6-K contains forward-looking statements. All statements other than statements of historical fact are
          &#8220;forward-looking statements&#8221; for purposes of this Report on Form 6-K. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from
          any future results, performance or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms including &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221;
          &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or the negative of these terms or other similar expressions. Forward-looking statements reflect our current views with respect to future events and are
          based on assumptions and subject to risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without
          limitation, the risks set forth under the caption &#8220;Risk Factors&#8221; below, which are incorporated herein by reference as well as those business risks and factors described elsewhere in this report and in our other filings with the Securities and
          Exchange Commission (the &#8220;SEC&#8221;), specifically our most recent Annual Report on Form 10-K filed with the SEC on March 20, 2023 (the &#8220;2022 Annual Report&#8221;), our Quarterly Reports on Form 10-Q and our filed Reports on Form 8-K and/or Form 6-K. All
          forward-looking statements speak only as of the date made, and we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">CERTAIN TERMS USED IN THIS CURRENT REPORT ON FORM 6-K</font>&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">As used in this Current Report on Form 6-K, unless the context otherwise requires:</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z0fd579ab920541f2a52c213a83170123">

          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 92%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">references to &#8220;Chemomab Therapeutics Ltd.&#8221;, &#8220;Chemomab,&#8221; the &#8220;Company,&#8221; &#8220;us,&#8221; &#8220;we&#8221; and &#8220;our&#8221; refer to Chemomab Therapeutics Ltd. an Israeli Company and its consolidated subsidiaries,
                although with respect to the presentation of financial results for historical periods that preceded the Merger (as defined below), these terms refer to the financial results of Chemomab Ltd., which was the accounting acquirer in the Merger;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z51ec3579ba5849eaaf2564195f965b51">

          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 92%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">references to &#8220;ordinary shares,&#8221; &#8220;our shares&#8221; and similar expressions refer to the Company&#8217;s ordinary shares, no nominal (par) value;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="zbe5376e7f1844721a4fd9e16ba152e6e">

          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 92%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">references to &#8220;ADS&#8221; refer to the American Depositary Shares listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;CMMB,&#8221; each representing twenty (20) ordinary shares;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="zf4b94cc20cd94c509e4221e66bb40c31">

          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 92%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">references to &#8220;dollars,&#8221; &#8220;U.S. dollars&#8221; and &#8220;$&#8221; are to U.S. Dollars;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="zb7be2eb75f804b8ab51c6e54eb5fcdbc">

          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 92%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">references to &#8220;NIS&#8221; are to New Israeli Shekels;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z18bf6d70de504fe98ba6a7492df58736">

          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 92%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">references to the &#8220;SEC&#8221; are to the U.S. Securities and Exchange Commission; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z802b61fab01440d991680a4d92f8681c">

          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 92%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">references to the &#8220;Merger&#8221; refer to the merger involving Anchiano Therapeutics Ltd. and Chemomab Ltd., whereby a wholly owned subsidiary of Anchiano Therapeutics Ltd. merged with and into
                Chemomab Ltd., with Chemomab Ltd. surviving as a wholly owned subsidiary of Anchiano Therapeutics Ltd. Upon consummation of the Merger, Anchiano Therapeutics Ltd. changed its name to &#8220;Chemomab Therapeutics Ltd.&#8221; and the business conducted
                by Chemomab Ltd. became primarily the business conducted by the Company.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">OPERATING AND FINANCIAL REVIEW AND PROSPECTS</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Company Overview</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chemomab is a clinical-stage biotechnology Company focused on the discovery and development of innovative therapeutics for fibrotic
          and inflammatory diseases with high unmet needs. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody designed to bind and block CCL24 activity.
          CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chemomab has pioneered the therapeutic targeting of CCL24, a chemokine that promotes various types of cellular processes that
          regulate inflammatory and fibrotic activities through the CCR3 receptor. The chemokine is expressed in various types of cells, including immune cells, endothelial cells and epithelial cells. We have developed a novel CCL24 inhibiting product
          candidate with dual anti-fibrotic and anti-inflammatory activity that modulates the complex interplay of both of these inflammatory and fibrotic mechanisms, which drive abnormal states of fibrosis and clinical fibrotic diseases. This innovative
          approach is being developed for difficult-to-treat rare diseases, also known as orphan indications or diseases, such as primary sclerosing cholangitis (&#8220;PSC&#8221;), and systemic sclerosis (&#8220;SSc&#8221;), for which patients have no established
          disease-modifying or standard-of-care treatment options. We estimate that there are approximately 77 thousand patients suffering from PSC in the U.S., EU and Japan, representing over a $1 billion market opportunity, and approximately 170 thousand
          patients suffering from SSc in those same markets, representing over a $1.5 billion market opportunity.</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">CM-101, our lead clinical product candidate, is a first-in-class humanized monoclonal antibody that attenuates the basic function of
          the soluble chemokine CCL24, also known as eotaxin-2, as a regulator of major inflammatory and fibrotic pathways. We have demonstrated that CM-101 interferes with the underlying biology of inflammation and fibrosis through a novel and
          differentiated mechanism of action. We are currently conducting a Phase 2 clinical study in PSC, a rare obstructive and cholestatic liver disease. The study is actively recruiting patients in the U.S., Europe and Israel and enrollment is going
          well. The study design includes a two doses of CM-101 vs placebo (10 or 20mg/kg), as well as an open label extension. A topline readout of initial trial results is expected in the second half of 2024.</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">In SSc, Chemomab has suspended initiation of the Phase 2 trial while it focuses resources on successfully
            completing the Phase 2 PSC study.&#160; The CM-101 SSc clinical program is Phase 2-ready and the Company believes that CM-101 could have disease-modifying potential in this poorly treated condition. Although our primary focus is on these two rare
            indications, The Company reported topline results from an additional Phase 2 clinical study in patients with liver fibrosis due to non-alcoholic steatohepatitis, or NASH, in January of this year.&#160; This trial provided safety and pharmacokinetic
            (&#8220;PK&#8221;) data and information useful for assessing the Company&#8217;s current subcutaneous formulation of CM-101. Additionally, the trial measured a number of biomarkers that may be relevant to the potential activity of CM-101 in other
            fibro-inflammatory conditions. The initial trial results showed that the trial met its primary endpoint of safety and tolerability, and that CM-101 demonstrated encouraging activity in secondary endpoints that include a range of liver fibrosis
            biomarkers and physiologic assessments. A more recent secondary analysis confirming and extending these initial results was reported at the 2023 EASL Congress in July 2023.</div>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Fibrosis is the abnormal and excessive accumulation of collagen and extracellular matrix, the non-cellular component in all tissues
          and organs, which provides structural and biochemical support to surrounding cells. When present in excessive amounts, collagen and extracellular matrix lead to scarring and thickening of connective tissues, affecting tissue properties and
          potentially leading to organ dysfunction and failure. Fibrosis can occur in many different tissues, including lung, liver, kidney, muscle, skin, and the gastrointestinal tract, resulting in a wide array of progressive fibrotic conditions.
          Fibrosis and inflammation are intrinsically linked. While a healthy inflammatory response is necessary for efficient tissue repair; after disease or injury, an excessive, uncontrolled inflammatory response can lead to tissue fibrosis that in turn
          can further stimulate inflammatory processes in a fibro-inflammatory vicious cycle.&#160;</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Recent Developments</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic; font-weight: bold;">&#160;New Executive Appointments and Extension of Cash Runway through Year-End 2024</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">On June 5, 2023, Chemomab announced that Adi Mor, PhD, co-founder and former Chief Executive Officer (CEO), and then Director and Chief Scientific
            Officer, had been reappointed to the role of CEO, replacing&#160;Dale Pfost, PhD.&#160;Sigal Fattal, former Chief Financial Officer (CFO) and then Vice President, Finance, had been reappointed to the role of CFO, replacing&#160;Donald Marvin. Nissim Darvish,
            MD, PhD, was appointed Chairman of the Board, replacing Dr. Pfost. All the appointments were effective&#160;June 1, 2023. The Company also announced that it was implementing additional cost-reduction measures, which extended&#160; its cash runway from
            mid-year 2024 to the end of 2024, after the expected topline data readout from the Phase 2 CM-101 PSC trial.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic; font-weight: bold;">Reported Secondary Analyses of CM-101 Phase 2 Liver Fibrosis Trial in NASH Patients</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On June 21, 2023, Chemomab reported topline results from secondary analyses of its Phase 2a liver fibrosis trial assessing CM-101 in
          patients with non-alcoholic steatohepatitis (NASH). The results were included in a late-breaking poster presentation at the 2023 EASL Congress.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>Overall, the data showed improvements across an additional set of inflammatory and fibrotic
          biomarkers that are consistent with the clinical results Chemomab released in January. Additionally, in NASH patients at greater risk of disease progression, CM-101 treatment resulted in a greater biomarker response than in NASH patients with
          lower risk disease or in placebo-treated patients. The new analyses<font style="font-weight: bold;">&#160;</font>assessed additional biomarkers and also used the FibroScan-AST (FAST) score to categorize study patients based on progressive disease
          risk. The results showed that:</div>
        <div style="line-height: 1.25;">&#160;<br>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zac750521e1a846db9d0b531f5468a77e">

              <tr>
                <td style="width: 36pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>FAST scores were improved in a higher proportion of CM-101-treated patients than in placebo patients.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z510a7c7970014d6589d3213d9c3978d0">

              <tr>
                <td style="width: 36pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>CM-101-treated patients with higher FAST scores demonstrated greater improvements in key fibro-inflammatory biomarkers than patients with lower FAST scores or placebo patients.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">In these secondary analyses, CM-101-treated patients showed improvements in an additional set of biomarkers
            associated with active fibrosis and inflammation including AST/ALT ratio, Neutrophil-to-Lymphocyte Ratio (NLR), FIB-4, and PRO-C3. Some of these biomarker scores were&#160; even further improved in CM-101-treated patients with higher FAST scores. It
            is noteworthy that as an overall indicator of fibrogenesis and fibrotic disease, PRO-C3 may also be viewed a &#8220;bridge&#8221; to PSC and other anti-fibrotic indications.</div>
        </div>
        <div style="line-height: 1.25;">&#160;<br>
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic; font-weight: bold;">Reported Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for PSC</div>
          <div style="line-height: 1.25;">&#160;</div>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">The Company presented two posters at the 2023 EASL Congress discussing the potential of CM-101 as a novel
            treatment for PSC. One of the posters reported on a new proteomic study demonstrating a direct relationship between the pro-inflammatory, pro-fibrotic activity of CCL24 and PSC disease-related pathways.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>The other poster described the
            clinical design of Chemomab&#8217;s double-blind, placebo-controlled, multiple dose Phase 2 trial of CM-101 in PSC patients. These followed a data presentation at the 2023 EASL Biliary Conference in May 2023, reinforcing the proinflammatory role of
            CCL24 in cholestatic disease.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic; font-weight: bold;">Published Peer-Reviewed Research Article Demonstrating the Key Role of CCL24 in PSC</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On June 28, 2023, Chemomab reported publication of a peer-reviewed research article in the June issue of the respected journal&#160; <font style="font-style: italic;">JCI Insight</font>. It was produced through collaborations with prominent academic groups and supports the key role of CCL24 in driving the self-perpetuating fibrosis and inflammation that result in the severe liver
          damage characterizing PSC.</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Corporate Information</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">We were incorporated on September 22, 2011, under the laws of the State of Israel. In March 2021, in connection
            with the Merger, we changed our name from Anchiano Therapeutics Ltd. to Chemomab Therapeutics Ltd. Our principal executive offices are located at Kiryat Atidim, Building 7, Tel Aviv, Israel 6158002, and our phone number is +972-77-331-0156. Our
            website is:&#160;<font style="font-style: italic;">www.chemomab.com.</font>&#160;</div>
        </div>
        <div style="line-height: 1.25;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Comparison of Period-to-Period Results of Operations</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The following tables summarize our results of operations in dollars and as a percentage of our total revenues for the periods
        indicated. The period-to-period comparison of results is not necessarily indicative of results for future periods.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">Components of Operating Results</font>&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Revenues</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">To date, we have not generated any revenue. We do not expect to generate revenue unless and until we obtain
            regulatory approval and commercialize a product candidate, or until we receive revenue from a collaboration such as a co-development or out-licensing agreement. There can be no assurance that we will receive such regulatory approvals, and if
            any product candidate is approved, that we will be successful in commercializing it<font style="font-style: italic;">.</font></div>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Research and Development Expenses</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Research and development expenses consist primarily of costs incurred in connection with the development of our product candidates.
          These expenses include:</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="za89d2483e19e493e9e57d21301d2129f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">&#8226;</font></div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">expenses incurred under agreements with contract research organizations or contract manufacturing organizations, as well as
                      investigative sites and consultants that conduct our clinical trials, preclinical studies and other scientific development services;</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf521a9fe6b7c40389d35bc67c3d003bd" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">&#8226;</font></div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">manufacturing scale-up expenses and the cost of acquiring and manufacturing preclinical and clinical trial materials;</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z3f043b2ff74f4601a1a1c7fc1174ee57" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">&#8226;</font></div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">employee-related expenses, including salaries, related benefits, travel and share-based compensation expenses for employees
                      engaged in research and development functions, as well as external costs, such as fees paid to outside consultants engaged in such activities;</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="za4e08824faa1413986d894914ef6bae7" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">&#8226;</font></div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">license maintenance fees and milestone fees incurred in connection with various license agreements;</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7d4784b05dad4e198e66b2b5bac5edff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">&#8226;</font></div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">costs related to compliance with regulatory requirements; and</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zff5078369ae44d628eec4041863922c0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">&#8226;</font></div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">depreciation and other expenses.</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We recognize external development costs based on an evaluation of the progress to completion of specific tasks using information
          provided to us by our service providers.</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We do not allocate costs of employees who are not engaged directly in Research and development or facility expenses, including
          depreciation or other indirect costs, to specific programs because these costs are deployed across multiple programs and, as such, are not separately classified. We use our internal resources primarily to oversee research, as well as for managing
          our preclinical development, process development, manufacturing and clinical development activities. Our employees work across multiple programs and, therefore, we do not track costs by program.</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Research and development activities are fundamental to our business. Product candidates in later stages of clinical development
          generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. As a result, we expect that our research and development expenses will
          increase substantially over the next several quarters and years as we continue to advance the development of our product candidates. We also expect to incur additional expenses related to milestone and royalty payments payable to third parties
          with whom we have entered into license agreements to acquire the rights to its product candidates.</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic; font-weight: bold;">General and Administrative Expenses</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">General and administrative expenses consist primarily of salaries, related benefits and share-based compensation expenses for
          personnel in executive and administrative functions. General and administrative expenses also include professional fees for legal, consulting, accounting and audit services.</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We anticipate that our general and administrative expenses will increase in the future as we increase headcount and general
          activities to support our continued research activities and development of our product candidates as well as expanding our presence in the United States. We also anticipate that we will incur increased headcount, accounting, audit, legal,
          regulatory, compliance, director and officer insurance costs, as well as investor and public relations expenses associated with being a public Company. We expect that the additional costs for these services will substantially increase our general
          and administrative expenses. Additionally, if and when we believe that regulatory approval of a product candidate appears likely, we expect to incur an increase in payroll and related expenses as a result of our preparation for commercial
          operations, especially as it relates to the sales and marketing of any product candidate.</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">Results of Operations</font>&#160;</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic; font-weight: bold;">Three and Six Months Ended June 30, 2023 Compared to the Three and Six Months Ended June 30, 2022</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Below is a summary of our results of operations for the periods indicated:</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-style: italic;">Three Months ended June 30, 2023 compared to the three months ended June 30, 2022</font><br>
          &#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" class="cfttable" id="zc60ae34a8b274ef3bed96ac79125d41a" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Three months ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"> June 30,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Increase/(decrease)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2023</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">%</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-style: italic;">(in thousands)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;">Operating expenses:</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-align: justify; text-indent: 10pt; line-height: 1.25;">Research and development</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">5,020</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">2,914</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">2,106</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">72.3</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">%</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 52%;">
              <div style="text-align: justify; text-indent: 10pt; line-height: 1.25;">General and administrative</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">3,175</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">3,340</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(165</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(4.9</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-align: justify; line-height: 1.25;">Operating loss</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(8,195</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(6,254</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(1,941</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">31</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">%</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 52%;">
              <div style="text-align: justify; text-indent: 10pt; line-height: 1.25;">Financing expense (Income), net</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(259</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">480</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(739</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">154</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">%</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
              <div style="text-align: justify; line-height: 1.25;">Income Tax (benefit)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">34</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(544</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">578</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(106.3</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
              <div style="line-height: 1.25;">)%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 52%; padding-bottom: 4px;">
              <div style="text-align: justify; line-height: 1.25;">Net loss</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(7,970</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(6,190</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(1.,780</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">28.8</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">%</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-style: italic;">Six Months ended June 30, 2023 compared to the six months ended June 30, 2022</font><br>
          &#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" class="cfttable" id="zb04ab10bf9254b33a3f9b0fc012c0b3f" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Six months ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"> June 30,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Increase/(decrease)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2023</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">%</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-style: italic;">(in thousands)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;">Operating expenses:</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-align: justify; text-indent: 10pt; line-height: 1.25;">Research and development</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">11,907</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">5,659</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">6,248</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">110</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 52%;">
              <div style="text-align: justify; text-indent: 10pt; line-height: 1.25;">General and administrative</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">5,337</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">5,915</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(578</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(9.8</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-align: justify; line-height: 1.25;">Operating loss</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(17,244</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(11,574</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(5,670</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">49</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 52%;">
              <div style="text-align: justify; text-indent: 10pt; line-height: 1.25;">Financing expense (Income), net</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(576</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">264</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(840</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(318.2</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
              <div style="text-align: justify; line-height: 1.25;">Income Tax (benefit)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">55</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(544</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">599</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">110.1</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 52%; padding-bottom: 4px;">
              <div style="text-align: justify; line-height: 1.25;">Net loss</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(16,723</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(11,294</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(5,429</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">48</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Our results of operations have varied in the past and can be expected to vary in the future due to numerous factors. We believe
          that period-to-period comparisons of our operating results are not necessarily meaningful and should not be relied upon as indications of future performance.</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-style: italic;">Research and development expenses</font>&#160;</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Research and development expenses increased by approximately $2.1 million, or 72%, for the three months ended June 30, 2023, as
          compared to the same period in 2022. The increase was primarily due to increased clinical activities.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Research and development expenses increased by approximately $6.2 million, or 110%, for the six months ended June 30, 2023, as
          compared to the same period in 2022 also due primarily to increased clinical and preclinical activities.</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">&#160;General and administrative expenses&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;"> <br>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">General and administrative expenses decreased by approximately $0.2 million, or 5%, for the three months ended June 30, 2023,
          compared to the same period in 2022. The decrease was primarily due to decrease in insurance expenses of $0.1 million and provision for expenses recorded in the three months ended June 30, 2022 related to an audit by the Israeli Tax Authority.
          The decrease was offset by an increase in legal expenses for the three months ended June 30, 2023.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">General and administrative expenses decreased by approximately $0.6 million, or 9.8%, for the six months ended June 30, 2023, as
          compared to the same period in 2022. The decrease was primarily due to decrease in D&amp;O insurance expenses of $0.2 million and a decrease of share-based expenses of $0.5 million and provision for expenses recorded in the six months ended June
          30, 2022, which related to an audit by the Israeli Tax Authority. The decrease was offset by increase in legal expenses in the six months ended June 30, 2023.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-style: italic;">Financing expenses/income, net</font>&#160;</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-indent: 37.5pt; line-height: 1.25;">Financing income, net for the three months ended June 30, 2023 was $259 thousand, compared to financing expense, net of $480 thousand in the same period in 2022. The change was mainly due to
            foreign currency exchange rate gain for the three months ended June 30, 2023, compared to foreign currency exchange rate loss (offset by interest on deposits) for the three months ended June 30, 2022.</div>
        </div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-indent: 37.5pt; line-height: 1.25;">Financing income, net for the six months ended June 30, 2023 was $264 thousand, compared to financing expense, net of $576 thousand in the same period in 2022. The change was mainly due to
            foreign currency exchange rate gain for the six months ended June 30, 2023, compared to foreign currency exchange rate loss (offset by interest on deposits) for the six months ended June 30, 2022.</div>
        </div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">Liquidity and Capital Resources</font>&#160;</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Since inception, we have not generated any revenue and have incurred significant operating losses and negative cash flows from our
          operations, resulting in an accumulated deficit as of June 30, 2023 of $80.5 million. We have funded our operations to date primarily with proceeds from the sale of our ADSs, and, prior to the Merger, other equity securities. Cash in excess of
          immediate requirements is invested primarily with a view to liquidity and capital preservation.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-indent: 37.5pt; line-height: 1.25;">
            <div style="text-indent: 37.5pt; line-height: 1.25;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                <div style="text-indent: 37.5pt; line-height: 1.25;">During the period from April 30, 2021 through June 30, 2023, we sold an aggregate of 1,470,906 ADSs
                  pursuant to Sales Agreement, dated April 30, 2021 with Cantor Fitzgerald &amp; Co. for a total gross consideration of $17.3 million. As of June 30, 2023, we had an aggregate of approximately $26.7 million of cash, cash equivalents and
                  short-term deposits.</div>
                <div style="line-height: 1.25">&#160;</div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Developing product candidates, conducting clinical trials and commercializing products are expensive, and we will need to raise
          substantial additional funds to achieve our strategic objectives. We believe that our existing cash resources, will be sufficient to fund our projected cash requirements through December 31, 2024. Nevertheless, we will require significant
          additional financing in the future to fund our operations, including if and when we progress into additional clinical trials, obtain regulatory approval for any of our product candidates and commercialize the same. We believe that we will need to
          raise significant additional funds before we have any cash flow from operations, if at all. Our future capital requirements will depend on many factors, including:</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z20b15b0ef97c4bff840c89ea995c0586">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the progress and costs of our preclinical studies, clinical trials and other research and development activities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z676873ce7c2c4a2cbc7146e799e0c120">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the scope, prioritization and number of our clinical trials and other research and development programs;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="za178e5d0bd52452ba4c1027197e35401">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the amount of revenues and contributions we receive under future licensing, development and commercialization arrangements with respect to our product candidates;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z0b1b21689c764e27810928decfebf38f">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the costs of the development and expansion of our operational infrastructure;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zbe28aa27ed5e47fda34243e79423c7c8">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the costs and timing of obtaining regulatory approval for our product candidates;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z1a455ea521a54797bab8283706d1523c">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zb9da32daa47c408fad40cedcd3be7c66">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the costs and timing of securing manufacturing arrangements for clinical or commercial production;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="ze3b7bc48fa4b459794e9ba202228d108">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the costs of contracting with third parties to provide sales and marketing capabilities for us;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zeed4441ed5d94f18b3d3729331a6f096">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the costs of acquiring or undertaking development and commercialization efforts for any future products, product candidates or platforms;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z6d0e197d7b6346c4a7c17b35ab1ecb7f">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the magnitude of our general and administrative expenses; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z0b341ad1aff14b519805fe02164c5172">

            <tr>
              <td style="width: 55.5pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any cost that we may incur under future in- and out-licensing arrangements relating to our product candidates.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We currently do not have any commitments for future external funding. In the future, we will need to raise additional funds, and
          we may decide to raise additional funds even before we need such funds if the conditions for raising capital are favorable. Until we can generate significant recurring revenues, we expect to satisfy our future cash needs through debt or equity
          financings, credit facilities or by out-licensing applications of our product candidates, or other strategic options. The sale of equity or convertible debt securities may result in dilution to our existing shareholders. The incurrence of
          indebtedness would result in increased fixed obligations and could also subject us to covenants that restrict our operations. We cannot be certain that additional funding, whether through grants from the Israel Innovation Authority, financings,
          credit facilities or out-licensing arrangements, will be available to us on acceptable terms, if at all. If sufficient funds are not available, we may be required to delay, reduce the scope of or eliminate research or development plans for, or
          commercialization efforts with respect to, one or more applications of our product candidates, or obtain funds through arrangements with collaborators or others that may require us to relinquish rights to certain potential products that we might
          otherwise seek to develop or commercialize independently.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold; font-style: italic;">Cash Flows</font>&#160;</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The table below shows a summary of our cash flow activities for the six months ended June 30, 2023 compared to the six months ended
          June 30, 2022:</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" class="cfttable" id="ze02930df9114496394a04880124efd47" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Six months ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"> June 30,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Increase/(decrease)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2023</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25;"> <font style="font-weight: bold;">$</font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">%</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-style: italic;">(in thousands)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 52%;">
              <div style="text-align: justify; line-height: 1.25;">Net cash used in operating activities</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(14,672</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(9,412</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">(5,260</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">55.9</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">%</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-align: justify; line-height: 1.25;">Net cash provided by (used in) investing activities</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">10,164</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">4,109</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">6,055</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">147</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">%</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 52%; padding-bottom: 2px;">
              <div style="text-align: justify; line-height: 1.25;">Net cash provided by financing activities</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">1,368</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">22</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">1,346</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">6,118</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">%</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
              <div style="text-align: justify; line-height: 1.25;">Net (decrease) in cash, cash equivalents and restricted cash</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(3,140</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">(5,281</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">2,141</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">59.5</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">%</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;">Operating activities</font>&#160;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25;">Net cash used in operating activities decreased by $5.3 million, or 55.9%, for the six months ended June 30 2023 compared to the same period in 2022. The decrease was primarily
        related to an increase in net loss of $5.4 million.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;">Investing activities</font>&#160;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25;">Net cash provided by investing activities for the six months ended June 30, 2023 increased by approximately $6 million compared to same period in 2022. The increase is
        primarily related to a decrease in short term bank deposits.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-style: italic;">Financing activities</font>&#160;</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-indent: 37.5pt; line-height: 1.25;">Net cash provided by financing activities for the six months ended June 30, 2023 increased by approximately $1.3 million, compared to the same period in 2022. The increase is primarily related
            to proceeds from the issuance of ADSs, net, in the six months ended June 30, 2023.</div>
        </div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">Critical Accounting Policies</font>&#160;</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Company&#8217;s financial statements are prepared in accordance with generally accepted accounting principles in the United States
          (&#8220;GAAP&#8221;). The preparation of the Company&#8217;s financial statements and related disclosures in accordance with GAAP requires it to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and
          the disclosure of contingent assets and liabilities in the Company&#8217;s financial statements. The Company bases its estimates on historical experience, known trends and events and various other factors that it believes are reasonable under the
          circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company evaluates its estimates and assumptions on an ongoing basis.
          The Company&#8217;s actual results may differ from these estimates under different assumptions or conditions.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">While the Company&#8217;s significant accounting policies are described in more detail in Note 2 to the Company&#8217;s consolidated financial
          statements included elsewhere in the 2022 Annual Report, the Company believes that the following accounting estimates are those that include a higher degree of judgment or complexity and are reasonably likely to have a material impact on our
          financial condition or results of operations and are therefore considered critical accounting estimates.</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-style: italic;">Share-Based Compensation</font>&#160;</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We apply Accounting Standard Codification (ASC) 718-10, &#8220;Share-Based Payment,&#8221; which requires the measurement and recognition of
          compensation expenses for all share-based payment awards made to employees and directors, including employee options under Chemomab&#8217;s option plans based on estimated fair values.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">ASC 718-10 requires that we estimate the fair value of equity-based payment awards on the date of grant using an option-pricing
          model. The fair value of the award is recognized as an expense over the requisite service periods in Chemomab&#8217;s statements of comprehensive loss. Chemomab recognizes share-based award forfeitures as they occur, rather than estimate by applying a
          forfeiture rate.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In June 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2018-07,
          &#8220;Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting&#8221;, which simplifies the accounting for nonemployee share-based payment transactions by aligning the measurement and classification guidance,
          with certain exceptions, to that for share-based payment awards to employees. The amendments expand the scope of the accounting standard for share-based payment awards to include share-based payment awards granted to non-employees in exchange for
          goods or services used or consumed in an entity&#8217;s own operations and supersedes the guidance related to equity-based payments to non-employees. We adopted these amendments on January 1, 2019.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We recognize compensation expenses for the fair value of non-employee awards over the requisite service period of each award.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We estimate the fair value of options granted as equity awards using a Black-Scholes options pricing model. The option-pricing
          model requires a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from the grant date until the options are exercised or expire). The Company determines the fair
          value per share of the underlying stock by taking into consideration its most recent sales of stock, as well as additional factors that the Company deems relevant. The Company&#8217;s board determined the fair value of ordinary shares based on
          valuations performed using the Option Pricing Method subject to relevant facts and circumstances. The Company has historically been a private Company and lacks Company-specific historical and implied volatility information of its stock. Expected
          volatility is estimated based on volatility of similar companies in the biotechnology sector. The Company has historically not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from
          governmental zero-coupon bonds with an equivalent term. The expected option term is calculated for options granted to employees and directors using the &#8220;simplified&#8221; method. Grants to non-employees are based on the contractual term. Changes in the
          determination of each of the inputs can affect the fair value of the options granted and the results of operations of the Company.</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">Recently-Issued Accounting Pronouncements</font>&#160;</div>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 37.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Certain recently-issued accounting pronouncements are discussed in Note 2, Summary of Significant Accounting Policies, to the
          audited consolidated financial statements in our 2022 Annual Report.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit_99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"> <u><font style="font-weight: bold;">Exhibit 99.3</font></u></div>
    <div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><img width="189" height="53" src="image00002.jpg"></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Chemomab Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Corporate Update</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-style: italic;">&#9472;On Track to Achieve CM-101 PSC Phase 2 Readout Expected in 2H2024&#8212;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-style: italic;">&#9472;Extended Estimated Cash Runway Through PSC Readout and 2024 Year-End&#9472;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-style: italic;">&#9472;Reported Positive Secondary Analysis of Data from CM-101 Phase 2 Liver Fibrosis Trial&#9472;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-style: italic;">&#9472;Successfully Implemented Senior Management Changes and Cost Saving Measures&#9472;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-style: italic;">&#9472;Published New Peer-Reviewed Articles and Presented Scientific Posters at European Medical Meetings Highlighting </div>
      <div style="text-align: center; line-height: 1.25; font-style: italic;">Therapeutic Potential of CM-101 for Treating Fibro-inflammatory Diseases&#9472;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">TEL AVIV, Israel, August 14, 2023</font>&#160;<font style="font-weight: bold;">&#9472; </font>Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company
        developing innovative therapeutics to treat rare fibro-inflammatory diseases with high unmet need, today announced financial and operating results for the second quarter ended June 30, 2023, and provided a corporate update.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">&#8220;I am pleased to report that the company continued to make good progress during the&#160; second quarter,&#8221; said Adi Mor, PhD, co-founder, Chief Executive Officer and Chief Scientific Officer of Chemomab. &#8220;In June, the Board
        of Directors re-appointed me to the CEO position and re-appointed then Vice President of Finance Sigal Fattal as Chief Financial Officer. Our extensive prior experience in these roles and ongoing active involvement in company management have made
        for a seamless transition.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Dr. Mor continued, &#8220;During the quarter we sharpened our corporate strategy. We extended our cash runway to take us through the end of 2024 and the readout of topline results from our Phase 2 trial of CM-101 in patients
        with primary sclerosing cholangitis (PSC), expected in the second half of 2024. Extension of the cash runway was achieved by tightening our focus and selectively pruning expenses. Enrollment in the PSC trial continues to go very well and we are
        pleased to have the resources on-board to take us through this major milestone. In addition, we are increasingly optimistic about the potential prospects for the PSC program based on additional positive biomarker data from our Phase 2 liver
        fibrosis trial that may also be applicable to PSC. As part of our strategic refresh, we suspended the planned start of our Phase 2 systemic sclerosis (SSc) trial; however, we remain enthusiastic that CM-101 may have disease-modifying potential in
        this poorly-treated condition and the SSc program remains fully Phase 2-ready.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Dr. Mor added, &#8220;The second quarter was notable for our many scientific presentations at important European medical meetings like EASL and EULAR. We also published a research article in a respected peer-reviewed
        journal, <font style="font-style: italic;">JCI Insight</font>. As a group, the studies reinforce our extensive data highlighting the central role of CCL24 in the pathophysiology of fibro-inflammatory diseases and confirm that our
        CCL24-neutralizing antibody, CM-101, has potential therapeutic utility in these conditions.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">&#8220;Promising new data from secondary analyses of our Phase 2 liver fibrosis trial in NASH patients was presented in a late-breaking poster at the 2023 EASL Congress in July. The new results show encouraging improvements
        in additional inflammatory and fibrogenesis-related biomarkers. Overall, the improvements in biomarkers seen in the Phase 2 liver fibrosis trial reinforce our belief that these data may serve as a potential bridge to other anti-fibrotic indications
        such as PSC, providing additional evidence that CM-101 could be a valuable therapy for this potentially fatal disease that lacks effective treatment options.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Corporate Developments</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Implemented Executive Changes</div>
      <div style="line-height: 1.25;">In June, Chemomab announced that Adi Mor, PhD, co-founder and former Chief Executive Officer (CEO), and then Director and Chief Scientific Officer, had been reappointed to the role of CEO, replacing&#160;Dale Pfost,
        PhD.&#160;Sigal Fattal, former Chief Financial Officer (CFO) and then Vice President, Finance, had been reappointed to the role of CFO, replacing&#160;Donald Marvin. Nissim Darvish, MD, PhD, was appointed Chairman of the Board, replacing Dr. Pfost. All the
        appointments were effective&#160;June 1, 2023.&#160;The company also announced that it was implementing additional cost-reduction measures that extend its cash runway from mid-year 2024 to the end of 2024, after the expected topline data readout from the
        Phase 2 CM-101 PSC trial.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Presented Data at 2023 EASL Biliary Conference Reinforcing the Proinflammatory Role of CCL24 in Cholestatic Disease</div>
      <div style="line-height: 1.25;">In a poster presentation at the 2023 EASL Biliary Conference in May, researchers used patient proteomic and animal data to demonstrate the proinflammatory role of CCL24 in cholestatic disease. In these studies, CM-101
        demonstrated an anti-inflammatory effect by interfering with the migration of monocytes and neutrophils to the damaged biliary area in a PSC animal model, thereby reducing fibrosis and biliary hyperplasia.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">Presented</font>&#160;<font style="font-weight: bold;">Patient Data at 2023 EULAR Congress Showing that Serum CCL24 Levels Can Predict Vascular and Fibrotic Complications of Systemic
          Sclerosis</font></div>
      <div style="line-height: 1.25;">In a poster presentation at the 2023 EULAR European Congress of Rheumatology in June, researchers presented results from a patient sample study demonstrating that high serum levels of CCL24 were correlated with SSc
        severity, including a higher incidence of fibrosis-associated symptoms; a three-fold increased risk of interstitial lung disease progression; and a shorter SSc-related 5-year survival time.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Reported Secondary Analyses of CM-101 Phase 2 Liver Fibrosis Trial</div>
      <div style="line-height: 1.25;">In a late-breaking poster presentation at the 2023 EASL Congress in July, Chemomab reported secondary analysis data from its Phase 2a liver fibrosis trial of CM-101 in patients with non-alcoholic steatohepatitis
        (NASH). The data showed improvements across an additional set of inflammatory and fibrotic biomarkers that are consistent with the positive topline clinical results Chemomab released in January. Additionally, in NASH patients at greater risk of
        disease progression, CM-101 treatment resulted in a greater biomarker response than in patients with lower risk disease or in placebo-treated patients.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Reported Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for PSC</div>
      <div style="line-height: 1.25;">At the 2023 EASL Congress in July, Chemomab presented two posters discussing the potential of CM-101 as a novel treatment for PSC. One of the posters reported on a new proteomic study demonstrating a direct
        relationship between the pro-inflammatory, pro-fibrotic activity of CCL24 and PSC disease-related pathways.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>The other poster described the clinical design of Chemomab&#8217;s double-blind, placebo-controlled, multiple dose Phase 2 trial of
        CM-101 in PSC patients.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Published Peer-Reviewed Research Article Demonstrating the Key Role of CCL24 in PSC</div>
      <div style="line-height: 1.25;">This peer-reviewed research article published in the June issue of <font style="font-style: italic;">JCI Insight</font> was produced through collaborations with prominent academic groups and supports the key role of
        CCL24 in driving the self-perpetuating fibrosis and inflammation that result in the severe liver damage characterizing PSC.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Second Quarter 2023 Financial Highlights</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb84dc4f15b8a4b11bb03ed1669132a8f">

          <tr>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top;">
              <div><font style="font-weight: bold;">Cash Position:&#160;</font>Cash, cash equivalents and short-term bank deposits were $26.7 million as of June 30, 2023, compared to $32.8 million on March 31, 2023.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z436f22ab53b940f68153204df53cd636">

          <tr>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top;">
              <div><font style="font-weight: bold;">Research and Development (R&amp;D) Expenses: </font>R&amp;D expenses were $5.0 million for the second quarter ended June 30, 2023, compared to $2.9 million for the same quarter in 2022. The increase was
                primarily due to increased clinical activities.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze6b33ff75ff74869aa0a15976f41bf23">

          <tr>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top;">
              <div><font style="font-weight: bold;">General and Administrative (G&amp;A) Expenses</font>: G&amp;A expenses were $3.2 million for the quarter ended June 30, 2023, compared to $3.3 million for the same quarter in 2022.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc2dddc94cd924371985a6f305f72d1d2">

          <tr>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top;">
              <div><font style="font-weight: bold;">Net Loss</font>: Net loss was $8.0 million, or a net loss of approximately $0.04 per basic and diluted ordinary share for the second quarter of 2023, compared to a net loss of $6.2 million, or a net loss
                of approximately $0.03 per basic and diluted ordinary share for the second quarter of 2022. The weighted average number of ordinary shares outstanding, basic and diluted, was 221,674,130 (equal to approximately 11.1 million ADSs) for the
                quarter ended June 30, 2023.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-weight: bold;">About Chemomab Therapeutics Ltd.</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique and pivotal role of CCL24 in promoting fibrosis and
          inflammation, Chemomab developed CM-101, a monoclonal antibody designed to neutralize CCL24 activity. In preclinical and clinical studies, CM-101 appears safe, with the potential to treat multiple severe and life-threatening fibro-inflammatory
          diseases. Chemomab has reported encouraging results from three clinical trials of CM-101 in patients, including a Phase 2 liver fibrosis trial and an investigator-initiated study in patients with severe lung injury. A Phase 2 trial in primary
          sclerosing cholangitis patients is ongoing, with topline data expected in the second half of 2024. For more information about Chemomab, visit <u>chemomab.com</u>.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-weight: bold;">Forward Looking Statements</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements include, among other things, statements regarding the
          clinical development pathway for CM-101; the future operations of Chemomab and its ability to successfully initiate and complete clinical trials and achieve regulatory milestones; the Company&#8217;s cash position and expectations regarding its ability
          to achieve the topline data readout from the Phase 2 primary sclerosing cholangitis (PSC) trial of CM-101 with its current cash; the nature, strategy and focus of Chemomab; the development and commercial potential and potential benefits of any
          product candidates of Chemomab; and that the product candidates have the potential to address high unmet needs of patients with serious fibrosis-related diseases and conditions. Any statements contained in this communication that are not
          statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based upon Chemomab's current expectations. Forward-looking statements involve risks and uncertainties. Because such statements
          deal with future events and are based on Chemomab's current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Chemomab could differ materially from those described in or implied
          by the statements in this presentation, including those found under the caption "Risk Factors" and elsewhere in Chemomab's filings and reports with the SEC. Chemomab expressly disclaims any obligation or undertaking to release publicly any
          updates or revisions to any forward-looking statements contained herein to reflect any change in Chemomab's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based, except as
          required by law.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25; font-weight: bold;">Contacts:</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za1ae1fb20c8d4656a58a9eb3bc4624cc">

          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">Media and Investors:</div>
              <div style="line-height: 1.25;">Barbara Lindheim<br>
              </div>
              <div style="line-height: 1.25;">Consulting Vice President, Investor &amp; </div>
              <div style="line-height: 1.25;">Public Relations, Strategic Communications</div>
              <div style="line-height: 1.25;">Phone: +1 917-355-9234</div>
              <div style="line-height: 1.25;"><u>barbara.lindheim@chemomab.com </u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><u>IR@chemomab.com</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chemomab Therapeutics Ltd. and its subsidiaries</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-weight: bold;">Condensed Consolidated Balance Sheets
          <hr align="center" style="height: 1px; width: 100%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div style="line-height: 1.25;">In USD thousands (except for share amounts)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" class="cfttable" id="zaa814ab833ef4a2b9b9db129c7b6df07" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

            <tr>
              <td valign="bottom" style="vertical-align: top;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;"> June 30,</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2023</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;"><br>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Unaudited</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Audited</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">Assets</div>
              </td>
              <td valign="bottom" rowspan="1" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" rowspan="1" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" rowspan="1" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" rowspan="1" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">Current assets</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
                <div style="line-height: 1.25;">Cash and cash equivalents</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25; font-weight: bold;">10,382</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25;">13,519</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">Short term bank deposits</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">16,207</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">26,374</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
                <div style="line-height: 1.25;">Restricted cash</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25; font-weight: bold;">74</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25;">77</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">Other receivables and prepaid expenses</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">1,042</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">1,766</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">Total current assets</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">27,705</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">41,736</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
                <div style="line-height: 1.25; font-weight: bold;">Non-current assets</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">Long term prepaid expenses</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">646</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;"><font style="font-weight: bold;"></font>733</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: top; width: 76%;">
                <div style="line-height: 1.25;">Property and equipment, net</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25; font-weight: bold;">338</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25;"><font style="font-weight: bold;"></font>367</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">Operating lease right-of-use assets</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">160</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">227</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;" rowspan="1">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">Total non-current assets</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">1,144</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;"><font style="font-weight: bold;"></font>1,327</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">Total assets</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">28,849</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">43,063</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">Current liabilities</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
                <div style="line-height: 1.25;">Trade payables</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25; font-weight: bold;">2,347</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25;">1,688</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">Accrued expenses</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">2,503</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">3,378</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
                <div style="line-height: 1.25;">Employee and related expenses</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25; font-weight: bold;">1,867</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25;">1,560</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">Operating lease liabilities</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">108</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">123</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">Total current liabilities</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">6,825</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">6,749</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">Non-current liabilities</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                <div style="line-height: 1.25;">Operating lease liabilities - long term</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">33</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">91</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                <div style="line-height: 1.25; font-weight: bold;">Total non-current liabilities</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">33</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">91</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
                <div style="line-height: 1.25; font-weight: bold;">Commitments and contingent liabilities</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                <div style="line-height: 1.25; font-weight: bold;">Total liabilities</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">6,858</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">6,840</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
                <div style="line-height: 1.25; font-weight: bold;">Shareholders' equity (*)</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: middle; width: 76%;">
                <div style="line-height: 1.25;"><font style="font-weight: bold;">Ordinary shares no par value</font> - Authorized: 650,000,000 shares as of&#160; June 30, 2023 and December 31, 2022;</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">Issued and outstanding: 248,058,700 Ordinary shares as of June 30, 2023 and 232,636,700 as of December 31, 2022;</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%;">
                <div style="line-height: 1.25;">Treasury share at cost (11,640,460 Ordinary shares as of June 30, 2023 and December 31, 2022)</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25; font-weight: bold;">(1,218</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
                <div style="line-height: 1.25; font-weight: bold;">)</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="line-height: 1.25;">(1,218</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
                <div style="line-height: 1.25;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">Additional paid in capital</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">103,751</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">101,260</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                <div style="line-height: 1.25;">Accumulated deficit</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">(80,542</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">)</div>
                </div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">(63,819</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">)</div>
                </div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                <div style="line-height: 1.25; font-weight: bold;">Total shareholders&#8217; equity</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">21,991</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">36,223</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25; font-weight: bold;">Total liabilities and shareholders&#8217; equity</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25; font-weight: bold;">28,849</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">43,063</div>
                </div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">(*) 1 American Depositary Share (ADS) represents 20 Ordinary Shares</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: right; line-height: 1.25;">Chemomab Therapeutics Ltd. and its subsidiaries</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-weight: bold;">Condensed Consolidated Interim Statements of Operations (Unaudited)
          <hr align="center" style="height: 1px; width: 100%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div style="line-height: 1.25;">In USD thousands (except for share and per share amounts)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" class="cfttable" id="zb3ffed99943d4d7f9abc2efbb52be274" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">Three months</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">Three months</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">Six months</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">Six months</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25;"><font style="font-weight: bold;"> June 30</font>,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25;"><font style="font-weight: bold;">June 30</font>,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25;"><font style="font-weight: bold;">June 30</font>,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">
              <div style="text-align: right; line-height: 1.25;"><font style="font-weight: bold;">June 30</font>,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25; font-weight: bold;"> 2023</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25; font-weight: bold;">2022</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25; font-weight: bold;">2023</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25; font-weight: bold;">2022</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Operating expenses</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Research and development</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">5,020</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">2,914</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">11,907</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">5,659</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">General and administrative</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">3,175</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">3,340</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">5,337</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">5,915</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Total operating expenses</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">8,195</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">6,254</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">17,244</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">11,574</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Financing expense (income), net</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">(259</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">480</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">(576</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">264</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Loss before taxes</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">7,936</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">6,734</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">16,668</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">11,838</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Taxes on income (benefit)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">34</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(544</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">55</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(544</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Net loss for the period</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">7,970</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">6,190</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">16,723</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">11,294</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" class="cfttable" id="z2511f47e76804f1e8c1ac056b1b24c02" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Basic and diluted loss per Ordinary Share (*)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">0.036</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">0.027</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">0.076</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">0.050</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" rowspan="1" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Weighted average number of Ordinary Shares outstanding, basic, and diluted (*)</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">221,674,130</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">228,173,276</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">221,338,951</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">228,132,249</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"></div>
      <div style="line-height: 1.25;">(*) 1 American Depositary Share (ADS) represents 20 Ordinary Shares</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    </div>
    <div> <br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cmmb-20230630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:cmmb="http://www.anchiano.com/20230630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" targetNamespace="http://www.anchiano.com/20230630" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
  <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets" id="StatementCondensedConsolidatedBalanceSheets">
        <link:definition>0002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
        <link:definition>0003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations" id="StatementUnauditedCondensedConsolidatedStatementsOfOperations">
        <link:definition>0004 - Statement - Condensed Consolidated Interim Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity" id="InterimStatementsOfChangesInEquity">
        <link:definition>0005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows" id="StatementUnauditedCondensedConsolidatedStatementsOfCashFlows">
        <link:definition>0006 - Statement - Condensed Consolidated Interim Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/General." id="General.">
        <link:definition>0007 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies" id="BasisOfPresentationAndSignificantAccountingPolicies">
        <link:definition>0008 - Disclosure - Basis of Presentation and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/Contingencies" id="Contingencies">
        <link:definition>0009 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" id="BasisOfPresentationAndSignificantAccountingPoliciesPolicies">
        <link:definition>0011 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/General.Details" id="General.Details">
        <link:definition>0013 - Disclosure - General (Detail Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AccountReceivableDueToExerciseOfOptions" id="cmmb_AccountReceivableDueToExerciseOfOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AccruedShareIssuanceExpenses" id="cmmb_AccruedShareIssuanceExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmericanDepositarySharesMember" id="cmmb_AmericanDepositarySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmericanDepositorySharesMember" id="cmmb_AmericanDepositorySharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" id="cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" id="cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" id="cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" id="cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CarrybackNetOperatingLosses" id="cmmb_CarrybackNetOperatingLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CashAcquiredInReverseRecapitalization" id="cmmb_CashAcquiredInReverseRecapitalization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DalePfostAndDonaldMarvinMember" id="cmmb_DalePfostAndDonaldMarvinMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectOfReverseCapitalizationTransaction" id="cmmb_EffectOfReverseCapitalizationTransaction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EffectOfReverseCapitalizationTransactionShares" id="cmmb_EffectOfReverseCapitalizationTransactionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EstimatedFairValueOfNetAssetsAcquired" id="cmmb_EstimatedFairValueOfNetAssetsAcquired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FinanceIncomeExpensesNet" id="cmmb_FinanceIncomeExpensesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FormerChemomabSecurityHoldersMember" id="cmmb_FormerChemomabSecurityHoldersMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesNetOfIssuanceCosts" id="cmmb_IssuanceOfSharesNetOfIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" id="cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" id="cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NatureOfOperationsDisclosureAbstract" id="cmmb_NatureOfOperationsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAdsIssuedAndOutstandingAfterMerger" id="cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesConsistedInDS" id="cmmb_NumberOfOrdinarySharesConsistedInDS" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" id="cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesDilutedAfterMerger" id="cmmb_NumberOfSharesDilutedAfterMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OneEmployeeOneOfficerConsultantAndSixBoardMember" id="cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesMember" id="cmmb_OrdinarySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesNoParValuePerShareMember" id="cmmb_OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentsToPurchaseOfDeposits" id="cmmb_PaymentsToPurchaseOfDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ProceedsFromSaleOfDeposits" id="cmmb_ProceedsFromSaleOfDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RepurchaseArrangementMember" id="cmmb_RepurchaseArrangementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RepurchaseOfAmericanDepositaryReceipts" id="cmmb_RepurchaseOfAmericanDepositaryReceipts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RetainedEarningsAccumulatedDeficits" id="cmmb_RetainedEarningsAccumulatedDeficits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" id="cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareholdingPercentageImmediatelyFollowingMerger" id="cmmb_ShareholdingPercentageImmediatelyFollowingMerger" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesConvertiblePerShareOfAcquireeEntity" id="cmmb_SharesConvertiblePerShareOfAcquireeEntity" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantIssuedDuringPeriodNewIssues" id="cmmb_StockAndWarrantIssuedDuringPeriodNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantsIssuedDuringPeriodValueNewIssues" id="cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TwoThousandFifteenPlanMember" id="cmmb_TwoThousandFifteenPlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsExercisablePeriod" id="cmmb_WarrantsExercisablePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>cmmb-20230630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#StatementUnauditedCondensedConsolidatedStatementsOfOperations" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#StatementUnauditedCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_RestrictedCashCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsNoncurrent_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_6" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_7" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_9" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_10" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12" xlink:to="loc_us-gaap_Liabilities_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13" xlink:to="loc_us-gaap_LiabilitiesCurrent_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_14" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_15" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_16" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_18" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_18" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_18" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12" xlink:to="loc_us-gaap_CommitmentsAndContingencies_21" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12" xlink:to="loc_us-gaap_StockholdersEquity_22" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22" xlink:to="loc_us-gaap_CommonStockValue_22" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22" xlink:to="loc_us-gaap_TreasuryStockValue_23" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22" xlink:to="loc_us-gaap_AdditionalPaidInCapital_24" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_25" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xlink:to="loc_cmmb_FinanceIncomeExpensesNet_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xlink:to="loc_us-gaap_OperatingExpenses_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_3" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_ProceedsFromSaleOfDeposits" xlink:label="loc_cmmb_ProceedsFromSaleOfDeposits_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_PaymentsToPurchaseOfDeposits" xlink:label="loc_cmmb_PaymentsToPurchaseOfDeposits_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_16"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_ShareBasedCompensation_8" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_11" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" xlink:to="loc_cmmb_ProceedsFromSaleOfDeposits_12" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" xlink:to="loc_cmmb_PaymentsToPurchaseOfDeposits_13" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15" xlink:to="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_15" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_16" order="10" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>cmmb-20230630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#InterimStatementsOfChangesInEquity" roleURI="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#General.Details" roleURI="http://www.anchiano.com/role/General.Details"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_dei_NoTradingSymbolFlag_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_39"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_AmericanDepositarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentType_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCentralIndexKey_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentPeriodEndDate_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentFiscalYearFocus_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_AmendmentFlag_13" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentQuarterlyReport_14" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentTransitionReport_15" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityFileNumber_16" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityRegistrantName_17" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_18" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityTaxIdentificationNumber_19" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine1_20" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine2_21" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressCityOrTown_22" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressPostalZipCode_23" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressCountry_24" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_CityAreaCode_25" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_LocalPhoneNumber_26" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityInformationFormerLegalOrRegisteredName_27" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_Security12bTitle_28" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_TradingSymbol_29" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_NoTradingSymbolFlag_30" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_SecurityExchangeName_31" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCurrentReportingStatus_32" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_33" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityFilerCategory_34" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntitySmallBusiness_35" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_36" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityExTransitionPeriod_37" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityShellCompany_38" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_39" order="330" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaap_TreasuryStockCommonMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_TreasuryStockCommonMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquity_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_SharesOutstanding_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_12" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_13" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetIncomeLoss_14" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_15" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_16" order="80" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.Details">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" xlink:label="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_DalePfostAndDonaldMarvinMember" xlink:label="loc_cmmb_DalePfostAndDonaldMarvinMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmericanDepositorySharesMember" xlink:label="loc_cmmb_AmericanDepositorySharesMember_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_34"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_FormerChemomabSecurityHoldersMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_DalePfostAndDonaldMarvinMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_PlanNameAxis_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_12" xlink:to="loc_us-gaap_PlanNameDomain_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_12" xlink:to="loc_cmmb_TwoThousandFifteenPlanMember_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_12" xlink:to="loc_us-gaap_PlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_16" xlink:to="loc_us-gaap_ClassOfStockDomain_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_16" xlink:to="loc_cmmb_AmericanDepositorySharesMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_16" xlink:to="loc_cmmb_OrdinarySharesMember_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_16" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_RangeAxis_21" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_21" xlink:to="loc_srt_RangeMember_21" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_21" xlink:to="loc_srt_MinimumMember_21" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_21" xlink:to="loc_srt_MaximumMember_22" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_21" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_26" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_26" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" xlink:to="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_26" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_26" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_31" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_32" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_33" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SeveranceCosts1_34" order="40" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>cmmb-20230630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AccountReceivableDueToExerciseOfOptions" xlink:label="loc_cmmb_AccountReceivableDueToExerciseOfOptions_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AccountReceivableDueToExerciseOfOptions" xlink:label="loc_cmmb_AccountReceivableDueToExerciseOfOptions_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AccountReceivableDueToExerciseOfOptions" xlink:label="loc_cmmb_AccountReceivableDueToExerciseOfOptions_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AccountReceivableDueToExerciseOfOptions" xlink:label="loc_cmmb_AccountReceivableDueToExerciseOfOptions_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AccruedShareIssuanceExpenses" xlink:label="loc_cmmb_AccruedShareIssuanceExpenses_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AccruedShareIssuanceExpenses" xlink:label="loc_cmmb_AccruedShareIssuanceExpenses_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmericanDepositorySharesMember" xlink:label="loc_cmmb_AmericanDepositorySharesMember_9"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmericanDepositorySharesMember" xlink:label="loc_cmmb_AmericanDepositorySharesMember_10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmericanDepositorySharesMember" xlink:label="loc_cmmb_AmericanDepositorySharesMember_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_17"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_18"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_19"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_21"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_22"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_23"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_CarrybackNetOperatingLosses" xlink:label="loc_cmmb_CarrybackNetOperatingLosses_24"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_CarrybackNetOperatingLosses" xlink:label="loc_cmmb_CarrybackNetOperatingLosses_25"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_CarrybackNetOperatingLosses" xlink:label="loc_cmmb_CarrybackNetOperatingLosses_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_29"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_DalePfostAndDonaldMarvinMember" xlink:label="loc_cmmb_DalePfostAndDonaldMarvinMember_30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_DalePfostAndDonaldMarvinMember" xlink:label="loc_cmmb_DalePfostAndDonaldMarvinMember_31"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_32"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_33"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_34"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_35"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_36"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_37"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_38"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_39"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_40"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_41"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_42"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_43"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_44"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_45"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_46"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_47"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_48"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_49"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" xlink:label="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_50"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" xlink:label="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_51"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" xlink:label="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_52"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" xlink:label="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_53"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" xlink:label="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_54"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" xlink:label="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_55"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_56"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_57"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_58"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_59"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_60"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_61"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_62"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_63"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_64"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_65"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NumberOfSharesDilutedAfterMerger" xlink:label="loc_cmmb_NumberOfSharesDilutedAfterMerger_66"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NumberOfSharesDilutedAfterMerger" xlink:label="loc_cmmb_NumberOfSharesDilutedAfterMerger_67"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_68"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_69"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_70"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_71"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_72"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_73"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_74"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_PaymentsToPurchaseOfDeposits" xlink:label="loc_cmmb_PaymentsToPurchaseOfDeposits_75"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_PaymentsToPurchaseOfDeposits" xlink:label="loc_cmmb_PaymentsToPurchaseOfDeposits_76"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_PaymentsToPurchaseOfDeposits" xlink:label="loc_cmmb_PaymentsToPurchaseOfDeposits_77"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_ProceedsFromSaleOfDeposits" xlink:label="loc_cmmb_ProceedsFromSaleOfDeposits_78"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_ProceedsFromSaleOfDeposits" xlink:label="loc_cmmb_ProceedsFromSaleOfDeposits_79"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_ProceedsFromSaleOfDeposits" xlink:label="loc_cmmb_ProceedsFromSaleOfDeposits_80"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_81"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_82"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_83"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_84"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_85"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_86"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_87"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_88"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_89"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_90"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_91"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_92"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_93"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_94"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_95"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_96"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_97"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_StockAndWarrantIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_98"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_StockAndWarrantIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_99"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_StockAndWarrantIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_100"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_101"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_102"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_103"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_104"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_105"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_106"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_107"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_108"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_109"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_111"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_112"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_113"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_114"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_115"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_116"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_117"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_118"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_119"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_121"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_122"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_123"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_124"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_125"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_126"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_127"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_128"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_129"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_131"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_132"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_133"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_134"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_135"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_136"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_137"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_138"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_139"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_141"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_142"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_143"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_144"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_145"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_146"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_147"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_148"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_149"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_151"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_152"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_153"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_154"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_155"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_156"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_157"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_158"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_159"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_161"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_162"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_163"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_164"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_165"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_166"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_167"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_168"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_169"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_dei_NoTradingSymbolFlag_170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_171"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_172"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_173"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_174"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_175"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_176"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_177"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_178"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_179"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_181"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_182"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_183"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_184"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_185"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_186"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_187"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_188"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_189"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_191"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_192"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_193"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_194"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_195"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_196"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_197"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_198"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_199"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_201"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_202"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_203"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_204"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_205"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_206"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_207"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_208"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_209"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaap_CommonStockNoParValue_210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_211"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_212"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_213"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_214"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_215"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_216"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_217"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_218"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_219"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_221"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_222"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_223"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_224"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_225"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_226"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_227"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_228"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_229"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_231"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_232"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInUnearnedPremiumsNet" xlink:label="loc_us-gaap_IncreaseDecreaseInUnearnedPremiumsNet_233"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_234"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_235"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_236"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_237"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_238"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_239"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_241"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_242"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_243"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_244"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_245"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_246"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_247"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_248"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_249"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_251"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_252"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_253"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_254"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_255"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_256"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_257"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_258"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_259"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_261"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_262"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_263"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_264"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_265"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_266"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_267"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_268"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_269"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_271"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_272"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_273"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_274"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_275"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_276"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_277"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_278"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_279"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_281"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_282"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_283"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_284"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_285"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_286"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_287"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_288"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_289"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_291"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_292"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_293"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_294"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_295"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_296"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_297"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_298"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_299"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_300"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_301"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_302"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_303"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_304"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_305"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_306"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_307"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_308"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_309"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_311"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_312"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaap_TreasuryStockCommonMember_313"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaap_TreasuryStockCommonMember_314"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaap_TreasuryStockCommonShares_315"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaap_TreasuryStockCommonShares_316"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_317"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_318"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_319"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_320"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_321"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AccountReceivableDueToExerciseOfOptions_0" xml:lang="en-US">Represent the amount of account receivable due to exercise of options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AccountReceivableDueToExerciseOfOptions_1" xml:lang="en-US">Account Receivable Due To Exercise Of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_AccountReceivableDueToExerciseOfOptions_2" xml:lang="en-US">Account receivable Due to Exercise of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_AccountReceivableDueToExerciseOfOptions_3" xml:lang="en-US">Receivable related to exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AccruedShareIssuanceExpenses_0" xml:lang="en-US">The amount of accrued issuance expenses non-cash investing and financing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AccruedShareIssuanceExpenses_1" xml:lang="en-US">Accrued share issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AmericanDepositarySharesMember_0" xml:lang="en-US">American Depositary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AmericanDepositarySharesMember_1" xml:lang="en-US">American Depositary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AmericanDepositorySharesMember_0" xml:lang="en-US">This member stands for American Depository Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AmericanDepositorySharesMember_1" xml:lang="en-US">American Depository Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_AmericanDepositorySharesMember_2" xml:lang="en-US">American Depositary Share ("ADS") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_0" xml:lang="en-US">Represents the amount of total sale and transfer of compounds and products kestrel paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_1" xml:lang="en-US">Amount Of Total Sale And Transfer Of Compounds And Products Kestrel Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_2" xml:lang="en-US">Amount of total sale and transfer of compounds and products kestrel paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_0" xml:lang="en-US">This member stands for At the Market Offering Agreement with Cantor Fitzgerald &amp; Co.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_1" xml:lang="en-US">At Market Offering Agreement With Cantor Fitzgerald And Co [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_2" xml:lang="en-US">At The Market Offering Agreement With Cantor Fitzgerald &amp; Co. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_0" xml:lang="en-US">The amount of of asset held for sale recogized prior to the completion of merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_1" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Asset Held For Sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_2" xml:lang="en-US">Asset held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0" xml:lang="en-US">Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_1" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2" xml:lang="en-US">Accrued liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CarrybackNetOperatingLosses_0" xml:lang="en-US">The amount of carryback net operating losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CarrybackNetOperatingLosses_1" xml:lang="en-US">Carryback Net Operating Losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_CarrybackNetOperatingLosses_2" xml:lang="en-US">Carryback net operating losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CashAcquiredInReverseRecapitalization_0" xml:lang="en-US">represents cash acquired from acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CashAcquiredInReverseRecapitalization_1" xml:lang="en-US">Cash acquired in reverse recapitalization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_CashAcquiredInReverseRecapitalization_2" xml:lang="en-US">Cash acquired in reverse recapitalization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_DalePfostAndDonaldMarvinMember_0" xml:lang="en-US">The member stands for Dale Pfost and Donald Marvin .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_DalePfostAndDonaldMarvinMember_1" xml:lang="en-US">Dale Pfost And Donald Marvin [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransaction_0" xml:lang="en-US">The amount of effect due reverse capitalization transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransaction_1" xml:lang="en-US">Effect of reverse capitalization transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_0" xml:lang="en-US">The number of shares isued due to effect of reverse capitalization transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_1" xml:lang="en-US">Effect Of Reverse Capitalization Transaction Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_2" xml:lang="en-US">Effect of reverse capitalization transaction (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_0" xml:lang="en-US">The amount of estimated fair value of the net assets acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_1" xml:lang="en-US">Estimated Fair Value Of Net Assets Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_2" xml:lang="en-US">Net acquired assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_0" xml:lang="en-US">The net amount of finance income earned and finance expenses incurred during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_1" xml:lang="en-US">Financing expense (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_2" xml:lang="en-US">Finance Income Expenses Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_3" xml:lang="en-US">Financing expense, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_FormerChemomabSecurityHoldersMember_0" xml:lang="en-US">This represents former Chemomab security holders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_FormerChemomabSecurityHoldersMember_1" xml:lang="en-US">Former Chemomab Security Holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_0" xml:lang="en-US">Issuance of shares net, of issuance costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_1" xml:lang="en-US">Issuance Of Shares Net Of Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_2" xml:lang="en-US">Issuance of shares net, of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_3" xml:lang="en-US">Issuance of Shares, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_0" xml:lang="en-US">The amount of liabilities assumed, net of non-cash assets received in reverse merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_1" xml:lang="en-US">Liabilities Assumed Net Of Non Cash Assets Received In Reverse Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_2" xml:lang="en-US">Liabilities assumed, net of non-cash assets received in reverse merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_0" xml:lang="en-US">This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1" xml:lang="en-US">Merger Agreement With Chemomab Israeli Limited Company And Clinical Stage Biotech Company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_2" xml:lang="en-US">Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NatureOfOperationsDisclosureAbstract_0" xml:lang="en-US">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NatureOfOperationsDisclosureAbstract_1" xml:lang="en-US">Nature Of Operations Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_0" xml:lang="en-US">Number of ADS issued and outstanding after the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_1" xml:lang="en-US">Number of ADS issued and outstanding after the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_0" xml:lang="en-US">Represent the number of ordinary shares consisted in one American depository share (ADS).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_1" xml:lang="en-US">Number Of Ordinary Shares Consisted In D S</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_2" xml:lang="en-US">Number of ordinary shares represented by each ADS (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_0" xml:lang="en-US">Number of shares of common stock for each preferred share converted before merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_1" xml:lang="en-US">Number Of Ordinary Shares For Each Preferred Share Converted Prior To Date Of Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_2" xml:lang="en-US">Number of common shares for each preferred share converted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfSharesDilutedAfterMerger_0" xml:lang="en-US">The number of shares diluted after the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfSharesDilutedAfterMerger_1" xml:lang="en-US">Number of shares diluted after the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_0" xml:lang="en-US">One employee one officer consultant and six Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_1" xml:lang="en-US">One Employee One Officer Consultant And Six Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_2" xml:lang="en-US">One employee one officer consultant and six Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OrdinarySharesMember_0" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OrdinarySharesMember_1" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OrdinarySharesNoParValuePerShareMember_0" xml:lang="en-US">Ordinary Shares, No Par Value Per Share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OrdinarySharesNoParValuePerShareMember_1" xml:lang="en-US">Ordinary Shares, No Par Value Per Share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_PaymentsToPurchaseOfDeposits_0" xml:lang="en-US">The cash outflow to purchase of deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_PaymentsToPurchaseOfDeposits_1" xml:lang="en-US">Increase in deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_PaymentsToPurchaseOfDeposits_2" xml:lang="en-US">Payments To Purchase Of Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ProceedsFromSaleOfDeposits_0" xml:lang="en-US">The cash inflow from the sale of deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ProceedsFromSaleOfDeposits_1" xml:lang="en-US">Proceeds From Sale Of Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ProceedsFromSaleOfDeposits_2" xml:lang="en-US">Decrease in bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RepurchaseArrangementMember_0" xml:lang="en-US">The member represents repurchase arrangement member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RepurchaseArrangementMember_1" xml:lang="en-US">Repurchase Arrangement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_RepurchaseArrangementMember_2" xml:lang="en-US">Repurchase Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_0" xml:lang="en-US">Represents the amount of repurchase of american depositary receipts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_1" xml:lang="en-US">Repurchase Of American Depositary Receipts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_2" xml:lang="en-US">Repurchase of ADSs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RetainedEarningsAccumulatedDeficits_0" xml:lang="en-US">The cumulative amount of the reporting entity's undistributed earnings or deficits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_RetainedEarningsAccumulatedDeficits_1" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RetainedEarningsAccumulatedDeficits_2" xml:lang="en-US">Retained Earnings Accumulated Deficits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_0" xml:lang="en-US">This member stands for Security holders of anchiano as of immediately prior to merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_1" xml:lang="en-US">Security Holders Of Anchiano As Of Immediately Prior To Merger [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_2" xml:lang="en-US">Security holders of Anchiano as of immediately prior to the merger [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_0" xml:lang="en-US">shareholding percentage immediately following the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_1" xml:lang="en-US">Shareholding percentage immediately following the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_0" xml:lang="en-US">Represents the shares convertible in merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_1" xml:lang="en-US">Shares Convertible Per Share Of Acquiree Entity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_2" xml:lang="en-US">Number of shares after merger for each share of Chemomab</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_0" xml:lang="en-US">it represents number of shares and warrants issued during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_1" xml:lang="en-US">Stock And Warrant Issued During Period New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_2" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs (In shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_0" xml:lang="en-US">Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_1" xml:lang="en-US">Stock And Warrants Issued During Period Value New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_2" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_TwoThousandFifteenPlanMember_0" xml:lang="en-US">2015 Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_TwoThousandFifteenPlanMember_1" xml:lang="en-US">Two Thousand Fifteen Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_TwoThousandFifteenPlanMember_2" xml:lang="en-US">2015 Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_WarrantsExercisablePeriod_0" xml:lang="en-US">Represent the warrants exercisable period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_WarrantsExercisablePeriod_1" xml:lang="en-US">Warrants exercisable period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_WarrantsExercisablePeriod_2" xml:lang="en-US">Warrants exercisable period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_0" xml:lang="en-US">Taxes on income (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_1" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_2" xml:lang="en-US">Taxes Expenses (Income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_3" xml:lang="en-US">Taxes on income (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0" xml:lang="en-US">Change in other receivables and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_TreasuryStockValue_0" xml:lang="en-US">Treasury share at cost (11,640,460 Ordinary shares as of June 30, 2023 and December 31, 2022)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockValue_1" xml:lang="en-US">Treasury Stock, Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TreasuryStockValue_2" xml:lang="en-US">Treasury share at cost (11,640,460 ordinary shares as of March 31, 2023 and December 31, 2022)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0" xml:lang="en-US">Loss before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" xml:lang="en-US">Loss before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_0" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_us-gaap_NetIncomeLoss_1" xml:lang="en-US">Net loss for the period/year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss_2" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_3" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_OperatingExpenses_0" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses_1" xml:lang="en-US">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses_2" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesOutstanding_0" xml:lang="en-US">Ending balance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesOutstanding_1" xml:lang="en-US">Beginning balance (In shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesOutstanding_2" xml:lang="en-US">Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity_2" xml:lang="en-US">Equity, Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity_3" xml:lang="en-US">Total shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode_0" xml:lang="en-US">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentQuarterlyReport_0" xml:lang="en-US">Document Quarterly Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport_0" xml:lang="en-US">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2_0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod_0" xml:lang="en-US">Entity Ex Transition Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode_0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInformationFormerLegalOrRegisteredName_0" xml:lang="en-US">Entity Information, Former Legal or Registered Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityShellCompany_0" xml:lang="en-US">Entity Shell Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntitySmallBusiness_0" xml:lang="en-US">Entity Small Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityTaxIdentificationNumber_0" xml:lang="en-US">Entity Tax Identification Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber_0" xml:lang="en-US">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_NoTradingSymbolFlag_0" xml:lang="en-US">No Trading Symbol Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle_0" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName_0" xml:lang="en-US">Name of Exchange on which Security is Registered</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol_0" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis_0" xml:lang="en-US">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_0" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent_0" xml:lang="en-US">Trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_0" xml:lang="en-US">Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapital_0" xml:lang="en-US">Additional paid in capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_0" xml:lang="en-US">Additional paid in capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Adjustments for operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Adjustments for operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets_0" xml:lang="en-US">Assets [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent_0" xml:lang="en-US">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrent_0" xml:lang="en-US">Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsNoncurrent_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0" xml:lang="en-US">Basis of Preparation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_0" xml:lang="en-US">Business Acquisition [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0" xml:lang="en-US">Prepaid and other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xml:lang="en-US">Change in cash, cash equivalents and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies_0" xml:lang="en-US">Commitments and contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" xml:lang="en-US">Contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember_0" xml:lang="en-US">Ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockMember_1" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockNoParValue_0" xml:lang="en-US">Common Stock, No Par Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued_0" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue_0" xml:lang="en-US">Ordinary shares no par value - Authorized: 650,000,000 shares as of September 30, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 227,956,060 ordinary shares at September 30, 2021 and 9,274,838 ordinary shares at December 31, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue_1" xml:lang="en-US">Ordinary shares no par value - Authorized: 650,000,000 shares as of March 31, 2022 and as of December 31, 2021; Issued and outstanding: 228,090,300 ordinary shares at March 31, 2022 as of December 31, 2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockValue_2" xml:lang="en-US">Ordinary shares no par value - Authorized: 650,000,000 shares as of June 30, 2023 and December 31, 2022; Issued and outstanding: 248,058,700 Ordinary shares as of June 30, 2023 and 232,636,700 as of December 31, 2022;</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepositsAssetsCurrent_0" xml:lang="en-US">Short term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Depreciation_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic_0" xml:lang="en-US">Basic and diluted loss per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic_1" xml:lang="en-US">Basic loss per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted_0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted_1" xml:lang="en-US">Diluted loss per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0" xml:lang="en-US">Employee and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityComponentDomain_0" xml:lang="en-US">Equity Component [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract_0" xml:lang="en-US">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0" xml:lang="en-US">Change in trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_0" xml:lang="en-US">Change in accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0" xml:lang="en-US">Change in employees and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1" xml:lang="en-US">Change in operating lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2" xml:lang="en-US">Change in operating lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInUnearnedPremiumsNet_0" xml:lang="en-US">(Increase) Decrease in Unearned Premiums, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities_1" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_0" xml:lang="en-US">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US">Total liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent_0" xml:lang="en-US">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NatureOfOperations_0" xml:lang="en-US">Nature of Operations [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NatureOfOperations_1" xml:lang="en-US">General</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash flows from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xml:lang="en-US">Net cash provided by investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash flows from investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash flows from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract_0" xml:lang="en-US">Operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_0" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0" xml:lang="en-US">Operating lease liabilities - long term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_0" xml:lang="en-US">Operating lease right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis_0" xml:lang="en-US">Plan Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xml:lang="en-US">Other receivables and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseNoncurrent_0" xml:lang="en-US">Long term prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_0" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_1" xml:lang="en-US">Exercise of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_2" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss_0" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProfitLoss_1" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_0" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis_0" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain_0" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems_0" xml:lang="en-US">Related Party Transaction [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract_0" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" xml:lang="en-US">Transaction with related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashCurrent_0" xml:lang="en-US">Restricted Cash, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RestrictedCashCurrent_1" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_0" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember_0" xml:lang="en-US">Accumulated deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsMember_1" xml:lang="en-US">Accumulated Deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_0" xml:lang="en-US">Aggregate offering price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_0" xml:lang="en-US">Gross proceeds from sale under agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0" xml:lang="en-US">Shares issued under agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0" xml:lang="en-US">Schedule of net assets acquired based on their estimated fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeveranceCosts1_0" xml:lang="en-US">Severance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SeveranceCosts1_1" xml:lang="en-US">Severance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation_0" xml:lang="en-US">Share-based compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis_0" xml:lang="en-US">Class of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_0" xml:lang="en-US">Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems_0" xml:lang="en-US">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable_0" xml:lang="en-US">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1" xml:lang="en-US">Shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xml:lang="en-US">Issuance of shares, net (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2" xml:lang="en-US">Issuance of shares, net of issuance expenses (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xml:lang="en-US">Exercise of options (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_1" xml:lang="en-US">Issuance of shares, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_2" xml:lang="en-US">Issuance of shares, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_0" xml:lang="en-US">Sale of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockCommonMember_0" xml:lang="en-US">Treasury Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TreasuryStockCommonMember_1" xml:lang="en-US">Treasury share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockCommonShares_0" xml:lang="en-US">Treasury Stock, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TreasuryStockCommonShares_1" xml:lang="en-US">Treasury Stock, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates_0" xml:lang="en-US">Use of estimates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding, diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding, basic, and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding, basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccountReceivableDueToExerciseOfOptions_1" xlink:to="lab_cmmb_AccountReceivableDueToExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccountReceivableDueToExerciseOfOptions_2" xlink:to="lab_cmmb_AccountReceivableDueToExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccountReceivableDueToExerciseOfOptions_3" xlink:to="lab_cmmb_AccountReceivableDueToExerciseOfOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccountReceivableDueToExerciseOfOptions_4" xlink:to="lab_cmmb_AccountReceivableDueToExerciseOfOptions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccruedShareIssuanceExpenses_5" xlink:to="lab_cmmb_AccruedShareIssuanceExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccruedShareIssuanceExpenses_6" xlink:to="lab_cmmb_AccruedShareIssuanceExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositarySharesMember_7" xlink:to="lab_cmmb_AmericanDepositarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositarySharesMember_8" xlink:to="lab_cmmb_AmericanDepositarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositorySharesMember_9" xlink:to="lab_cmmb_AmericanDepositorySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositorySharesMember_10" xlink:to="lab_cmmb_AmericanDepositorySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositorySharesMember_11" xlink:to="lab_cmmb_AmericanDepositorySharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_12" xlink:to="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_13" xlink:to="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_14" xlink:to="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_15" xlink:to="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_16" xlink:to="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_17" xlink:to="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_18" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_19" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_20" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_21" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_22" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_23" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CarrybackNetOperatingLosses_24" xlink:to="lab_cmmb_CarrybackNetOperatingLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CarrybackNetOperatingLosses_25" xlink:to="lab_cmmb_CarrybackNetOperatingLosses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CarrybackNetOperatingLosses_26" xlink:to="lab_cmmb_CarrybackNetOperatingLosses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashAcquiredInReverseRecapitalization_27" xlink:to="lab_cmmb_CashAcquiredInReverseRecapitalization_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashAcquiredInReverseRecapitalization_28" xlink:to="lab_cmmb_CashAcquiredInReverseRecapitalization_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashAcquiredInReverseRecapitalization_29" xlink:to="lab_cmmb_CashAcquiredInReverseRecapitalization_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_DalePfostAndDonaldMarvinMember_30" xlink:to="lab_cmmb_DalePfostAndDonaldMarvinMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_DalePfostAndDonaldMarvinMember_31" xlink:to="lab_cmmb_DalePfostAndDonaldMarvinMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransaction_32" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransaction_33" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_34" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_35" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_36" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_37" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_38" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_39" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_40" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_41" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_42" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_43" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FormerChemomabSecurityHoldersMember_44" xlink:to="lab_cmmb_FormerChemomabSecurityHoldersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FormerChemomabSecurityHoldersMember_45" xlink:to="lab_cmmb_FormerChemomabSecurityHoldersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_46" xlink:to="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_47" xlink:to="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_48" xlink:to="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_49" xlink:to="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_50" xlink:to="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_51" xlink:to="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_52" xlink:to="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_53" xlink:to="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_54" xlink:to="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_55" xlink:to="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_56" xlink:to="lab_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_57" xlink:to="lab_cmmb_NatureOfOperationsDisclosureAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_58" xlink:to="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_59" xlink:to="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_60" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_61" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_62" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_63" xlink:to="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_64" xlink:to="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_65" xlink:to="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfSharesDilutedAfterMerger_66" xlink:to="lab_cmmb_NumberOfSharesDilutedAfterMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfSharesDilutedAfterMerger_67" xlink:to="lab_cmmb_NumberOfSharesDilutedAfterMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_68" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_69" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_70" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesMember_71" xlink:to="lab_cmmb_OrdinarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesMember_72" xlink:to="lab_cmmb_OrdinarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesNoParValuePerShareMember_73" xlink:to="lab_cmmb_OrdinarySharesNoParValuePerShareMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesNoParValuePerShareMember_74" xlink:to="lab_cmmb_OrdinarySharesNoParValuePerShareMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsToPurchaseOfDeposits_75" xlink:to="lab_cmmb_PaymentsToPurchaseOfDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsToPurchaseOfDeposits_76" xlink:to="lab_cmmb_PaymentsToPurchaseOfDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsToPurchaseOfDeposits_77" xlink:to="lab_cmmb_PaymentsToPurchaseOfDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromSaleOfDeposits_78" xlink:to="lab_cmmb_ProceedsFromSaleOfDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromSaleOfDeposits_79" xlink:to="lab_cmmb_ProceedsFromSaleOfDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromSaleOfDeposits_80" xlink:to="lab_cmmb_ProceedsFromSaleOfDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseArrangementMember_81" xlink:to="lab_cmmb_RepurchaseArrangementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseArrangementMember_82" xlink:to="lab_cmmb_RepurchaseArrangementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseArrangementMember_83" xlink:to="lab_cmmb_RepurchaseArrangementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_84" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_85" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_86" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RetainedEarningsAccumulatedDeficits_87" xlink:to="lab_cmmb_RetainedEarningsAccumulatedDeficits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RetainedEarningsAccumulatedDeficits_88" xlink:to="lab_cmmb_RetainedEarningsAccumulatedDeficits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RetainedEarningsAccumulatedDeficits_89" xlink:to="lab_cmmb_RetainedEarningsAccumulatedDeficits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_90" xlink:to="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_91" xlink:to="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_92" xlink:to="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_93" xlink:to="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_94" xlink:to="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_95" xlink:to="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_96" xlink:to="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_97" xlink:to="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_98" xlink:to="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_99" xlink:to="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_100" xlink:to="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_101" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_102" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_103" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandFifteenPlanMember_104" xlink:to="lab_cmmb_TwoThousandFifteenPlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandFifteenPlanMember_105" xlink:to="lab_cmmb_TwoThousandFifteenPlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandFifteenPlanMember_106" xlink:to="lab_cmmb_TwoThousandFifteenPlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WarrantsExercisablePeriod_107" xlink:to="lab_cmmb_WarrantsExercisablePeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WarrantsExercisablePeriod_108" xlink:to="lab_cmmb_WarrantsExercisablePeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WarrantsExercisablePeriod_109" xlink:to="lab_cmmb_WarrantsExercisablePeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_110" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_111" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_112" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_113" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_114" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_115" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_116" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_117" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_118" xlink:to="lab_us-gaap_TreasuryStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_119" xlink:to="lab_us-gaap_TreasuryStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_120" xlink:to="lab_us-gaap_TreasuryStockValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_121" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_122" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_123" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_124" xlink:to="lab_us-gaap_NetIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_125" xlink:to="lab_us-gaap_NetIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_126" xlink:to="lab_us-gaap_NetIncomeLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_127" xlink:to="lab_us-gaap_NetIncomeLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_128" xlink:to="lab_us-gaap_OperatingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_129" xlink:to="lab_us-gaap_OperatingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_130" xlink:to="lab_us-gaap_OperatingExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_131" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_132" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_133" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_134" xlink:to="lab_us-gaap_SharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_135" xlink:to="lab_us-gaap_SharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_136" xlink:to="lab_us-gaap_SharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_137" xlink:to="lab_us-gaap_StockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_138" xlink:to="lab_us-gaap_StockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_139" xlink:to="lab_us-gaap_StockholdersEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_140" xlink:to="lab_us-gaap_StockholdersEquity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_141" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_142" xlink:to="lab_dei_CityAreaCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_143" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_144" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_145" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_146" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport_147" xlink:to="lab_dei_DocumentQuarterlyReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_148" xlink:to="lab_dei_DocumentTransitionReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_149" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_150" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2_151" xlink:to="lab_dei_EntityAddressAddressLine2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_152" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_153" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_154" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_155" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_156" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_157" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_158" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod_159" xlink:to="lab_dei_EntityExTransitionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_160" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_161" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_162" xlink:to="lab_dei_EntityIncorporationStateCountryCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationFormerLegalOrRegisteredName_163" xlink:to="lab_dei_EntityInformationFormerLegalOrRegisteredName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_164" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_165" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_166" xlink:to="lab_dei_EntityShellCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_167" xlink:to="lab_dei_EntitySmallBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_168" xlink:to="lab_dei_EntityTaxIdentificationNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_169" xlink:to="lab_dei_LocalPhoneNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag_170" xlink:to="lab_dei_NoTradingSymbolFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_171" xlink:to="lab_dei_Security12bTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_172" xlink:to="lab_dei_SecurityExchangeName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_173" xlink:to="lab_dei_TradingSymbol_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_174" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_175" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_176" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis_177" xlink:to="lab_srt_TitleOfIndividualAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_178" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_179" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_180" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital_181" xlink:to="lab_us-gaap_AdditionalPaidInCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_182" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_183" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_184" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_185" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_186" xlink:to="lab_us-gaap_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_187" xlink:to="lab_us-gaap_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_188" xlink:to="lab_us-gaap_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_189" xlink:to="lab_us-gaap_AssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_190" xlink:to="lab_us-gaap_AssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_191" xlink:to="lab_us-gaap_AssetsCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_192" xlink:to="lab_us-gaap_AssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_193" xlink:to="lab_us-gaap_AssetsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_194" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_195" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_196" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_197" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_198" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_199" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_200" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_201" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_202" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_203" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_204" xlink:to="lab_us-gaap_CommitmentsAndContingencies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_205" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_206" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_207" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_208" xlink:to="lab_us-gaap_CommonStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_209" xlink:to="lab_us-gaap_CommonStockMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNoParValue_210" xlink:to="lab_us-gaap_CommonStockNoParValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_211" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_212" xlink:to="lab_us-gaap_CommonStockSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_213" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_214" xlink:to="lab_us-gaap_CommonStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_215" xlink:to="lab_us-gaap_CommonStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_216" xlink:to="lab_us-gaap_CommonStockValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent_217" xlink:to="lab_us-gaap_DepositsAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_218" xlink:to="lab_us-gaap_Depreciation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_219" xlink:to="lab_us-gaap_EarningsPerShareBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_220" xlink:to="lab_us-gaap_EarningsPerShareBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_221" xlink:to="lab_us-gaap_EarningsPerShareDiluted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_222" xlink:to="lab_us-gaap_EarningsPerShareDiluted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_223" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_224" xlink:to="lab_us-gaap_EquityComponentDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_225" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_226" xlink:to="lab_us-gaap_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_227" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_228" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_229" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_230" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_231" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_232" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInUnearnedPremiumsNet_233" xlink:to="lab_us-gaap_IncreaseDecreaseInUnearnedPremiumsNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_234" xlink:to="lab_us-gaap_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_235" xlink:to="lab_us-gaap_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_236" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_237" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_238" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_239" xlink:to="lab_us-gaap_LiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_240" xlink:to="lab_us-gaap_LiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_241" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_242" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_243" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_244" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_245" xlink:to="lab_us-gaap_NatureOfOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_246" xlink:to="lab_us-gaap_NatureOfOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_247" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_248" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_249" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_250" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_251" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_252" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_253" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_254" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_255" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_256" xlink:to="lab_us-gaap_OperatingExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_257" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_258" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_259" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_260" xlink:to="lab_us-gaap_PlanNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_261" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseNoncurrent_262" xlink:to="lab_us-gaap_PrepaidExpenseNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_263" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_264" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_265" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_266" xlink:to="lab_us-gaap_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_267" xlink:to="lab_us-gaap_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_268" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_269" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_270" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_271" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_272" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_273" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_274" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_275" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_276" xlink:to="lab_us-gaap_RestrictedCashCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_277" xlink:to="lab_us-gaap_RestrictedCashCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_278" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_279" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_280" xlink:to="lab_us-gaap_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_281" xlink:to="lab_us-gaap_RetainedEarningsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_282" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_283" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_284" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_285" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_286" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_287" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1_288" xlink:to="lab_us-gaap_SeveranceCosts1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1_289" xlink:to="lab_us-gaap_SeveranceCosts1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_290" xlink:to="lab_us-gaap_ShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_291" xlink:to="lab_us-gaap_ShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_292" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis_293" xlink:to="lab_us-gaap_StatementClassOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_294" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_295" xlink:to="lab_us-gaap_StatementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_296" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_297" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_298" xlink:to="lab_us-gaap_StatementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_299" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_300" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_301" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_302" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_303" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_304" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_305" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_306" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_307" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_308" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_309" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_310" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_311" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_312" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember_313" xlink:to="lab_us-gaap_TreasuryStockCommonMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember_314" xlink:to="lab_us-gaap_TreasuryStockCommonMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares_315" xlink:to="lab_us-gaap_TreasuryStockCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares_316" xlink:to="lab_us-gaap_TreasuryStockCommonShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_317" xlink:to="lab_us-gaap_UseOfEstimates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_318" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_319" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_320" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_321" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>cmmb-20230630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#BalanceSheetsParenthetical" roleURI="http://www.anchiano.com/role/BalanceSheetsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#General." roleURI="http://www.anchiano.com/role/General."/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#InterimStatementsOfChangesInEquity" roleURI="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#StatementUnauditedCondensedConsolidatedStatementsOfOperations" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#StatementUnauditedCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#BasisOfPresentationAndSignificantAccountingPolicies" roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#BasisOfPresentationAndSignificantAccountingPoliciesPolicies" roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#General.Details" roleURI="http://www.anchiano.com/role/General.Details"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230630.xsd#Contingencies" roleURI="http://www.anchiano.com/role/Contingencies"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/BalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaap_CommonStockNoParValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaap_TreasuryStockCommonShares_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockNoParValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_TreasuryStockCommonShares_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_31"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_RestrictedCashCurrent_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_AssetsCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_AssetsNoncurrent_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_Assets_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_14" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_14" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_14" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_14" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_15" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_14" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_16" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_14" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_17" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_14" xlink:to="loc_us-gaap_LiabilitiesCurrent_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_20" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_20" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_20" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_20" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_CommitmentsAndContingencies_23" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_Liabilities_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" xlink:to="loc_us-gaap_CommonStockValue_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" xlink:to="loc_us-gaap_TreasuryStockValue_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" xlink:to="loc_us-gaap_AdditionalPaidInCapital_27" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_28" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" xlink:to="loc_us-gaap_StockholdersEquity_29" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_31" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_dei_NoTradingSymbolFlag_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_37"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_AmericanDepositarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentType_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityCentralIndexKey_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentPeriodEndDate_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_CurrentFiscalYearEndDate_8" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentFiscalYearFocus_9" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_AmendmentFlag_11" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentQuarterlyReport_12" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentTransitionReport_13" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityFileNumber_14" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityRegistrantName_15" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_16" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityTaxIdentificationNumber_17" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressAddressLine1_18" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressAddressLine2_19" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressCityOrTown_20" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressPostalZipCode_21" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressCountry_22" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_CityAreaCode_23" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_LocalPhoneNumber_24" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityInformationFormerLegalOrRegisteredName_25" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_Security12bTitle_26" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_TradingSymbol_27" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_NoTradingSymbolFlag_28" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_SecurityExchangeName_29" order="240" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityCurrentReportingStatus_30" order="250" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityInteractiveDataCurrent_31" order="260" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityFilerCategory_32" order="270" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntitySmallBusiness_33" order="280" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityEmergingGrowthCompany_34" order="290" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityExTransitionPeriod_35" order="300" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityShellCompany_36" order="310" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_37" order="320" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.">
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_NatureOfOperations_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaap_TreasuryStockCommonMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_TreasuryStockCommonMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockholdersEquity_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_SharesOutstanding_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_NetIncomeLoss_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockholdersEquity_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_SharesOutstanding_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_OperatingExpenses_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_cmmb_FinanceIncomeExpensesNet_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasic_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_ProceedsFromSaleOfDeposits" xlink:label="loc_cmmb_ProceedsFromSaleOfDeposits_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_24"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AccountReceivableDueToExerciseOfOptions" xlink:label="loc_cmmb_AccountReceivableDueToExerciseOfOptions_24"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_ShareBasedCompensation_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_6" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_8" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_cmmb_ProceedsFromSaleOfDeposits_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_24" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_24" xlink:to="loc_cmmb_AccountReceivableDueToExerciseOfOptions_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_2" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.Details">
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" xlink:label="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_DalePfostAndDonaldMarvinMember" xlink:label="loc_cmmb_DalePfostAndDonaldMarvinMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AmericanDepositorySharesMember" xlink:label="loc_cmmb_AmericanDepositorySharesMember_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_21"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230630.xsd#cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_27"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_4" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_FormerChemomabSecurityHoldersMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_DalePfostAndDonaldMarvinMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_PlanNameAxis_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_10" xlink:to="loc_us-gaap_PlanNameDomain_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_10" xlink:to="loc_cmmb_TwoThousandFifteenPlanMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_13" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_13" xlink:to="loc_us-gaap_ClassOfStockDomain_13" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_13" xlink:to="loc_cmmb_AmericanDepositorySharesMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_13" xlink:to="loc_cmmb_OrdinarySharesMember_14" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_RangeAxis_17" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_17" xlink:to="loc_srt_RangeMember_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_17" xlink:to="loc_srt_MinimumMember_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_17" xlink:to="loc_srt_MaximumMember_18" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_21" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_21" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_21" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_21" xlink:to="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_24" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_24" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_24" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_24" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_25" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_24" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_26" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_24" xlink:to="loc_us-gaap_SeveranceCosts1_27" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/Contingencies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image00002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !S 98# 2(  A$! Q$!_\0
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M97E(X_P#\6'UO4QH/B&V6SU3.Q' *K(P_A*G[K5V_C+4[K1O!VJZC9.J7-O
M7C9EW 'Z5XE\8KS0;K5]-U[P_J=I->YVS_9I 3E<%6./Q'Y5ZAXHU#^U?@W>
MWY^]<::)&^I S^M3.G&\9I63Z#C)V:?0\ZT;XQ>)KW1VL(+<:AX@N+@K $@
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MD('\1;;G\@*^B;&S@T^P@L[:-8X((Q'&BC@ "E4=."4XQU814I-Q;V/"-/\
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M,>X%.HHH :T:,<LBDCN13J** $95<890P]",T!0HPH  [ 4M% !4,UI;7/\
MK[>*7']] W\ZFHH AAM;>V_U%O%%G^X@7^52,B/]]%;'3(S3J*  # P*:(T#
M;@BAO4#FG44 07%E:W8Q<VT,P_Z:(&_G2V]I;6J[;>WBA'I&@7^5344[L HH
MHI %%%% !52]TNPU$8O+2&;'=UR?SJW13C)Q=XNP;E2STRQT\8L[2&'/4HN#
M^=6Z**)2<G=NX&+K_BS0_#"(VKZA%;M)]Q#DLWT YJ?1/$6D^([0W6DWL5U&
MIPVP\J?0@\BOFOXOK?#XCZ@;S=M(7R,]/+P,8_6MKX"K>GQI=-#O^R"T;[1_
M=SD;<^^<X_&NQX6*H\]]3!57S\MCZ-HHHKB-PHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** (1=VQ;:+B$L3C&\5*S*N-S 9.
M!D]36##868\4SJ+:(!;9' VC@[CS]:G\0LZPV+1IO<7D>U<XR>>]5RJ]A7T-
M<LH8*6 8]!GK39)HH0#+(B ]-S 5C--=2Z_IWVBT$&$FVXD#YX7VHUQ#)J.F
MJ+5+GYI/W3L #\OO1RZA<VU=70.K!E/0@Y%,CGAE)$<J.1U"L#BF(@CL=HB6
M+"?ZM>B\=*Y714\R[TI5MA;,D;R&;=S.O(QQ^?-"C=,&SL:165U#*05/0@UF
MZ_=&WTMD3=YD["%=@R>>I 'H,FH/#TR+'<6*"15MWS$)%*GRVY'!]\C\*.72
MX7UL:SSPQN$>5%8] S $T\D $D@ <DFN;U.(SZ[<1K8B[9K0  L $.3SD_TK
M2EADMO#,L,TF^1+5E9O4[30X[!<OQSPS$B*6-\==K XI^Y=Q7<-P&2,\UE:#
M#Y=E&WV".V)C3YE8$OQU/%.B_P"1GNO^O6/_ -":AK5A<TPRMG:P.#@X/2HC
M=VP;:;B$$'&-XJCI'^OU/_K[;_T%:K3Z?9GQ+;@VT1#0.Q^4<G(YHLKA<W&9
M57+, /4FEK,U_P#Y!#?]=8O_ $8M)K\CQZ9A7,:R2I'(X."JE@":$KA<OI<0
M22&-)HV<=55@2/PITDL<2;Y'5%'=C@56ATJP@,;16L2-%]Q@.1^-5]7LI+E[
M66)(IC Q8P2G D!&/S':E97#4TU974,I!4\@@\&BJ.D26[V.+:%H%1V5HFZH
MV>1^=%#T8R_1112 **** "BBB@#'U[PSHOB*%%U?3H+OR_N,XPR_0CFI]&T/
M2] LOLNE6,-I"3N*QK]X^I/4_C115<SM:^@K*]S1HHHJ1A1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4TB0:Q+,%_>&$*3G
MMFC4(DE%MO7.V=6'/0\T45740L\2-J-I(5RZ*^TYZ9QFJ.O1@BWDRRR(QVLC
ME2,CGI111'= ]B[8Y;2X]S,V4.2S$D_B:J+:PI8Z?M3'DR#RSD_+G.:**.H%
MR>))-2M79<M&KE>>A.!0T2#5HY@O[PPE2<]1D&BB@ 6)!JTDH7YS"%)SVS4M
MVBR6<Z,,JT; CVQ112ZC,?005D=/,E*J@ 5I&8#Z9-/\0Q*D4=VA9+A3L$B.
M5.T]N***O[9/0T--MXK:QC2)-H8;VY)))ZDD]30\2'58I2OSK$P!SVR***CJ
M/H&HQ)-9E)%RN]#C/HP-6)HHYX7BE0/&XPRL."***.@SG=+A!UB2$O*T=N?W
M2-*Q"_@36AK\2FR%P-RS1'Y'5BI7/7I115OXD2MBSID$<&GQ"-<;AO8DDDL>
*2231114/<I'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043234160736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">6-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CHEMOMAB THERAPEUTICS LTD.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Kiryat Atidim<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel-Aviv<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043233345264">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10,382<span></span>
</td>
<td class="nump">$ 13,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short term bank deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,207<span></span>
</td>
<td class="nump">26,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other receivables and prepaid expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,042<span></span>
</td>
<td class="nump">1,766<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,705<span></span>
</td>
<td class="nump">41,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Long term prepaid expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">646<span></span>
</td>
<td class="nump">733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">338<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">160<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,144<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,849<span></span>
</td>
<td class="nump">43,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,347<span></span>
</td>
<td class="nump">1,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,503<span></span>
</td>
<td class="nump">3,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee and related expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">1,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">108<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,825<span></span>
</td>
<td class="nump">6,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - long term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">33<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">33<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,858<span></span>
</td>
<td class="nump">6,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares no par value - Authorized: 650,000,000 shares as of June 30, 2023 and December 31, 2022; Issued and outstanding: 248,058,700 Ordinary shares as of June 30, 2023 and 232,636,700 as of December 31, 2022;</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury share at cost (11,640,460 Ordinary shares as of June 30, 2023 and December 31, 2022)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,218)<span></span>
</td>
<td class="num">(1,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">103,751<span></span>
</td>
<td class="nump">101,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(80,542)<span></span>
</td>
<td class="num">(63,819)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">21,991<span></span>
</td>
<td class="nump">36,223<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 28,849<span></span>
</td>
<td class="nump">$ 43,063<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">1 American Depositary Share (ADS) represents 20 Ordinary Shares</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043235546544">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common Stock, No Par Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">650,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">248,058,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">232,636,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">248,058,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">232,636,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,640,460<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">11,640,460<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">1 American Depositary Share (ADS) represents 20 Ordinary Shares</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043229863616">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,020<span></span>
</td>
<td class="nump">$ 2,914<span></span>
</td>
<td class="nump">$ 11,907<span></span>
</td>
<td class="nump">$ 5,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,175<span></span>
</td>
<td class="nump">3,340<span></span>
</td>
<td class="nump">5,337<span></span>
</td>
<td class="nump">5,915<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,195<span></span>
</td>
<td class="nump">6,254<span></span>
</td>
<td class="nump">17,244<span></span>
</td>
<td class="nump">11,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_FinanceIncomeExpensesNet', window );">Financing expense (income), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(259)<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="num">(576)<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,936<span></span>
</td>
<td class="nump">6,734<span></span>
</td>
<td class="nump">16,668<span></span>
</td>
<td class="nump">11,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Taxes on income (benefit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34<span></span>
</td>
<td class="num">(544)<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="num">(544)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7,970<span></span>
</td>
<td class="nump">$ 6,190<span></span>
</td>
<td class="nump">$ 16,723<span></span>
</td>
<td class="nump">$ 11,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per Ordinary Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0.036<span></span>
</td>
<td class="nump">$ 0.027<span></span>
</td>
<td class="nump">$ 0.076<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per Ordinary Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.036<span></span>
</td>
<td class="nump">$ 0.027<span></span>
</td>
<td class="nump">$ 0.076<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Ordinary Shares outstanding, basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">221,674,130<span></span>
</td>
<td class="nump">228,173,276<span></span>
</td>
<td class="nump">221,338,951<span></span>
</td>
<td class="nump">228,132,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of Ordinary Shares outstanding, diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">221,674,130<span></span>
</td>
<td class="nump">228,173,276<span></span>
</td>
<td class="nump">221,338,951<span></span>
</td>
<td class="nump">228,132,249<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">1 American Depositary Share (ADS) represents 20 Ordinary Shares</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_FinanceIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of finance income earned and finance expenses incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_FinanceIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043230788512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Changes in Equity (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Ordinary Shares [Member]</div></th>
<th class="th"><div>Treasury share [Member]</div></th>
<th class="th"><div>Additional paid in capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th" colspan="2"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97,639<span></span>
</td>
<td class="num">$ (36,173)<span></span>
</td>
<td class="nump">$ 61,466<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (In shares) at Dec. 31, 2021</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">874<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">874<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period/year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,104)<span></span>
</td>
<td class="num">(5,104)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,513<span></span>
</td>
<td class="num">(41,277)<span></span>
</td>
<td class="nump">57,236<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,639<span></span>
</td>
<td class="num">(36,173)<span></span>
</td>
<td class="nump">61,466<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (In shares) at Dec. 31, 2021</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period/year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,294)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,303<span></span>
</td>
<td class="num">(47,467)<span></span>
</td>
<td class="nump">51,836<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="nump">228,633,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,513<span></span>
</td>
<td class="num">(41,277)<span></span>
</td>
<td class="nump">57,236<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (In shares) at Mar. 31, 2022</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">761<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">761<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="nump">542,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period/year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,190)<span></span>
</td>
<td class="num">(6,190)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,303<span></span>
</td>
<td class="num">(47,467)<span></span>
</td>
<td class="nump">51,836<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="nump">228,633,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">101,260<span></span>
</td>
<td class="num">(63,819)<span></span>
</td>
<td class="nump">36,223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (In shares) at Dec. 31, 2022</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="num">(11,640,460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period/year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,753)<span></span>
</td>
<td class="num">(8,753)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">101,744<span></span>
</td>
<td class="num">(72,572)<span></span>
</td>
<td class="nump">27,954<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="num">(11,640,460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">101,260<span></span>
</td>
<td class="num">(63,819)<span></span>
</td>
<td class="nump">36,223<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (In shares) at Dec. 31, 2022</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="num">(11,640,460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period/year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,723)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">103,751<span></span>
</td>
<td class="num">(80,542)<span></span>
</td>
<td class="nump">21,991<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">248,058,700<span></span>
</td>
<td class="num">(11,640,460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">101,744<span></span>
</td>
<td class="num">(72,572)<span></span>
</td>
<td class="nump">27,954<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (In shares) at Mar. 31, 2023</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="num">(11,640,460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">639<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">639<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period/year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,970)<span></span>
</td>
<td class="num">(7,970)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares, net of issuance expenses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">1,368<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">1,368<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, net of issuance expenses (in shares)</a></td>
<td class="nump">15,422,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">$ 103,751<span></span>
</td>
<td class="num">$ (80,542)<span></span>
</td>
<td class="nump">$ 21,991<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">248,058,700<span></span>
</td>
<td class="num">(11,640,460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">1 American Depositary Share (ADS) represents 20 Ordinary Shares</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043230757168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss for the period</a></td>
<td class="num">$ (16,723)<span></span>
</td>
<td class="num">$ (11,294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments for operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1,123<span></span>
</td>
<td class="nump">1,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Change in other receivables and prepaid expenses</a></td>
<td class="nump">811<span></span>
</td>
<td class="num">(1,483)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Change in operating lease liability</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Change in trade payables</a></td>
<td class="nump">659<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Change in accrued expenses</a></td>
<td class="num">(875)<span></span>
</td>
<td class="nump">1,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Change in employees and related expenses</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Adjustments for operating activities</a></td>
<td class="nump">2,051<span></span>
</td>
<td class="nump">1,882<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(14,672)<span></span>
</td>
<td class="num">(9,412)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ProceedsFromSaleOfDeposits', window );">Decrease in bank deposits</a></td>
<td class="nump">10,167<span></span>
</td>
<td class="nump">4,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">10,164<span></span>
</td>
<td class="nump">4,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_IssuanceOfSharesNetOfIssuanceCosts', window );">Issuance of Shares, net of issuance expenses</a></td>
<td class="nump">1,368<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,368<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash, cash equivalents and restricted cash</a></td>
<td class="num">(3,140)<span></span>
</td>
<td class="num">(5,281)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">13,596<span></span>
</td>
<td class="nump">15,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">10,456<span></span>
</td>
<td class="nump">9,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_AccountReceivableDueToExerciseOfOptions', window );">Receivable related to exercise of options</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_AccountReceivableDueToExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of account receivable due to exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_AccountReceivableDueToExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_IssuanceOfSharesNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of shares net, of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_IssuanceOfSharesNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ProceedsFromSaleOfDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ProceedsFromSaleOfDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043238961808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>Nature Of Operations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">General</a></td>
<td class="text">
          <div>
            <div>
              <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note 1 - General.</span></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <table cellpadding="0" cellspacing="0">

                    <tr style="vertical-align:top">
                      <td style="width:36pt">&#160;</td>
                      <td style="text-align:right;vertical-align:top;width:36pt">
                        <div style="text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">A.</span></span></span></span></span></div>
                      </td>
                      <td style="text-align:left;vertical-align:top;width:auto">
                        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Chemomab Therapeutics Ltd. (the </span></span>&#8220;<span><span>Company") is an Israeli-based company incorporated under the laws of the State of Israel in September 2011. The </span></span>Company&#8217;s<span><span> registered office is located in Kiryat Atidim, Tel Aviv, Israel. The Company is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis. The wholly owned subsidiaries of the Company are: Chemomab Ltd. ("Chemomab"), Chemomab Therapeutics Israel Ltd. and Chemomab Therapeutics Inc.</span></span></span></span></div>
                        <div style="text-align:justify">&#160;</div>
                        <div>
                          <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company currently has no products approved for sale. The Company&#8217;s operations are funded primarily by its Shareholders. The Company has incurred operating losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval for its products. Continuation of the Company&#8217;s development programs depend on its future ability to raise sources of financing. The Company believes that its existing liquidity resources as of June 30, 2023, will enable it to fund its operations through December 31, 2024 with the ability to perform cost reductions in order to extend the operations even further, if required to do so.</span></span></div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="text-indent:-36pt;margin-left:72pt;line-height:1.25;font-weight:bold">&#160;</div>
              <table cellpadding="0" cellspacing="0">

                  <tr>
                    <td style="width:36pt">&#160;</td>
                    <td style="width:36pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>B.</span></span></span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On April 30, 2021, the Company entered into an At the Market Offering Agreement (the "ATM Agreement") with Cantor Fitzgerald &amp; Co., ("Cantor"). According to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75 million through Cantor or the ATM Agreement. On April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance and sale of up to $18,125,000 of its ADSs in connection with the reactivation of the ATM Agreement Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject to certain exceptions, limits the amount of securities the Company is able to offer and sell under such registration statement to one-third of the Company's unaffiliated public float. From April 30, 2021, through June 30, 2023, the Company issued 1,470,906 ADSs under the ATM Agreement, resulting in gross proceeds of $17,327 thousand.</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0">

                  <tr>
                    <td style="width:36pt">&#160;</td>
                    <td style="width:36pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>C.</span></span></span></span></td>
                    <td style="width:auto;vertical-align:top">
                      <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On June 1, 2023, the board of directors </span></span>(the &#8220;Board&#8221;)<span><span> of the Company appointed Dr. Adi Mor as Chief Executive Officer of the Company (to replace Dr. Dale Pfost), and Sigal Fattal as the Chief Financial Officer of the Company (to replace Donald Marvin), effective as of the same date. The company has recorded in June 2023 a provision for severance payments to Dale Pfost and Donald Marvin in the amount of $1,110 thousand.</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043230769792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif">Note 2 -&#160; Basis of Presentation and Significant Accounting Policies</span></span></span></div>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                      <tr style="vertical-align:top">
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">A.</span></span></span></span></div>
                        </td>
                        <td style="vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis of Preparation</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;line-height:normal;font-family:Times New Roman, serif">The condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#8217;s financial position as of June 30, 2023, and its results of operations for the six months ended June 30, 2023, and 2022, changes in shareholders&#8217; equity for the six months ended June 30, 2023 and 2022, and cash flows for the six months ended June 30, 2023 and 2022. The results of operations for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other future annual or interim period. These financial statements should be read in conjunction with the audited financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022. The Company&#8217;s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2022 included in the Company&#8217;s Annual Report on Form 10-K. Since the date of such financial statements, there have been no changes to the Company&#8217;s significant accounting policies.</span></p>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>

            <div style="line-height:1.25">&#160;</div>

              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                      <tr style="vertical-align:top">
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">B.</span></span></span></span></div>
                        </td>
                        <td style="vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Use of estimates</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></p>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>

          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043230769792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <div>
            <div>
              <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note 3 - Contingencies</span></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>During 2022, the Israeli tax authority ("ITA&#8221;) notified the Company that it had initiated a routine VAT audit to include tax years 2017 through 2020. The ITA raised several claims, mainly in respect with the recoverability of VAT with respect to Merger Agreement related expenses and the classification of the Company as a holding company. On July 2022, the ITA proposed a settlement, which the Company rejected. As a result, the ITA issued an assessment.&#160;On November 2022, The Company appealed the ITA&#8217;s assessment. The Company has recorded a provision in 2022 that is inherently subjective due to the inherent uncertainty of these matters and the judicial process. Therefore, the outcome may differ from the estimated liability recorded by the Company during 2022. &#160;</span></span></span></div>
            </div>
          </div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043235756320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Preparation</a></td>
<td class="text">
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                      <tr style="vertical-align:top">
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">A.</span></span></span></span></div>
                        </td>
                        <td style="vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis of Preparation</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;line-height:normal;font-family:Times New Roman, serif">The condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#8217;s financial position as of June 30, 2023, and its results of operations for the six months ended June 30, 2023, and 2022, changes in shareholders&#8217; equity for the six months ended June 30, 2023 and 2022, and cash flows for the six months ended June 30, 2023 and 2022. The results of operations for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other future annual or interim period. These financial statements should be read in conjunction with the audited financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022. The Company&#8217;s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2022 included in the Company&#8217;s Annual Report on Form 10-K. Since the date of such financial statements, there have been no changes to the Company&#8217;s significant accounting policies.</span></p>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text">
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                      <tr style="vertical-align:top">
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">B.</span></span></span></span></div>
                        </td>
                        <td style="vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Use of estimates</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:36pt">&#160;</td>
                        <td style="vertical-align:top;width:auto">
                          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></p>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140043234075664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Detail Textuals) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 25, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesMember', window );">American Depositary Share ("ADS") [Member] | At The Market Offering Agreement With Cantor Fitzgerald &amp; Co. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate offering price</a></td>
<td class="nump">$ 18,125,000<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Gross proceeds from sale under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,327,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,470,906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=cmmb_DalePfostAndDonaldMarvinMember', window );">Dale Pfost And Donald Marvin [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,110,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cmmb_DalePfostAndDonaldMarvinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cmmb_DalePfostAndDonaldMarvinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>zk2330149_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cmmb="http://www.anchiano.com/20230630"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cmmb-20230630.xsd" xlink:type="simple"/>
    <context id="C_20230101to20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20230401to20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20230630_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-25</endDate>
        </period>
    </context>
    <context id="C_20230101to20230630_srtTitleOfIndividualAxis_cmmbDalePfostAndDonaldMarvinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cmmb:DalePfostAndDonaldMarvinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230101to20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <unit id="Share">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_per_share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="C_20230101to20230630" id="FFact_288">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="C_20230101to20230630" id="FFact_289">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="C_20230101to20230630" id="FFact_290">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="C_20230101to20230630" id="FFact_292">0001534248</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_20230101to20230630" id="FFact_1">6-K</dei:DocumentType>
    <dei:EntityFileNumber contextRef="C_20230101to20230630" id="FFact_5">001-38807</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_20230101to20230630" id="FFact_6">CHEMOMAB THERAPEUTICS LTD.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="C_20230101to20230630" id="FFact_9">Kiryat Atidim</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_20230101to20230630" id="FFact_10">Building 7</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_20230101to20230630" id="FFact_11">Tel-Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="C_20230101to20230630" id="FFact_12">IL</dei:EntityAddressCountry>
    <dei:DocumentPeriodEndDate
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230811013527039">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230811013617502">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_30"
      unitRef="USD">10382000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_31"
      unitRef="USD">13519000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_32"
      unitRef="USD">16207000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_33"
      unitRef="USD">26374000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20230501160610892_Fact_30"
      unitRef="USD">74000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230501160610892_Fact_31"
      unitRef="USD">77000</us-gaap:RestrictedCashCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_34"
      unitRef="USD">1042000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_35"
      unitRef="USD">1766000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_36"
      unitRef="USD">27705000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_37"
      unitRef="USD">41736000</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20220504175928392"
      unitRef="USD">646000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_40"
      unitRef="USD">733000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_42"
      unitRef="USD">338000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_43"
      unitRef="USD">367000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_46"
      unitRef="USD">160000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_47"
      unitRef="USD">227000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_48"
      unitRef="USD">1144000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_49"
      unitRef="USD">1327000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_50"
      unitRef="USD">28849000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_51"
      unitRef="USD">43063000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_52"
      unitRef="USD">2347000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_53"
      unitRef="USD">1688000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_54"
      unitRef="USD">2503000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_55"
      unitRef="USD">3378000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_56"
      unitRef="USD">1867000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_57"
      unitRef="USD">1560000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_58"
      unitRef="USD">108000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_59"
      unitRef="USD">123000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_60"
      unitRef="USD">6825000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_61"
      unitRef="USD">6749000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_62"
      unitRef="USD">33000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_63"
      unitRef="USD">91000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_64"
      unitRef="USD">33000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_65"
      unitRef="USD">91000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20230630"
      id="Fxbrl_20221108051943260_Fact_64"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20221231"
      id="Fxbrl_20221108051943260_Fact_65"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Liabilities
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_66"
      unitRef="USD">6858000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_67"
      unitRef="USD">6840000</us-gaap:Liabilities>
    <us-gaap:CommonStockNoParValue
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20220505092446513"
      unitRef="USD_per_share">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="C_20230630"
      decimals="0"
      id="Fxbrl_20220719155003261"
      unitRef="USD_per_share">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20220505092709497"
      unitRef="Share">650000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20230630"
      decimals="INF"
      id="Fxbrl_20220719155025581"
      unitRef="Share">650000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20230630"
      decimals="INF"
      id="Fxbrl_20230810033306000"
      unitRef="Share">248058700</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20230630"
      decimals="INF"
      id="Fxbrl_20230809214010119"
      unitRef="Share">248058700</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230810033400540"
      unitRef="Share">232636700</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230809214014304"
      unitRef="Share">232636700</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20220505093047469"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220505093055381"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230526182645930"
      unitRef="Share">11640460</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_20230630"
      decimals="INF"
      id="Fxbrl_20230501130254826"
      unitRef="Share">11640460</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20230501130942230"
      unitRef="USD">1218000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230501131017943"
      unitRef="USD">1218000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_78"
      unitRef="USD">103751000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_79"
      unitRef="USD">101260000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_80"
      unitRef="USD">-80542000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_81"
      unitRef="USD">-63819000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20220719200901554_Fact_84"
      unitRef="USD">21991000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220719200901554_Fact_85"
      unitRef="USD">36223000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_84"
      unitRef="USD">28849000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20221108131652038"
      unitRef="USD">43063000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230809215223124"
      unitRef="USD">5020000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230809215220236"
      unitRef="USD">2914000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_88"
      unitRef="USD">11907000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_89"
      unitRef="USD">5659000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230809215231300"
      unitRef="USD">3175000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230809215228919"
      unitRef="USD">3340000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_92"
      unitRef="USD">5337000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_93"
      unitRef="USD">5915000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230809215241397"
      unitRef="USD">8195000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230809215238845"
      unitRef="USD">6254000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_96"
      unitRef="USD">17244000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_97"
      unitRef="USD">11574000</us-gaap:OperatingExpenses>
    <cmmb:FinanceIncomeExpensesNet
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230809215250293"
      unitRef="USD">259000</cmmb:FinanceIncomeExpensesNet>
    <cmmb:FinanceIncomeExpensesNet
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230809215247462"
      unitRef="USD">-480000</cmmb:FinanceIncomeExpensesNet>
    <cmmb:FinanceIncomeExpensesNet
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20221026182150611"
      unitRef="USD">576000</cmmb:FinanceIncomeExpensesNet>
    <cmmb:FinanceIncomeExpensesNet
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230501164940410"
      unitRef="USD">-264000</cmmb:FinanceIncomeExpensesNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230809215258235"
      unitRef="USD">-7936000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230809215256180"
      unitRef="USD">-6734000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220808224756229"
      unitRef="USD">-16668000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220808224804527"
      unitRef="USD">-11838000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230809215305931"
      unitRef="USD">34000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230809215303547"
      unitRef="USD">-544000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220728231430174"
      unitRef="USD">55000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230809224849158"
      unitRef="USD">-544000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230809215314651"
      unitRef="USD">-7970000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230809215311694"
      unitRef="USD">-6190000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_104"
      unitRef="USD">-16723000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_105"
      unitRef="USD">-11294000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20230401to20230630"
      decimals="3"
      id="Fxbrl_s_20230809215336487"
      unitRef="USD_per_share">0.036</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20230401to20230630"
      decimals="3"
      id="Fxbrl_20230809215336487"
      unitRef="USD_per_share">0.036</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220401to20220630"
      decimals="3"
      id="Fxbrl_s_20230809215334095"
      unitRef="USD_per_share">0.027</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220401to20220630"
      decimals="3"
      id="Fxbrl_20230809215334095"
      unitRef="USD_per_share">0.027</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20230101to20230630"
      decimals="3"
      id="Fxbrl_20221108042029242"
      unitRef="USD_per_share">0.076</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20230101to20230630"
      decimals="3"
      id="Fxbrl_20220801220211119"
      unitRef="USD_per_share">0.076</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220101to20220630"
      decimals="3"
      id="Fxbrl_20221108042048740"
      unitRef="USD_per_share">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220101to20220630"
      decimals="3"
      id="Fxbrl_20220801220307005"
      unitRef="USD_per_share">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20230401to20230630"
      decimals="INF"
      id="Fxbrl_s_20230809215346232"
      unitRef="Share">221674130</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20230401to20230630"
      decimals="INF"
      id="Fxbrl_20230809215346232"
      unitRef="Share">221674130</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220401to20220630"
      decimals="INF"
      id="Fxbrl_s_20230809215343204"
      unitRef="Share">228173276</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220401to20220630"
      decimals="INF"
      id="Fxbrl_20230809215343204"
      unitRef="Share">228173276</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20230101to20230630"
      decimals="INF"
      id="Fxbrl_20230501140837133"
      unitRef="Share">221338951</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20230101to20230630"
      decimals="INF"
      id="Fxbrl_20230501140723514"
      unitRef="Share">221338951</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220101to20220630"
      decimals="INF"
      id="Fxbrl_20230501141120971"
      unitRef="Share">228132249</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220101to20220630"
      decimals="INF"
      id="Fxbrl_20230501141042185"
      unitRef="Share">228132249</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220719171142064_xbrl_20220504161436664"
      unitRef="Share">232636700</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220719171142064_xbrl_20220505093740414"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="INF"
      id="Fxbrl_20230501151602018"
      unitRef="Share">-11640460</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230501151611321"
      unitRef="USD">-1218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230501151742804"
      unitRef="USD">101260000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230501152649480"
      unitRef="USD">-63819000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230501152914617"
      unitRef="USD">36223000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220719171155021_xbrl_20220505093821193"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230809235850335"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230501153041825"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220719171155021_xbrl_20220504161917493"
      unitRef="USD">484000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220719171155021_xbrl_20220505093815054"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20220719171155021_xbrl_20220504161939600"
      unitRef="USD">484000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220719171210751_xbrl_20220505093843525"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230809235858412"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230501153100009"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220719171210751_xbrl_20220505093847704"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230501152819814"
      unitRef="USD">-8753000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20230501152925490"
      unitRef="USD">-8753000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230501152450068"
      unitRef="Share">232636700</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220719171143948_xbrl_20220505093740414"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="INF"
      id="Fxbrl_20230501152541868"
      unitRef="Share">-11640460</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230501152556917"
      unitRef="USD">-1218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230501152618776"
      unitRef="USD">101744000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230501152728382"
      unitRef="USD">-72572000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331"
      decimals="-3"
      id="Fxbrl_20230501152949713"
      unitRef="USD">27954000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230809235554008"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230809234301148_xbrl_20220719171155021_xbrl_20220505093821193"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230809234301148_xbrl_20230501153041825"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230809234301148_xbrl_20220719171155021_xbrl_20220504161917493"
      unitRef="USD">639000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230809234301148_xbrl_20220719171155021_xbrl_20220505093815054"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230809234301148_xbrl_20220719171155021_xbrl_20220504161939600"
      unitRef="USD">639000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230809235546224"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230809234310705_xbrl_20220719171210751_xbrl_20220505093843525"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230809234310705_xbrl_20230501153100009"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230809234310705_xbrl_20220719171210751_xbrl_20220505093847704"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230809234310705_xbrl_20230501152819814"
      unitRef="USD">-7970000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230809234310705_xbrl_20230501152925490"
      unitRef="USD">-7970000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230809234322626_xbrl_20230501152450068"
      unitRef="Share">15422000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230809234322626_xbrl_20220719171143948_xbrl_20220505093740414"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230809234322626_xbrl_20230501152541868"
      unitRef="USD">-0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230809234322626_xbrl_20230501152556917"
      unitRef="USD">-0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230809234322626_xbrl_20230501152618776"
      unitRef="USD">1368000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20230401to20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230809234322626_xbrl_20230501152728382"
      unitRef="USD">-0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230809234322626_xbrl_20230501152949713"
      unitRef="USD">1368000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesOutstanding
      contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230809234317544_xbrl_20230501152450068"
      unitRef="Share">248058700</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230809234317544_xbrl_20220719171143948_xbrl_20220505093740414"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="INF"
      id="Fxbrl_20230809234317544_xbrl_20230501152541868"
      unitRef="Share">-11640460</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockCommonMember"
      decimals="-3"
      id="Fxbrl_20230809234317544_xbrl_20230501152556917"
      unitRef="USD">-1218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230809234317544_xbrl_20230501152618776"
      unitRef="USD">103751000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20230630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230809234317544_xbrl_20230501152728382"
      unitRef="USD">-80542000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20230809234317544_xbrl_20230501152949713"
      unitRef="USD">21991000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220504161436664"
      unitRef="Share">228090300</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093740414"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504161607482"
      unitRef="USD">97639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504161812745"
      unitRef="USD">-36173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220504161847247"
      unitRef="USD">61466000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093821193"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504161917493"
      unitRef="USD">874000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220505093815054"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220504161939600"
      unitRef="USD">874000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093843525"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220505093847704"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504162015389"
      unitRef="USD">-5104000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220504162029289"
      unitRef="USD">-5104000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220504162054050"
      unitRef="Share">228090300</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093917037"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504162134224"
      unitRef="USD">98513000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504162140381"
      unitRef="USD">-41277000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331"
      decimals="-3"
      id="Fxbrl_20220504162145961"
      unitRef="USD">57236000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230809232027512_xbrl_20220505093821193"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230809232027512_xbrl_20220504161917493"
      unitRef="USD">761000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230809232027512_xbrl_20220505093815054"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230809232027512_xbrl_20220504161939600"
      unitRef="USD">761000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230809234813983"
      unitRef="Share">542820</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230809234833293"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230809234835878"
      unitRef="USD">29000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230809234838560"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230809234841545"
      unitRef="USD">29000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230809232045869_xbrl_20220505093843525"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230809232045869_xbrl_20220505093847704"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230809232045869_xbrl_20220504162015389"
      unitRef="USD">-6190000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230810025638731"
      unitRef="USD">-6190000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230809232054352_xbrl_20220504162054050"
      unitRef="Share">228633120</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230809232054352_xbrl_20220505093917037"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230809232054352_xbrl_20220504162134224"
      unitRef="USD">99303000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230809232054352_xbrl_20220504162140381"
      unitRef="USD">-47467000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20230809232054352_xbrl_20220504162145961"
      unitRef="USD">51836000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_193"
      unitRef="USD">-16723000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_194"
      unitRef="USD">-11294000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_195"
      unitRef="USD">32000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_196"
      unitRef="USD">27000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_205"
      unitRef="USD">1123000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_206"
      unitRef="USD">1635000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_197"
      unitRef="USD">-811000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220719185926153"
      unitRef="USD">1483000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220719190053059"
      unitRef="USD">-6000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230809222022215"
      unitRef="USD">-15000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_199"
      unitRef="USD">659000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_200"
      unitRef="USD">97000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230501141051534"
      unitRef="USD">-875000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_202"
      unitRef="USD">1157000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230501141057759"
      unitRef="USD">307000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_204"
      unitRef="USD">464000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230810032428783"
      unitRef="USD">2051000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220719185858022"
      unitRef="USD">1882000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_209"
      unitRef="USD">-14672000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_210"
      unitRef="USD">-9412000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cmmb:ProceedsFromSaleOfDeposits
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_211"
      unitRef="USD">10167000</cmmb:ProceedsFromSaleOfDeposits>
    <cmmb:ProceedsFromSaleOfDeposits
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220719190124821"
      unitRef="USD">4134000</cmmb:ProceedsFromSaleOfDeposits>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_215"
      unitRef="USD">3000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_216"
      unitRef="USD">25000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_217"
      unitRef="USD">10164000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_218"
      unitRef="USD">4109000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <cmmb:IssuanceOfSharesNetOfIssuanceCosts
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230809221403519_Fact_215"
      unitRef="USD">1368000</cmmb:IssuanceOfSharesNetOfIssuanceCosts>
    <cmmb:IssuanceOfSharesNetOfIssuanceCosts
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230809221403519_Fact_216"
      unitRef="USD">0</cmmb:IssuanceOfSharesNetOfIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230809221407295_Fact_215"
      unitRef="USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230809221407295_Fact_216"
      unitRef="USD">22000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="FFact_229"
      unitRef="USD">1368000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_230"
      unitRef="USD">22000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230809221912445"
      unitRef="USD">-3140000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230501141209877"
      unitRef="USD">-5281000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_233"
      unitRef="USD">13596000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_234"
      unitRef="USD">15241000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20230630"
      decimals="-3"
      id="FFact_235"
      unitRef="USD">10456000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_236"
      unitRef="USD">9960000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <cmmb:AccountReceivableDueToExerciseOfOptions
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230809221409968_Fact_215"
      unitRef="USD">0</cmmb:AccountReceivableDueToExerciseOfOptions>
    <cmmb:AccountReceivableDueToExerciseOfOptions
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230809221409968_Fact_216"
      unitRef="USD">7000</cmmb:AccountReceivableDueToExerciseOfOptions>
    <us-gaap:NatureOfOperations
      contextRef="C_20230101to20230630"
      id="Fxbrl_20221108050710796">
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Note 1 - General.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0"&gt;

                    &lt;tr style="vertical-align:top"&gt;
                      &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:top;width:36pt"&gt;
                        &lt;div style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
                        &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Chemomab Therapeutics Ltd. (the &lt;/span&gt;&lt;/span&gt;&#x201c;&lt;span&gt;&lt;span&gt;Company") is an Israeli-based company incorporated under the laws of the State of Israel in September 2011. The &lt;/span&gt;&lt;/span&gt;Company&#x2019;s&lt;span&gt;&lt;span&gt; registered office is located in Kiryat Atidim, Tel Aviv, Israel. The Company is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis. The wholly owned subsidiaries of the Company are: Chemomab Ltd. ("Chemomab"), Chemomab Therapeutics Israel Ltd. and Chemomab Therapeutics Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:justify"&gt;&#160;&lt;/div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company currently has no products approved for sale. The Company&#x2019;s operations are funded primarily by its Shareholders. The Company has incurred operating losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval for its products. Continuation of the Company&#x2019;s development programs depend on its future ability to raise sources of financing. The Company believes that its existing liquidity resources as of June 30, 2023, will enable it to fund its operations through December 31, 2024 with the ability to perform cost reductions in order to extend the operations even further, if required to do so.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="text-indent:-36pt;margin-left:72pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:36pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On April 30, 2021, the Company entered into an At the Market Offering Agreement (the "ATM Agreement") with Cantor Fitzgerald &amp;amp; Co., ("Cantor"). According to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75 million through Cantor or the ATM Agreement. On April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance and sale of up to $18,125,000 of its ADSs in connection with the reactivation of the ATM Agreement Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject to certain exceptions, limits the amount of securities the Company is able to offer and sell under such registration statement to one-third of the Company's unaffiliated public float. From April 30, 2021, through June 30, 2023, the Company issued 1,470,906 ADSs under the ATM Agreement, resulting in gross proceeds of $17,327 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:36pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;C.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On June 1, 2023, the board of directors &lt;/span&gt;&lt;/span&gt;(the &#x201c;Board&#x201d;)&lt;span&gt;&lt;span&gt; of the Company appointed Dr. Adi Mor as Chief Executive Officer of the Company (to replace Dr. Dale Pfost), and Sigal Fattal as the Chief Financial Officer of the Company (to replace Donald Marvin), effective as of the same date. The company has recorded in June 2023 a provision for severance payments to Dale Pfost and Donald Marvin in the amount of $1,110 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:NatureOfOperations>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_20230101to20230630_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="-6"
      id="Fxbrl_20230810001855292"
      unitRef="USD">75000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="0"
      id="Fxbrl_20230810001930712"
      unitRef="USD">18125000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_20230101to20230630_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="INF"
      id="Fxbrl_20230810002052582"
      unitRef="Share">1470906</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="C_20230101to20230630_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="-3"
      id="Fxbrl_20230810002107131"
      unitRef="USD">17327000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SeveranceCosts1
      contextRef="C_20230101to20230630_srtTitleOfIndividualAxis_cmmbDalePfostAndDonaldMarvinMember"
      decimals="-3"
      id="Fxbrl_20230810014738513"
      unitRef="USD">1110000</us-gaap:SeveranceCosts1>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_20230101to20230630"
      id="Fxbrl_20220505134338955">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note 2 -&#160; Basis of Presentation and Significant Accounting Policies&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Basis of Preparation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;line-height:normal;font-family:Times New Roman, serif"&gt;The condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#x2019;s financial position as of June 30, 2023, and its results of operations for the six months ended June 30, 2023, and 2022, changes in shareholders&#x2019; equity for the six months ended June 30, 2023 and 2022, and cash flows for the six months ended June 30, 2023 and 2022. The results of operations for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other future annual or interim period. These financial statements should be read in conjunction with the audited financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2022. The Company&#x2019;s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2022 included in the Company&#x2019;s Annual Report on Form 10-K. Since the date of such financial statements, there have been no changes to the Company&#x2019;s significant accounting policies.&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Use of estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, serif"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_20230101to20230630"
      id="Fxbrl_20221108051936803">
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Basis of Preparation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;line-height:normal;font-family:Times New Roman, serif"&gt;The condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#x2019;s financial position as of June 30, 2023, and its results of operations for the six months ended June 30, 2023, and 2022, changes in shareholders&#x2019; equity for the six months ended June 30, 2023 and 2022, and cash flows for the six months ended June 30, 2023 and 2022. The results of operations for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any other future annual or interim period. These financial statements should be read in conjunction with the audited financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2022. The Company&#x2019;s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2022 included in the Company&#x2019;s Annual Report on Form 10-K. Since the date of such financial statements, there have been no changes to the Company&#x2019;s significant accounting policies.&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_20230101to20230630"
      id="Fxbrl_20221108051959534">
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Use of estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, serif"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:UseOfEstimates>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_20230101to20230630"
      id="Fxbrl_20220728222325384">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Note 3 - Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;margin-left:36pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;During 2022, the Israeli tax authority ("ITA&#x201d;) notified the Company that it had initiated a routine VAT audit to include tax years 2017 through 2020. The ITA raised several claims, mainly in respect with the recoverability of VAT with respect to Merger Agreement related expenses and the classification of the Company as a holding company. On July 2022, the ITA proposed a settlement, which the Company rejected. As a result, the ITA issued an assessment.&#160;On November 2022, The Company appealed the ITA&#x2019;s assessment. The Company has recorded a provision in 2022 that is inherently subjective due to the inherent uncertainty of these matters and the judicial process. Therefore, the outcome may differ from the estimated liability recorded by the Company during 2022. &#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#FFact_78"
          xlink:label="FFact_78"
          xlink:type="locator"/>
        <link:footnote id="FN20230810010143416" xlink:label="FN20230810010143416" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">1 American Depositary Share (ADS) represents 20 Ordinary Shares</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_78"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_79"
          xlink:label="FFact_79"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_79"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_80"
          xlink:label="FFact_80"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_80"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_81"
          xlink:label="FFact_81"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_81"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220505093047469"
          xlink:label="Fxbrl_20220505093047469"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220505093047469"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220505093055381"
          xlink:label="Fxbrl_20220505093055381"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220505093055381"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220719155003261"
          xlink:label="Fxbrl_20220719155003261"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220719155003261"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220719155025581"
          xlink:label="Fxbrl_20220719155025581"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220719155025581"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220719200901554_Fact_85"
          xlink:label="Fxbrl_20220719200901554_Fact_85"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220719200901554_Fact_85"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220719200901554_Fact_84"
          xlink:label="Fxbrl_20220719200901554_Fact_84"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220719200901554_Fact_84"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230501130254826"
          xlink:label="Fxbrl_20230501130254826"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230501130254826"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230501130942230"
          xlink:label="Fxbrl_20230501130942230"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230501130942230"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230501131017943"
          xlink:label="Fxbrl_20230501131017943"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230501131017943"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230809214010119"
          xlink:label="Fxbrl_20230809214010119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230809214010119"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230809214014304"
          xlink:label="Fxbrl_20230809214014304"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230809214014304"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220801220211119"
          xlink:label="Fxbrl_20220801220211119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220801220211119"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220801220307005"
          xlink:label="Fxbrl_20220801220307005"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220801220307005"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230501140723514"
          xlink:label="Fxbrl_20230501140723514"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230501140723514"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230501141042185"
          xlink:label="Fxbrl_20230501141042185"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230501141042185"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230809215334095"
          xlink:label="Fxbrl_20230809215334095"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230809215334095"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230809215336487"
          xlink:label="Fxbrl_20230809215336487"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230809215336487"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230809215343204"
          xlink:label="Fxbrl_20230809215343204"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230809215343204"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230809215346232"
          xlink:label="Fxbrl_20230809215346232"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230809215346232"
          xlink:to="FN20230810010143416"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>23
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M'"5C:[1G,Q@?U6&4C-RRDBGFSR$8),7GUHZ7LK;O<T^-,,R-GP0I*-B01TM
M7G==XD,X'A*W1PHF638R)3U#PC!%7N2Y:&BXID&7Z- \PD. KA3&Z1C G@]A
MF!!_JC8E?Z34UC5!2]N2!]&ZI >SQ FG1VJ^4T[VT?;4"(-4Y-2V0RL]\_09
M3A7V"*&Q7.Q9#89I;;_1.(330VL9&G8;/JDT'FF!4<]L*#JZWSB $P4Y\MD[
ME!>RMN]WSY/H>3RYX[O>A)9/;8DW#BX-XF&^>F06<&2N=K:0SV7*0S/F$J&+
MU)491=I3)3JP!>15Q93ID=I=0<YK$^MC( <-^Y<%\*ZO_V]HW_F>B%%X7]E.
MTR$_W;UBDLV'U<DK%8\44M33)IH'D_YF301=\[*@0OY@^UGUZ 499-]G9_P+
M6=MWNB=C=&"_*@I6$_$(I/%>ZCS2C8, ]Z1LJ$[YBT:MN6#_TN(4)/-H&D7V
M[TF:2,!7X'U3T^Y0R:[L:[W_K6[U1OCIK.A'\$Y*0_KF+6^45/I"K_U3@.)L
M&LVS::JM#L&,F4<831.<6)U6QAW0$^O+ ['X&_[CG6^WRQCN 8(B^S/3=R'H
MP+9<Z!+</ 4#$*7KA53@-833)(ZF<7)\O)SHO/%&)XQG+#IN5W,"$71R]I#8
M?I3Z[@>%NY^+HF#F!%O7%KM19C7(R8;I6N-U,6QLS$5?RX33.1SZZ).#:*S%
M0WWCA,*-D^Z8FZII^]""KEC.?!OLRP-6QKQS6ZB3+)H[1T\^N01G8^>-N&^V
M</@8H64&>5SUO3Q@;,1)[!XK(+A8#&?0(X83--;YXKZOPN&^RB$_FY9'NGRU
M-;Y[T.O;0GO$ EMH;!JL_2<[1]GA1D8'&8*+B@J6DUI7%WM";.J0I5#P^N+Z
MYHW>.%G",LT.VBE55D3ZN&NV\QE%V[ZSGZ.DKGI-K=IS]NYI]\GKTGX9&C['
MZ/0*(^\;K-_8;SVS?HCV&]MO1-RQ6NK.=Z6'B]ZF.I"B_6S5WBB^L1]R;KE2
MO+*7:ZIWVL((Z/<KSM73C1F@^WBX_ ]02P,$%     @ NT .5VV&SY)" P
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MZ"913V+W&ZL$^9HO$HDL?M&NPCH6BC92B;0R!@]2GI7_]*4*Q($!=D\8D,J
M- W\$P9N9> V#;P3!EYEX)T[@U\9^.?.$%0&13+M,EA%I,=4T>$@%SN4:S2P
MZ8LB784U!)AGNK)F*H>G'.S4<"2R&.J$Q0BNI$AX3!7<O,\4RWF*9@INH9"4
M1&*!/JY93G5!2'3QG-%-S %[B:[1\VR,+MY=HG>(9^C32FPDS6(YL!5XJ.>Q
MH\J;4>D-.>&-BSZ(3*TDFH!7L<%^TFT?=-C;$)DZ/.0U/"/22?C[)KM!KG.%
MB$-<@S_C\\V)2<[_FWWZW;,?!<.M:\4M^+P3?%7ZLR5B+VM=-,8,EQRNF4-O
ME+=R32-V9\%.*%F^9=;PYY]PX/QB"N^/))O\2++I#R([2H17)\+K8A\^ 2/-
MHQ6"50;;Z!;>#VN]2$WI*)G\@DF_9K9#WR'.P-X>AKD-(GWL'8,F;1#&?2<\
M1DT-\P5^OP8=Z?5KO7ZGWE]9!I67%')I#+L@ETI7XI:9%)=<P8$'+@[]AF(#
MR/4:89FT0;[K-@4;0'WLFP4'M>"@4_ GH4"N.&N]!:WY>[C?E-L&!<1O)K@-
MPB'Q&JBI 87]T#,+#FO!8:?@*<]H%AU(11<\BT3*+J]0QHR%';;\N"8'A5;J
M;H.\7C/+!B(_#!JJVR 2G-#<JS7W.C7_(:1$<P;=(4.*OIBSVVO-&_;=AG/C
M-B@(W69VVR <!$&OH=. PCVW9U;:KY7VN\M9JT/01Y8Y11=S6- +KBY-BOOM
ME=F0,FY#KOUFG4[:(+^Q*J9O\!QIQ<Z^HW(ZU?X)WP.)SBUD%JD50[",N3!U
M,Z.*R3]*;]C<G0VH ';>AEX#"@>A[AN.-)M@F/1/J3[H(W&GZ@<J>53J!KWH
M8Q[#DLZ_H=F*YJ9M^N$-OK_Q/\:(E5;A@?O.C=-:$688"9LQ,\):B[^"]8YA
M)_9X3/8A(YT2QSS9Z&;[_*"-*L8WY1MA;?E&6%L^^2_R]]TD[NR1AI^+KS[0
M3[?PGELRE&W2.41!?V@<!0*VCHV2"M[^\(*XTA^2/#)65/=\IRK*;6_M!%:.
MA]W60C1!>SAT23-F$S.KZ_;Z/FZ&U\SJ$N*=Z)OPOE'$W9WB]\8X+DO3&"_O
M_'B9H"?B960UQ\O,VA4OW6@>C^P[,=S=BD'58'2?PA8>T0R-V5I(KNJPH8O[
M\>P2Y:SH\O5G,G&:D34U_/;!%SMP+XNS%8DBL<E4V1?7H_7YS4-Q:M$8'^';
M,3:,3_1YCV'\'ONWD_*<I?4D@"?EJ<+>I?* Z0/-EQR^^A.V /><FQ!>'WEY
M9E/>*+$NSACF0BF1%I<K1F.6:P \7PBA7F_T!/7)V?!?4$L#!!0    ( +M
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M>  ZQ=BU+7NHYDK>;.T!8=3(FF+KAZPSLD1N9'62=**VKVK(BH@FTO:'^X(
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M5=*8W4R@E!63>S99_?X;CKP_7"Y?R-A) ((V ,&8]=5?T)@RH<!](9%.&8(
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M1Z!XG$';P@"P>PXG ;1Y.G^3V;QH0AWTD=MB ?:6 ] [^L3+%Y7&EA>TB,]
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MC0!\WPJAGQ?F!]K+]=7_4$L#!!0    ( +M #E?)5/ 5R 8  +,.   8
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M';#I@IQ>O*GCI71I/%UQXV-)VH*6-]#WPM"=HWEA!^U_*=-_ %!+ P04
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MQ_(&Q,]*'EWTP4#.2R=7N%^$ +MG?/834$L#!!0    ( +M #E=<7R VXP0
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M]"Q\V)/.L#5]:/F&3Z53H,Q"QF&-I5"9IOL#FY1)A#-GN=XXY_#E!HM[E/_
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M=\>!GG+[1!%4%=.&/<$XDB08 KWH[M$X1K(3P\=='^PIB:(D<2. N15$$8;
MTX@CF +0@"%1U)V#!^=1L#FG@NV_'V:_ %!+ P04    " "[0 Y7EXJ[',
M   3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!
M5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]I
MSI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z
M3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=
MQ_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( +M
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M?=>><0,-[1HY8+>J S\?Y)TA!>1 "=XYHU$QAQ*W4DO*0020Z0AD.B'DSS2
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M?6FW:VZDL@>^Z/Z,YI]02P$"% ,4    " "[0 Y7!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( +M
M#E>L:D!C[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( +M #E>97)PC$ 8  )PG   3              "
M <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ NT .5V& [@8>
M P  %0L  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( +M #E<PF-#.;08  $@<   8              "
M@6(+  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "[0 Y7
M;8;/DD(#   R"@  &               @($%$@  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ NT .5W+$9NCY!   11,  !@
M     ("!?14  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M +M #E?MC='>8P@  (T]   8              " @:P:  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    " "[0 Y77MX E8D%  !H%P  &
M            @(%%(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ NT .5\E4\!7(!@  LPX  !@              ("!!"D  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( +M #E=F[]5LU@0  +$,
M   8              " @0(P  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    " "[0 Y76BV%XIL#  #2!P  &               @($.-0
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ NT .5UQ?(#;C
M!   V P  !D              ("!WS@  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    " "[0 Y7:%JSO&D#  "Q"P  &0
M@('Y/0  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( +M
M#E=?%]QK$ ,  (L0   -              "  9E!  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ NT .5Y>*NQS     $P(   L              ( !U$0
M %]R96QS+RYR96QS4$L! A0#%     @ NT .5\%+-UKI 0  @@@   \
M         ( !O44  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( +M #E=P
M4I#K[    *@'   :              "  =-'  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( +M #E=QYD;,00$  "$)   3
M      "  ?=(  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     3 !, _ 0
' &E*      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>50</ContextCount>
  <ElementCount>88</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>7</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - Condensed Consolidated Interim Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Interim Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/InterimStatementsOfChangesInEquity</Role>
      <ShortName>Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - Condensed Consolidated Interim Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Interim Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/General.</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - Basis of Presentation and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0011 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies</ParentRole>
      <Position>10</Position>
    </Report>
    <Report instance="zk2330149.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0013 - Disclosure - General (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/General.Details</Role>
      <ShortName>General (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/General.</ParentRole>
      <Position>11</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cmmb-20230630.xsd</File>
    <File>cmmb-20230630_cal.xml</File>
    <File>cmmb-20230630_def.xml</File>
    <File>cmmb-20230630_lab.xml</File>
    <File>cmmb-20230630_pre.xml</File>
    <File doctype="6-K" isDefinitelyFs="true" isUsgaap="true" original="zk2330149.htm">zk2330149.htm</File>
    <File doctype="6-K" isDefinitelyFs="true" isUsgaap="true" original="exhibit_99-1.htm">exhibit_99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="232">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="13">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>28
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zk2330149.htm exhibit_99-1.htm": {
   "nsprefix": "cmmb",
   "nsuri": "http://www.anchiano.com/20230630",
   "dts": {
    "schema": {
     "local": [
      "cmmb-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "cmmb-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cmmb-20230630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cmmb-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmmb-20230630_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "exhibit_99-1.htm",
      "zk2330149.htm"
     ]
    }
   },
   "keyStandard": 84,
   "keyCustom": 4,
   "axisStandard": 4,
   "axisCustom": 0,
   "memberStandard": 4,
   "memberCustom": 3,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 50,
   "entityCount": 1,
   "segmentCount": 7,
   "elementCount": 167,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 232,
    "http://xbrl.sec.gov/dei/2023": 13
   },
   "report": {
    "R1": {
     "role": "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
     "longName": "0001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2330149.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2330149.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets",
     "longName": "0002 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_20230630",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230630",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.anchiano.com/role/BalanceSheetsParenthetical",
     "longName": "0003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_20230630",
      "name": "us-gaap:CommonStockNoParValue",
      "unitRef": "USD_per_share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:CommonStockNoParValue",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230630",
      "name": "us-gaap:CommonStockNoParValue",
      "unitRef": "USD_per_share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:CommonStockNoParValue",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations",
     "longName": "0004 - Statement - Condensed Consolidated Interim Statements of Operations (Unaudited)",
     "shortName": "Condensed Consolidated Interim Statements of Operations (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_20230401to20230630",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230401to20230630",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity",
     "longName": "0005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)",
     "shortName": "Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows",
     "longName": "0006 - Statement - Condensed Consolidated Interim Statements of Cash Flows (Unaudited)",
     "shortName": "Condensed Consolidated Interim Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.anchiano.com/role/General.",
     "longName": "0007 - Disclosure - General",
     "shortName": "General",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies",
     "longName": "0008 - Disclosure - Basis of Presentation and Significant Accounting Policies",
     "shortName": "Basis of Presentation and Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.anchiano.com/role/Contingencies",
     "longName": "0009 - Disclosure - Contingencies",
     "shortName": "Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies",
     "longName": "0011 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)",
     "shortName": "Basis of Presentation and Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.anchiano.com/role/General.Details",
     "longName": "0013 - Disclosure - General (Detail Textuals)",
     "shortName": "General (Detail Textuals)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cmmb_AccountReceivableDueToExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "AccountReceivableDueToExerciseOfOptions",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of account receivable due to exercise of options.",
        "label": "Account Receivable Due To Exercise Of Options",
        "terseLabel": "Account receivable Due to Exercise of Options",
        "verboseLabel": "Receivable related to exercise of options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r10"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r307",
      "r388"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid in capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r220",
      "r338",
      "r339",
      "r340",
      "r375",
      "r389"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Adjustments for operating activities",
        "documentation": "The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_AmericanDepositarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "AmericanDepositarySharesMember",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares [Member]",
        "label": "American Depositary Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_AmericanDepositorySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "AmericanDepositorySharesMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for American Depository Shares.",
        "label": "American Depository Shares [Member]",
        "terseLabel": "American Depositary Share (\"ADS\") [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Default Label]",
        "totalLabel": "Total assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r70",
      "r85",
      "r111",
      "r114",
      "r116",
      "r118",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r165",
      "r169",
      "r180",
      "r196",
      "r254",
      "r307",
      "r319",
      "r346",
      "r347",
      "r378"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r74",
      "r85",
      "r118",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r165",
      "r169",
      "r180",
      "r307",
      "r346",
      "r347",
      "r378"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r118",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r165",
      "r169",
      "r180",
      "r346",
      "r347",
      "r378"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for At the Market Offering Agreement with Cantor Fitzgerald &amp; Co.",
        "label": "At Market Offering Agreement With Cantor Fitzgerald And Co [Member]",
        "terseLabel": "At The Market Offering Agreement With Cantor Fitzgerald &amp; Co. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Preparation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r302",
      "r303"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r163",
      "r302",
      "r303"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r69",
      "r296"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r44",
      "r83"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash, cash equivalents and restricted cash",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r44"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of non-cash investing and financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r71",
      "r72",
      "r73",
      "r85",
      "r101",
      "r102",
      "r104",
      "r106",
      "r109",
      "r110",
      "r118",
      "r134",
      "r136",
      "r137",
      "r138",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r180",
      "r214",
      "r215",
      "r216",
      "r217",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r242",
      "r263",
      "r280",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r327",
      "r336",
      "r341"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingent liabilities",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r27",
      "r197",
      "r241"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/Contingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r128",
      "r129",
      "r293",
      "r345"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares [Member]",
        "terseLabel": "Ordinary Shares [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r338",
      "r339",
      "r375",
      "r387",
      "r389"
     ]
    },
    "us-gaap_CommonStockNoParValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockNoParValue",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, No Par Value",
        "documentation": "Face amount per share of no-par value common stock."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r242"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r34",
      "r242",
      "r260",
      "r389",
      "r390"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares no par value - Authorized: 650,000,000 shares as of September 30, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 227,956,060 ordinary shares at September 30, 2021 and 9,274,838 ordinary shares at December 31, 2020",
        "terseLabel": "Ordinary shares no par value - Authorized: 650,000,000 shares as of March 31, 2022 and as of December 31, 2021; Issued and outstanding: 228,090,300 ordinary shares at March 31, 2022 as of December 31, 2021",
        "verboseLabel": "Ordinary shares no par value - Authorized: 650,000,000 shares as of June 30, 2023 and December 31, 2022; Issued and outstanding: 248,058,700 Ordinary shares as of June 30, 2023 and 232,636,700 as of December 31, 2022;",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r198",
      "r307"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_DalePfostAndDonaldMarvinMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "DalePfostAndDonaldMarvinMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for Dale Pfost and Donald Marvin .",
        "label": "Dale Pfost And Donald Marvin [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositsAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short term bank deposits",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r21"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r324"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted loss per Ordinary Share",
        "terseLabel": "Basic loss per Ordinary Share",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r92",
      "r93",
      "r94",
      "r95",
      "r99",
      "r101",
      "r104",
      "r105",
      "r106",
      "r107",
      "r178",
      "r179",
      "r193",
      "r205",
      "r297"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted loss per Ordinary Share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r92",
      "r93",
      "r94",
      "r95",
      "r101",
      "r104",
      "r105",
      "r106",
      "r107",
      "r178",
      "r179",
      "r193",
      "r205",
      "r297"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee and related expenses",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r65",
      "r77",
      "r78",
      "r79",
      "r86",
      "r87",
      "r88",
      "r90",
      "r96",
      "r98",
      "r108",
      "r119",
      "r120",
      "r148",
      "r155",
      "r156",
      "r157",
      "r160",
      "r161",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r189",
      "r208",
      "r209",
      "r210",
      "r220",
      "r280"
     ]
    },
    "cmmb_FinanceIncomeExpensesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "FinanceIncomeExpensesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of finance income earned and finance expenses incurred during the period.",
        "negatedLabel": "Financing expense (income), net",
        "label": "Finance Income Expenses Net",
        "terseLabel": "Financing expense, net"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_FormerChemomabSecurityHoldersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "FormerChemomabSecurityHoldersMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents former Chemomab security holders.",
        "label": "Former Chemomab Security Holders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r265"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Loss before taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r40",
      "r53",
      "r111",
      "r113",
      "r115",
      "r117",
      "r194",
      "r202",
      "r299"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Taxes on income (benefit)",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Taxes Expenses (Income)",
        "verboseLabel": "Taxes on income (benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r62",
      "r97",
      "r98",
      "r112",
      "r159",
      "r162",
      "r206"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in trade payables",
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in accrued expenses",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in employees and related expenses",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Change in operating lease liability",
        "verboseLabel": "Change in operating lease liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r334"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in other receivables and prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "cmmb_IssuanceOfSharesNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "IssuanceOfSharesNetOfIssuanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of shares net, of issuance costs.",
        "label": "Issuance Of Shares Net Of Issuance Costs",
        "terseLabel": "Issuance of shares net, of issuance costs",
        "verboseLabel": "Issuance of Shares, net of issuance expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r85",
      "r118",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r166",
      "r169",
      "r170",
      "r180",
      "r240",
      "r298",
      "r319",
      "r346",
      "r378",
      "r379"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r52",
      "r200",
      "r307",
      "r337",
      "r343",
      "r376"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r68",
      "r85",
      "r118",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r166",
      "r169",
      "r170",
      "r180",
      "r307",
      "r346",
      "r378",
      "r379"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r29",
      "r30",
      "r31",
      "r32",
      "r85",
      "r118",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r166",
      "r169",
      "r170",
      "r180",
      "r346",
      "r378",
      "r379"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r133",
      "r150",
      "r191",
      "r207",
      "r232",
      "r233",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r294",
      "r295",
      "r300",
      "r301",
      "r304",
      "r308",
      "r348",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385"
     ]
    },
    "cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company.",
        "label": "Merger Agreement With Chemomab Israeli Limited Company And Clinical Stage Biotech Company [Member]",
        "terseLabel": "Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r133",
      "r150",
      "r191",
      "r207",
      "r232",
      "r233",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r294",
      "r295",
      "r300",
      "r301",
      "r304",
      "r308",
      "r348",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.anchiano.com/role/General."
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operations [Text Block]",
        "verboseLabel": "General",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r63"
     ]
    },
    "cmmb_NatureOfOperationsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "NatureOfOperationsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Nature Of Operations Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r46"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity",
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net loss for the period",
        "positiveLabel": "Net loss for the period/year",
        "label": "Net loss for the period",
        "totalLabel": "Net loss for the period",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r46",
      "r54",
      "r66",
      "r75",
      "r76",
      "r79",
      "r85",
      "r89",
      "r91",
      "r92",
      "r93",
      "r94",
      "r97",
      "r98",
      "r103",
      "r111",
      "r113",
      "r115",
      "r117",
      "r118",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r179",
      "r180",
      "r204",
      "r262",
      "r278",
      "r279",
      "r299",
      "r317",
      "r346"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "OneEmployeeOneOfficerConsultantAndSixBoardMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One employee one officer consultant and six Board [Member]",
        "label": "One Employee One Officer Consultant And Six Board [Member]",
        "verboseLabel": "One employee one officer consultant and six Board [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities - long term",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "cmmb_OrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "OrdinarySharesMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares [Member]",
        "label": "Ordinary Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_OrdinarySharesNoParValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares, No Par Value Per Share [Member]",
        "label": "Ordinary Shares, No Par Value Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "cmmb_PaymentsToPurchaseOfDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "PaymentsToPurchaseOfDeposits",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to purchase of deposits.",
        "negatedLabel": "Increase in deposits",
        "label": "Payments To Purchase Of Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other receivables and prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term prepaid expenses",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "cmmb_ProceedsFromSaleOfDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "ProceedsFromSaleOfDeposits",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of deposits.",
        "label": "Proceeds From Sale Of Deposits",
        "terseLabel": "Decrease in bank deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options",
        "terseLabel": "Exercise of Shares",
        "verboseLabel": "Exercise of options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r7"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "verboseLabel": "Net loss for the period",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r75",
      "r76",
      "r81",
      "r85",
      "r89",
      "r97",
      "r98",
      "r111",
      "r113",
      "r115",
      "r117",
      "r118",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r164",
      "r167",
      "r168",
      "r179",
      "r180",
      "r194",
      "r203",
      "r219",
      "r262",
      "r278",
      "r279",
      "r299",
      "r305",
      "r306",
      "r318",
      "r333",
      "r346"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r195",
      "r201",
      "r307"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r133",
      "r149",
      "r150",
      "r152",
      "r153",
      "r154",
      "r190",
      "r191",
      "r207",
      "r232",
      "r233",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r294",
      "r295",
      "r300",
      "r301",
      "r304",
      "r308",
      "r311",
      "r344",
      "r348",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r133",
      "r149",
      "r150",
      "r152",
      "r153",
      "r154",
      "r190",
      "r191",
      "r207",
      "r232",
      "r233",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r294",
      "r295",
      "r300",
      "r301",
      "r304",
      "r308",
      "r311",
      "r344",
      "r348",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r158",
      "r386"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash, Current",
        "verboseLabel": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r335"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r330",
      "r335"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r50",
      "r199",
      "r211",
      "r212",
      "r218",
      "r243",
      "r307"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit [Member]",
        "terseLabel": "Accumulated Deficit [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r86",
      "r87",
      "r88",
      "r90",
      "r96",
      "r98",
      "r119",
      "r120",
      "r155",
      "r156",
      "r157",
      "r160",
      "r161",
      "r171",
      "r173",
      "r174",
      "r176",
      "r177",
      "r208",
      "r210",
      "r220",
      "r389"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate offering price",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds from sale under agreement",
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued under agreement",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Exchange on which Security is Registered",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Security holders of anchiano as of immediately prior to merger.",
        "label": "Security Holders Of Anchiano As Of Immediately Prior To Merger [Member]",
        "verboseLabel": "Security holders of Anchiano as of immediately prior to the merger [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Severance Costs",
        "terseLabel": "Severance costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation expense",
        "verboseLabel": "Share-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (In shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation and Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r84"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r71",
      "r72",
      "r73",
      "r85",
      "r101",
      "r102",
      "r104",
      "r106",
      "r109",
      "r110",
      "r118",
      "r134",
      "r136",
      "r137",
      "r138",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r180",
      "r214",
      "r215",
      "r216",
      "r217",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r242",
      "r263",
      "r280",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r327",
      "r336",
      "r341"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r16",
      "r65",
      "r77",
      "r78",
      "r79",
      "r86",
      "r87",
      "r88",
      "r90",
      "r96",
      "r98",
      "r108",
      "r119",
      "r120",
      "r148",
      "r155",
      "r156",
      "r157",
      "r160",
      "r161",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r189",
      "r208",
      "r209",
      "r210",
      "r220",
      "r280"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87",
      "r88",
      "r108",
      "r192",
      "r213",
      "r231",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r242",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r280",
      "r312"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87",
      "r88",
      "r108",
      "r192",
      "r213",
      "r231",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r242",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r280",
      "r312"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of shares, net (in shares)",
        "verboseLabel": "Issuance of shares, net of issuance expenses (in shares)",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r33",
      "r34",
      "r50",
      "r214",
      "r280",
      "r289"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of options (in shares)",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r33",
      "r34",
      "r50",
      "r151"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of shares, net of issuance expenses",
        "verboseLabel": "Issuance of shares, net",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r33",
      "r34",
      "r50",
      "r220",
      "r280",
      "r289",
      "r318"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r33",
      "r34",
      "r50"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r16",
      "r50"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity",
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "label": "Equity, Attributable to Parent",
        "totalLabel": "Total shareholders' equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r37",
      "r38",
      "r48",
      "r244",
      "r260",
      "r281",
      "r282",
      "r307",
      "r319",
      "r337",
      "r343",
      "r376",
      "r389"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Shareholders' equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r342",
      "r377"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury share [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury share at cost (11,640,460 Ordinary shares as of June 30, 2023 and December 31, 2022)",
        "label": "Treasury Stock, Value",
        "terseLabel": "Treasury share at cost (11,640,460 ordinary shares as of March 31, 2023 and December 31, 2022)",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r22",
      "r23"
     ]
    },
    "cmmb_TwoThousandFifteenPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20230630",
     "localname": "TwoThousandFifteenPlanMember",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Plan [Member]",
        "label": "Two Thousand Fifteen Plan [Member]",
        "terseLabel": "2015 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r58",
      "r59",
      "r60",
      "r61"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average number of Ordinary Shares outstanding, diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r106"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of Ordinary Shares outstanding, basic, and diluted",
        "terseLabel": "Weighted average number of Ordinary Shares outstanding, basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r106"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r334": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r335": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r336": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r339": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r340": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r341": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r342": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r343": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r344": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r345": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r346": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r347": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r348": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r349": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r377": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r379": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r380": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r381": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r382": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r383": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r384": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r385": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r386": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r388": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r390": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>29
<FILENAME>0001178913-23-002860-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-23-002860-xbrl.zip
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M')Z[5 RV^.E'67YM(\21YW"[9OZX1MKH]236)&NRX.C[?*=*9X*CO,,'%M5
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M(1<^WD3ZN2NJGD.&OOP?4$L#!!0    ( +M #E?1M1VC,$,   D? P 5
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M-5Z\>(G_0Z_XB<3H.=]@#E@6XCTTO)691.N_J)6T<-NJ7FB'H?V'L;;#T#[
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MV"V"0P/\R4L+F._=J><$_WE*YV05YX'0HMU<)W=24O.5.1E*LKNGM-T:T:X
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M0P(Y2RM_!ZW\_8][/^R[YZ<[/#K<^W3T2<CHV_WPWWS,/\4+A^TG.[?0JGD
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ME7&2YJ"9D=-5U#.K.4^7 IA\4>22/I#X.KVA#Y@R-*71%5DB/8NM=JS#,T\
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M>Q'E#T=!^1 &KN&44Z[B_'34/K,%I-U1ME6.@#U<8AJM)CY*"068]I9\T7S
M:OSR:L[/EF58.[V#V3T8:?B1S.:PY'^%\<<[B$((93WGTY%'@$'/=WK',6,J
M(3H]VZO./4$OQ <;#_:L@9>8Z_/0!_N<I<R/QKRBVX33LSV5YY#I6V;R2O8%
M6/,#;()6Z,7'SQ1Y6&-EDM<ZB@@TA@U=2:MJ <1UG)[M=?9VL?3#%<:/V$_"
MB4S$J*SK]'X\ZM2_0;2JED5=T>G97H>-7H1(\[87W1P&(ZM-6<_IVU[()/U
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MQ2^;)"FD(56@3!;)"M392/0X-$^YO;7PGY8P>A0I)^RPIBB\&<TDI6NU*RO
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M>7^<]<FG*=TVXO]Q9K[X%_9RWC<<5IO-9'M)1*$GCR16=2_6Z2+X5R4, A8
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MML& M487?D]0*LZ,.6*W.P 8 -C) !B/>*66@U<EYO/TAH,!X%7G Q8M<*V
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MHC)37B2_T\M3-(>HY>71M5 M!344A@2@R2UH,C54'@^$1'W;*D 3U,=:>:Q
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MFDE::"9U20#$ES>E>I"T !@/& \87S7&Z_IROK2H.P @K+QIO<534S=]@#"
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MR>2OH2I*WVNM!*NL4CL'LM#"6!] %T 70!>/T%5YH=:BT%5]'&TX$ '- ,T
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M3(8)66R3PM^7I'^QJ25C6;C.@ODV-#(>W[="!R)+*M]HU,7_9.XE(C)H\X'
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MA%$HWC#Y5]N.TC1:P-C+[RR) M]E=L"=R_Q^&BU?LT'UYEP@O&C&WXOY23C
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MV"&PHY:B9W*?A7BVZR/KB6/I=")=08$Y-Y ,_FJN_,,F?[<J"@$; .JU+)X
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M!M.^F(KAV.U9_:X%_^Y-O;O&8I1EQ\W1&'>(E-CH[:^M6EH*?3 Q.D; ;@B
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M# ]>C) 2&B7)G+FZ[4O?,X8_^?(\!N>.WU+:+H618)23QZ^B&+>\PWX+4S_
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M9-*U>@/AN8/Q=NS#NYF$):9@TDV)HVVAA\&6F@]LSEK94[G2^Y;HU!\>;0]
MH"O!Q#?3;"53]:)")_LNK%DW]>T =_-T'EB*MF:J#]WOWAX&.[#M:,#_\'XU
M&X?>34.9';:[?'(.O97N4'=FV]42R$I15AV5[@?7>S+V7,LY8(Y^$)W#ZN:P
M369SR$CR4;F5?GJI2U0]IMC[5EMTW0LU&C[XI'SP=GFZC:YRCV&&:",VC/!I
M&>'!8PFZ WYP)-FZ4?3C(<V-?+O^F/=^N(<E=6\K(/57Y?G;>INE8T#2!BD?
MR\GNUA_D66AQ/XK"=@2NQ>HYQDLZ0I:E$I.]&Q:-9_&@7%N-9['Q+-Z_5?46
MNU+3Z6*6R.+?1<7(XJCQ0-K<_0 =[9Y9_\F'M)T=M$;CO1N;3[>_A])#LB&N
M9T!<T]; >D:T=;-/8C_=F[>N$N^89C?/]P>DX<V+/1Z:'K9ZH^[SH>E&7FX1
M^,?5-OG^R#(<=HZV1_D^Q%VM-_2.XFXW=O .+5R5Y$Z=P5XJ<_>5JN5_B/;N
M;IC'$[&%/1&\U6U9H\&A^/BW -,&BYX BP8MJ[MWN;%UD.[0\MB/3;''>1P
MTHU:W>'PZ)&NX5Q/*_\&XT-$H>>HR=[[1&>7496U2G#1D.+05-_Z.)4?P.2^
M<_C+<5GF6XGJJ>5GK?YH<JP6_$%$?#5$U1!5A:CV'\M[2!2URP.9O5'8$Y_2
M[(;B#NXT9I=B;3!ZSD1XE$3W0Q#9CTM4HY9E_6BZXG,TG&\RB0?;-8F+Y$X,
M?=S<4S:O#J9Z1AZHE3QX#"-^I->L2M98/LF-,BSW\DBZWGV0UE;XV/86_++?
ML@9[#^EX,+X=:P1'0ST_)O4,6[V)]<-2SX\>T[@%JMS9<>-A4ND>3S5W!X >
MB+SC(=J#L76/0V8=RGGJ[M!W..T<X-G]DXF<+1J5^E>U^OK#2IGNI;+JG4W0
M]6('U43AK[79>!M+G]ZXU T%.N]7]71C7?D[IA(R;7'3"?1?AYT^6_A!X$<A
M56+&@-V_M6XM;;JALBE?" 9C^A$-CT5+9&5Q/2:[Y@FVH%[PV ^,XNK40$!^
MAQ<5Q?$;(:PIB!(J( V3'>C)=G8/]X<AS,?:<-8#1Q@S**$N'O>NI6Z+6O"V
M:KKY'?8Z%0%@VDAO70EM-J),@01)@2<YZI0PID O^$(RC^*42JLSFX>7<&\9
M)7Y:[4#Q2+@?7.WF*AI^J TMV7+)YN-JI5&2<=49/)A<ZF)XMD$NELF8[\QH
M#:I9)Y:RW)==YQQJ?I%W1_"3)..R 00[>7>1M) !MY@?WF$YZ]7N#QG%=EP^
M_<6OI]B. UM4GC@.]J1'%#F+ NSM\-PI$3'U%%$Z7&'O(VO\)M%T!/!*4D!6
MV?6!4S,X(7'?I^898$ 0@E)#"-5J"U!<MM6 IW@!;2  ^.(2.RHJ!/XM]/&9
M"QPA,<GA)?5@ZK[YQ\G)&?VTWKR2%"6'EVTO5-?TNTV=#BVDD'+]Q $E)HOE
M3*JKP$%UZPIX@)K5+/BE8"B'%]3T#K_V1^;.Y+=E\Q//HZX;<^SHL02AAXM?
MX-IE5[XD$=B*)/#SYI$MW1FG9?1>U2W)UKK]4'_X?.*ZC27 E=KYT=?I \8
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M@"/TTV;K[".A'@$#1V4,"*-%1P #I;$8K9H9^!=4QT_D31[]@Y%)$(A!3D!
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M=?#].=(O8MMYR"S&;[$0/%)OZ&4S?!TMRT[RJHIU?Y)X#L?<-JH-J2/!V^G
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M2U AFQP7+.)7RAT?9?-)^-V=FF]Z:EW7N;Z$D^+(/?"^4CQ!<95U0->R.Y_
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M J(Q1DLE!C+XC42<$3[+0J=XV!E;:CQR$VPI^!56B)J&7_[EY(8PL%/8"6:
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M4D[F0W 1?(8Z^*T^IEY3WVJOH_\#4$L! A0#%     @ NT .5U\R,R'P"0
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M,#(S,#8S,%]L86(N>&UL4$L! A0#%     @ NT .5] ?DI0Z%@  8D(! !4
M             ( !KF$  &-M;6(M,C R,S V,S!?<')E+GAM;%!+ 0(4 Q0
M   ( +M #E?-.C]P,%L  )TJ"  0              "  1MX  !E>&AI8FET
M7SDY+3$N:'1M4$L! A0#%     @ NT .5S':6V&X0   15T" !
M     ( !>=,  &5X:&EB:71?.3DM,BYH=&U02P$"% ,4    " "[0 Y71K7!
M"HHG   E= ( $               @ %?% $ 97AH:6)I=%\Y.2TS+FAT;5!+
M 0(4 Q0    ( +M #E=LTSF"EPT  #IC   -              "  1<\ 0!Z
B:S(S,S Q-#DN:'1M4$L%!@     )  D 0 (  -E) 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
